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Abstract  
 
This study describes the development of a novel, REIMS-based characterisation and 
identification tool for unicellular organisms. A bipolar handheld sampling probe was 
optimised and characterised on several instrumental platforms before being applied to the 
acquisition of a large scale spectral database of bacteria and yeasts. Using this database, the 
specificity of the method was characterised using multivariate statistics and found to yield 
comparable identification results as MALDI-TOF-MS based techniques for a set of 28 
clinically relevant bacterial species. Further tests were performed on sub-species level such as 
ribotype in case of C. difficile, serotype in case of S. pneumoniae, antibiotic resistance in K. 
pneumoniae and strain-level differentiation for E. coli. The method could be further applied 
to yeasts and yielded excellent results for a set of five Candida species. 
To extend the range of the methodology to cell line cultures, the method was further tested 
for reproducibility and robustness initially using three cell lines. Subsequently, REIMS 
profiles were collected for the whole NCI60 cancer cell line panel and investigated for their 
spectral reproducibility, clustering behaviour with regards to tissue type of origin and 
comparison with spectra of corresponding bulk cancer tissue specimens. REIMS profiles 
were additionally correlated with publicly available gene and protein expression data in order 
to elucidate the sensitivity of this REIMS-based approach. 
Finally, taxon-specific bacterial biomarkers were derived from a dataset containing 228 
bacterial species by finding spectral features that show specificity for a certain phylogenetic 
group of bacteria. Using these markers, bacteria were detected in tissue sections of both 
cancerous and healthy colorectal tissue previously acquired using DESI-MSI. Findings were 
in good agreement with data obtained using 16S rRNA gene sequencing-based analysis and 
relevant literature. 
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Background and Objectives 
Background 
Mass spectrometry-based identification of microorganisms has been shown to be a universal 
tool and is in the process of revolutionising clinical microbiology. This is especially true for 
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF-
MS) which can be found in an increasing number of clinical microbiology laboratories 
around the planet. Although MALDI-TOF-MS significantly improves routine workflows by 
providing microbial identifications more quickly and at a lower cost per sample, it becomes 
increasingly apparent that the commercially available systems only provide a partial solution 
to the needs of clinical microbiologists. Knowledge of the identity of a pathogen causing 
disease facilitates adequate medical treatment, however, in routine clinical settings, more 
information exceeding the sole taxonomical identity of an organism is required. This is 
highlighted by the increasing prevalence of antibiotic resistance among bacterial pathogens 
which make alternative antibiotic treatments necessary than those that would be administered 
as standard choice of care. A quick decision on the most suitable antibiotic treatment can 
significantly shorten the duration of the infection and in some cases such as meningitidis or 
sepsis directly impact the chances of survival of a patient.  
Extensive research was performed using MALDI-TOF-MS to address this and other 
shortcomings in subspecies typing and led to solutions being developed for some of these 
problems such as the detection of β-lactamase activity to determine susceptibility to β-lactam 
antibiotics. However, these solutions are coming at the price of additional sample-preparation 
and culturing steps which do not currently fit into routine microbiological practice. Therefore 
many of the proposed solutions are unlikely to be implemented into routine clinical 
laboratories in the near future. In addition to limitations in subspecies typing, it is currently 
unlikely that MALDI-TOF-MS would find application directly to clinical samples without 
any sample preparation or culturing due to the strong background generated by the human 
proteome.  
Thus, there is still an unmet need for a microbial identification method that would lead to 
species-level information while ideally simultaneously providing the crucial information on 
microbial phenotypes required by physicians to choose the adequate antimicrobial treatment. 
It is also becoming increasingly apparent that ribosomal protein-profiling might not be able to 
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deliver the desired sensitivity and specificity. Likely alternatives are sequencing of specific 
gene targets supplementing 16S rRNA ribosomal gene sequencing, or the use of small-
molecular microbial cell constituents, the metabolome, which is more closely related to the 
phenotype of a given microorganism. Among those, cell membrane lipids have long been 
known to contain information that can be directly linked to microbial taxonomy.(1) This 
close connection is further highlighted by the specificity and longevity of fatty acid profiling. 
Fatty acid composition of bacterial cells however is strongly influenced by culturing 
conditions while the composition of intact phospholipids was shown to be more reproducible. 
Although it was often proven that species-specific lipid fingerprints were obtained for 
different types of bacteria, general applicability of this approach has so far not been 
demonstrated on a sufficiently large dataset. This is likely to be associated with intrinsic 
shortcomings of the lipidomic techniques applied such as excessive sample preparation, 
limited information content of mass spectra, limited reproducibility or limited sensitivity of 
the mass spectrometric technique applied. 
The recently developed ambient mass spectrometry technique rapid evaporative ionisation 
mass spectrometry (REIMS) was demonstrated to generate highly specific phospholipid 
profiles of different biological tissue types. Spectral profiles showed the required 
reproducibility and specificity to distinguish between histological and histopathological tissue 
types using a training set of 302 patients and test sets of 81 patients covering large biological 
variance.(2) Therefore, it is a promising methodology for the development of a lipid-based, 
sample-preparation-free microbial identification system. 
Objectives 
- Development of a REIMS-based method for the lipidomic characterisation of 
microorganisms including bacteria and fungi. This comprises development of a 
sampling probe for analysing microbial cultures directly from the agar plate and 
characterising this method for instrumental parameter dependence. 
- Build a large scale spectral database of mass spectra acquired from pure microbial 
cultures that contains the most common human pathogens. Approximately 5000 
database entries will be acquired from the 100 most common clinical isolates. 
Microbial cultures will include bacteria (aerobic, anaerobic, microaerophilic) and 
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yeasts. For this purpose, a collaboration has to be established allowing regular access 
to microbial isolates from clinical origin. 
- Assess the specificity of the method by characterising and identifying microorganisms 
from different phylogenetic levels using multivariate statistical methods. Specificity 
should be comparable to specificity obtained using commercially available MALDI-
TOF-MS systems (>95% on species-level). Smaller sample sets will be analysed to 
assess specificity on subspecies-level such as antibiotic resistance, serotype or 
ribotype. 
- Develop a workflow for the detection of bacteria directly in clinical specimens and in 
complex microbial mixtures. A taxon-specific biomarker approach is proposed, that 
consists of finding bacterial biomarkers that show specificity for a certain bacterial 
taxon such as genus, class, or phylum. Consequently these univariate biomarkers can 
be used to detect bacteria in complex matrices using REIMS or other compatible mass 
spectrometric techniques.  
- Adapt REIMS-based method to the characterisation of cell lines to generate shotgun 
lipidomic profiles of the NCI60 cancer cell line panel. Characterise spectral 
information by correlating REIMS spectral profiles to protein and gene expression 
data.  
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1. Introduction 
1.1. Microorganisms 
Although largely invisible to the naked eye, prokaryotes (single-celled organisms) are an 
essential component of the world as we know it. Their total number in our ecosystem was 
estimated to be 4-6·1030 cells of which 1.2·1029, 2.6·1029, 3.5·1030 and 0.2-2.5·1030 are 
located in the open ocean, in soil, and in oceanic and terrestrial subsurfaces, respectively.(3) 
Prokaryotes comprise the two kingdoms Archaea and Bacteria, however, microorganisms is a 
wider category which is used for microscopic living organisms and also includes algae, fungi, 
protozoa, and viruses.  
Microorganisms are ubiquitous and live in every part of the biosphere. They fulfil a range of 
essential tasks such as the decomposition of biomass for recycling nutrients within the 
ecosystem or the generation of atmospheric oxygen by algae as well as being a vital part of 
the nitrogen cycle. Bacteria and yeasts also play an important role in modern biotechnological 
applications such as food and beverage production (alcohol production, dairy products, etc.), 
biogas reactors, degradation of environmental pollutants, and the production of antibiotics, 
bioplastics, specific enzymes and commodity chemicals. A comparably small proportion of 
microorganisms are defined as pathogens and can cause acute and chronic illnesses to 
otherwise healthy higher ordered organisms. However, there is also increasing awareness of 
the vital role of microorganisms as symbionts and the resulting beneficial effects on the 
health of the same organisms including plants, insects, animals and humans. A paradigm 
change was the treatment of the microbiome as an entity in itself. This change was initiated 
by the discovery that a bacterium, Helicobacter pylori, was the causative agent of peptic ulcer 
disease, a disease which was previously thought to be stress-related. This led to significant 
improvements for correct diagnosis, prevention and treatment of the disease and was 
rewarded with a Nobel prize in physiology or medicine in 2005.(4-6) More and more 
research is conducted trying to elucidate host-microbial interactions and determine the 
contribution of the microbiome to health and disease development.  
In humans, microbial genes outnumber human genes by about 100-fold and the majority of 
symbiotic bacteria are located on mucosal surfaces, especially within the gut (termed gut 
microbiota).(7) The gut microbiome co-develops with the human host from birth. The initial 
set of microorganisms is transferred from mother to child via a so-called “seed ecology” 
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which the child takes up by swallowing the vaginal microbiota during natural birth. In case of 
caesarean sections this initial set of microorganisms was found to be similar to the maternal 
skin microbiota.(8,9) The subsequent composition of the gut microbiota is influenced by the 
host genome, diet and life-style, disease state and use of antibiotics.(10) The composition of 
the gut microbiome was associated with several chronic diseases such as obesity(11), type 2 
diabetes(12), inflammatory bowel disease(13), or cancer, especially in such organs that are 
continuously exposed to microorganisms such as the gastrointestinal tract.(14) 
Due to the increasing importance associated with both microbial pathogens and commensals, 
the development of fast and reliable identification systems for microorganisms is a rapidly 
developing field.(15) Although a number of concepts have been proposed, none have proven 
to be specific, universal, fast and at the same time cheap enough to find widespread 
application. Until today, in routine clinical microbiology settings, identification of an isolate 
is still mostly accomplished by observing phenotypic characteristics such as colonial 
morphology, Gram-stain behaviour, and different enzymatic properties or carbon source 
utilisation patterns. However, these techniques are time-consuming, need experienced 
personnel and often lack specificity. 
Bacterial species are defined by their 16S rRNA gene sequence, thus sequencing of the 16S 
rRNA encoding gene serves as the gold standard for bacterial identification and 
classification. The 16S rRNA is a part of the 30S small subunit in prokaryotic ribosomes and 
is approximately 1.5kbp in size. It is used for bacterial phylogeny due to its slow evolution 
rate which makes it a highly conserved region. It contains nine hypervariable regions which 
differ between bacterial species and are used to distinguish different taxa.(16) Although 
disputed, an often applied definition of a bacterial species is taken as organisms with at least 
97% homology in their 16S rRNA gene sequences.(17) Partial or full 16S rRNA gene 
sequencing has the advantage of being culture-independent and thus is especially valuable for 
fastidious microorganisms. However, the sensitivity and specificity for direct sample 
applications varies considerably.(18) Despite of its role as gold standard, in some cases 
bacterial species cannot be confidently identified by their 16S rRNA gene sequence which 
can still make the application of additional techniques such as sequencing of further gene 
targets necessary.(19,20) One such example are the Edwardsiella type strains which share 
99.35-99.81% of their 16S rRNA gene sequence while only showing 28-50% relatedness 
when the entire DNA is considered.(19) In addition, genotypic methods generally need 
extensive and careful sample preparation, they are comparably expensive and still need at 
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least several hours for identification. Due to these reasons, sequencing methods are rarely 
applied in routine clinical settings but mostly find application in reference laboratories.  
Although not a taxonomical classification, the Gram-stain of bacteria is a widely used 
classification system, especially in clinical microbiological practice. Using Gram-staining, 
bacteria can generally be subdivided into two groups, Gram-positive and Gram-negative 
staining bacteria. The Gram-staining behaviour is determined by the capabilities of the 
peptidoglycan layer of the bacterial cell wall to retain the crystal violet dye. Peptidoglycan is 
a polymer consisting of glycan strands cross-linked by short peptides that forms a mesh-like 
layer outside the cytoplasmic membrane of most bacteria which constitutes the cell wall. 
There is a high diversity in the composition and sequence of the peptides in the peptidoglycan 
observed for different bacterial species and its structure can significantly vary with growth 
conditions. The function of peptidoglycan is providing structural strength, as well as 
counteracting the osmotic pressure of the cytoplasm. Gram-positive bacteria have very thick 
cell walls that consist of up to 90% dry weight of peptidoglycan which effectively retains the 
purple crystal violet molecules. In comparison, the cell envelope of Gram-negative bacteria 
usually contains only about 10% of peptidoglycan and does not retain the Gram-stain 
molecules.(21) As Figure 1 shows, Gram-positive bacteria have only one membrane formed 
of a phospholipid bilayer which is then surrounded by a thick layer of peptidoglycan (30-100 
nanometers). Threading through the peptidoglycan structure are long anionic polymers called 
teichoic acids, which are composed largely of glycerol phosphate, glucosyl phosphate, or 
ribitol phosphate repeats. Wall teichoic acids are covalently attached to the peptidoglycan 
itself while lipoteichoic acids are anchored to the lipid head groups of the cytoplasmic 
membrane bilayer.(22) 
In contrast, Gram-negative bacteria are diderm containing an inner and outer cell membrane 
separated by a thin peptidoglycan layer (7-8 nanometers). The outer membrane has an 
asymmetric structure where lipopolysaccharides (LPS) make up the outer monolayer of most 
Gram-negative bacteria. LPS consist of a glucosamine disaccharide with six or seven acyl 
chains (lipid A), a polysaccharide core and an extended polysaccharide chain that is called 
the O-antigen. LPS triggers innate immune response in humans which can lead to life-
threatening endotoxic shock in bacterial septicemia.(23) Although not discussed here, both 
inner and outer bacterial membranes are hosting a variety of proteins that are embedded into 
the lipid matrix. Unlike eukaryotic cells, bacteria lack intracellular organelles, and 
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consequently, all of the membrane-associated functions found in eukaryotic organelles are 
thus performed on the inner membrane.  
 
Figure 1. Artistic impression of bacterial cell wall for Gram-positive (left) and Gram-negative (right) 
bacteria (omitting proteins). 
While the Gram-stain behaviour largely correlates with the main bacterial phyla (Gram-
positive Actinobacteria and Firmicutes, Gram-negative Proteobacteria, Cyanobacteria, 
Fusobacteria, Bacteroidetes), this is not universally true. In addition, some Gram-variable and 
Gram-indeterminate groups have to be differentiated. Gram-stains are of significant 
importance in clinical microbiology settings as Gram-positives generally are more susceptible 
to antibiotics due to the lack of the outer cell membrane. 
Bacteria are reliant on their cell envelope to protect them from unexpected and often hostile 
environmental conditions. The survival of bacteria depends especially on membrane lipid 
homeostasis and the ability to adjust lipid composition to acclimatise the bacterial cell to 
different environments. Although there is a considerable diversity of phospholipid structures 
in the bacterial world, most membrane phospholipids are glycerolipids that contain two acyl 
chains. These phospholipid acyl chains determine the fluidity of the membrane, which in turn 
influences many crucial membrane-associated functions, such as the passive permeability of 
hydrophobic molecules, active solute transport and protein–protein interactions.(24,25)  
The most commonly encountered glycerophospholipids are phosphatidic acids (PAs), 
phosphatidylethanolamines (PEs), phosphatidylglycerols (PGs), phosphatidylcholines (PCs), 
phosphatidylinositols (PIs) and phosphatidylserines (PSs), as displayed in Figure 2. They 
share a common phosphatidylglycerolphosphate backbone but differ in the chemical nature of 
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their respective headgroups. Two fatty acids are attached to the glycerol backbone in sn1- and 
sn2-position and usually are present in various chain lengths of between 14 and 20 carbons. 
The formation of cyclopropane rings by methylation of cis double bonds and branched 
methyl groups are commonly occurring modifications among bacterial lipids. Bacteria have 
evolved a number of different mechanisms to control the de-novo formation of fatty acids and 
modify the structure of existing fatty acids in order to adjust membrane fluidity to the 
environmental requirements. These membrane lipid alterations are of importance not only for 
environmental bacteria, but also for pathogens that must adapt to the host environment.(25) 
 
Figure 2. Most common glycerolphospholipid structures encountered in prokaryotic and eukaryotic cells. 
X symbolises headgroup, R1 and R2 fatty acyl chain in sn1- and sn2-position, respectively.  
1.2. Identification and characterisation of microorganisms using mass 
spectrometry 
1.2.1. 1970-1995 
Mass spectrometry (MS) gained attention for microbial identification more than four decades 
ago due to its intrinsic advantages of fast data acquisition, high sensitivity and high 
specificity.(26-28) In mass spectrometry, molecular compounds are transformed into gaseous 
ions which are subsequently separated according to their mass over charge ratio using 
electromagnetic fields. Different methodological approaches can differ in both the method 
used for ion generation (ionisation) and the method used for mass analysis (mass analyser). 
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Earlier studies reporting mass spectrometric signals generated from bacterial biomass for the 
purpose of bacterial identification were published in the first half of the 1970s and were using 
pyrolysis (thermal degradation of molecules in an inert atmosphere) followed by electron 
impact (EI) or chemical ionisation.(29,30) Meuzelaar and Kistemaker demonstrated in 1973 
striking differences in the mass spectra of three bacterial species by coupling Curie-Point 
pyrolysis at 510°C to EI ionisation and a quadrupole mass analyser. However, due to the high 
pyrolysis temperatures, only small molecular weight ions were observed that were tentatively 
assigned to fragments originating from proteins, carbohydrates, lipids, nucleic acids, and 
porphyrins. All analysed bacterial strains could be readily distinguished using these mass 
spectra, however, generally the same mass spectrometric signals were observed even for 
taxonomically distant species.  
Although the concept of bacterial fingerprinting was suggested in these early studies already, 
the widely accepted first milestone was set by Anhalt and Fenselau in 1975.(26) Using lower 
pyrolysis temperatures of 300-350°C, they reported the production of characteristic mass 
spectra from lyophilised pathogenic bacteria. Significantly larger molecules up to m/z 800 
were observed especially from Gram-negative bacteria. These spectra showed a significantly 
higher amount of complexity both in molecular weight of the ions observed as in variance of 
mass spectral appearance. The observed signals were assigned to fragments of phospholipids 
and ubiquinones. This was a key development for bacterial identification using mass 
spectrometry as it was demonstrated that biomolecules from different pathogenic bacteria 
allow taxonomic distinctions to be made based on the characteristic mass spectral 
“fingerprint” signatures for individual organisms.  
Another major methodological breakthrough that persists until this day was the introduction 
of fatty acid profiling of bacteria using gas-chromatography coupled to a flame ionisation 
detector (GC-FID).(31) In this methodology, volatile fatty acid methyl esters (FAMEs) are 
prepared from whole bacterial cells using hydrolysis by sodium hydroxide (saponification) 
and subsequent acid-catalysed methylation before chromatographic analysis is carried out on 
the organic extracts.(32) Although there is a limited variability among the fatty acid species a 
certain type of bacterium will produce, the relative fatty acid distribution can vary 
considerably in relation to culturing medium, temperature, atmosphere, culture age and 
growth phase. Hence, standard growth procedures have to be followed for successful and 
reliable identification results. This system was commercialised by Microbial Identification 
Inc. (MIDI, Newark, Delaware, USA) under the name of Sherlock Microbial ID System 
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(SherlockMIS) and records both retention time and quantitative information on fatty acids 
with 9-20 carbons in length. However, the overall process is rather time-consuming with the 
chromatographic separation alone taking 20-30 minutes. More rapid methods were reported 
that use pyrolysis to perform an in-situ thermal hydrolysis methylation (THM) during 
pyrolysis followed by EI mass spectrometry for detection of FAMEs to reduce the overall 
analysis time to less than 10 minutes. This system has been implemented into a field-portable 
mass spectrometer and was proposed for the detection of biological warfare agents.(33,34) 
Throughout the 1980s, emerging desorption ionisation techniques (plasma desorption, laser 
desorption, fast atom bombardment) were evaluated for the generation of molecular 
biomarker ions from microorganisms. Considerable success was achieved using fast atom 
bombardment mass spectrometry (FAB-MS) which allowed monitoring of larger 
biomolecules such as intact complex glycerophospholipid species desorbed directly from 
lysed bacterial cells.(35,36) Each three Gram-positive and Gram-negative bacteria were 
analysed and could be distinguished based on their phospholipid content. Mass spectral 
signals up to m/z 1400 were observed, however, signal intensity for these higher molecular 
weight species was comparably low. An advantage of intact phospholipid analysis as 
compared to fatty acid analysis is that phospholipid patterns are expected to be more 
conserved than the fatty acid composition alone. While bacteria are able to change their 
membrane lipid composition by altering their fatty acid components, the phospholipid 
headgroup and thus the actual type of lipid will stay the same.(25) 
1.2.2. 1996 onwards: soft ionisation techniques 
1.2.2.1. Matrix-assisted laser desorption ionisation mass spectrometry 
The end of the 1980s saw the introduction of two new major ionisation methods that soon 
became the most widely used ionisation techniques for mass spectrometric applications, 
matrix-assisted laser desorption ionisation (MALDI) and electrospray ionisation 
(ESI).(37,38) Both techniques soon enabled ionisation of very large molecules such as 
peptides, proteins and oligonucleotides.(39,40) The basic ionisation principles of the two 
techniques are depicted in Figure 3.  
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Figure 3. Schematic representation of ionisation processes occurring during A) Matrix-assisted laser 
desorption ionisation (MALDI) and B) Electrospray ionisation (ESI).  
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In MALDI MS, the sample is mixed with a thin layer of a matrix compound, most commonly 
small aromatic organic acids such as α-cyano-4-hydroxycinnamic acid (CHCA) or 2,5-
dihydroxybenzoic acid (DHB). During application of the matrix layer, molecular constituents 
from the sample surface are solvated and co-crystallise with the matrix molecules. 
Subsequently, the sample is irradiated with a pulsed laser (most commonly a UV laser such 
as nitrogen (N2) laser operating at 337nm). The matrix compound absorbs the laser energy 
which leads to ablation of matrix and analyte compounds from the sample surface. Protons 
are transferred from the matrix compound to the analyte which results in the formation of 
predominantly singly charged ions(41) which are subsequently separated according to their 
m/z ratio in the mass analyser. An alternative mode of ionisation for molecules which are 
residing as pre-exisiting ions within the matrix lattice (as is the case for many highly 
polarised compounds such as glycerophospholipids) is described by the lucky survivor 
model.(42) Upon laser irradiation and matrix evaporation, these pre-existing ions turn into 
gaseous ions which are subsequently pulled through a plume of gaseous matrix 
decomposition products by the extracting voltage. During this process, the majority of these 
ions are neutralised apart from a small proportion which are called the ‘lucky surviviors’ and 
subsequently undergo mass analysis. 
In electrospray ionisation (ESI), a solution of the sample in an electrically conductive solvent 
system is delivered through a capillary. When high electric potential is applied to the liquid 
sample, it leads to the formation of a Taylor-cone at the end of the capillary, which emits 
multiply charged fine droplets. The aerosol formation is often facilitated by an annular gas 
jet. Ionisation occurs either via the direct emission of ions from the surface of nanodroplets 
(‘ion evaporation model’) or the by the complete evaporation of the solvent leaving the 
charged residue behind (‘charged residue model’).(43) Based on chemical nature and size of 
the analyte molecules, singly and/or multiply charged ions can be generated. The electrospray 
plume is subsequently sampled by the mass spectrometer for mass analysis. While ionisation 
using MALDI is usually performed under vacuum conditions, electrospray ionisation is 
performed at atmospheric pressure while only mass analysis is performed under vacuum 
conditions. 
In the mid 1990s, a decade after their invention, both techniques found their first application 
on the field of bacterial identification.(44-50) MALDI analysis of bacterial samples soon 
gained momentum and became the most widely used technique for bacterial characterisation 
and identification. This can be explained by the rich spectral content, high sensitivity, small 
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required sample amounts, and short sample preparation and acquisition times.(51) The 
inherent disadvantage of the electrospray method is that it requires clear liquid samples, 
which makes extraction and filtration/centrifugation steps necessary for bacterial biomass to 
avoid clogging of the electrospray tip. In contrast, MALDI allows the direct analysis of 
bacterial smears that are distributed on a target plate and coated by MALDI matrix and thus 
does not require any sample extraction or lysis. In most of the cases, the organic solvents and 
acidic conditions of the MALDI matrix will lead to lysis of the bacterial cells in-situ.(51)  
In the context of bacterial characterisation, the vast majority of MALDI applications are 
based on the analysis of cellular proteins, predominantly protein profiling in the mass range 
of 2-20kDa. Proteins are the most abundant class of molecules in microorganisms, they are 
estimated to make up 60-70% of the dry weight in E. coli and bacilli, they ionise easily and 
therefore are readily observed using MALDI mass spectrometry. In addition, protein primary 
structure is directly determined by the DNA sequence which makes them more characteristic 
biomarkers on a genotypic level than lipids or metabolites which are strongly influenced by 
the phenotype of the organism. While in the next years there was continuing interest in using 
MALDI-MS for the characterisation and identification of microorganisms, little was known 
about the nature of the protein biomarkers in MALDI spectra of whole bacterial cells. 
Thousands of proteins are encoded by the genome, but only a small subset of these proteins 
actually are detected using MALDI-MS measurements. To understand why some proteins are 
detected and so many others are not, the molecular masses of proteins detected from E. coli 
K-12 were matched against masses predicted for proteins based on its genome. It was shown, 
that the biomarkers detected from whole cells by MALDI share the properties of high 
abundance, strong basicity, and medium hydrophobicity. In the case of E. coli, all the 
detected proteins originated from the cell interior, with about half of those coming from the 
ribosome.(52) In case of bacterial spores, comparably little mass spectrometric signals are 
detected, which are predominantly originating from the small acid-soluble protein 
family.(53,54)  
As is the case for lipids, the growth medium had a significant influence on the 
proteins/peptides detected.(47) However, a common subset of bacterial protein signals 
remained detected and led to correct identification results when an adapted identification 
algorithm developed at the Pacific Northwest National Laboratory (Richland, WA, USA) was 
used.(55,56) 
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The two main commercial MALDI-TOF platforms were developed for routine clinical 
identification of microbes, the Bruker BioTyper instruments (Bruker Daltonics, Bremen, 
Germany) and the VitekMS series originating from a strategic partnership between 
bioMerieux Inc. (Marcy-l'Étoile, France) and Shimadzu (Kyoto, Japan). The inherent speed 
of analysis, high sensitivity and specificity combined with the good agreement with 16S 
rRNA sequencing led to the widespread use of MALDI-MS for the identification of 
microorganisms, both in research and in clinical microbiology laboratories.(15) These 
commercial MALDI-TOF microbial identification systems are approved for clinical 
microbiology routine use in the European Union since 2009, as well as in many other 
countries around the world and most recently gained approval by the US Food and Drug 
Administration (FDA). 
 
Figure 4. Routine MALDI Biotyper workflow used in clinical microbiology laboratories for the 
identification of bacteria. 
36 
 
The Bruker Biotyper is arguably the most widely used mass spectrometric microbial ID 
platform in clinical microbiology laboratories worldwide(15) and does give a simple 
identification result to the microbiologist based on a score between 0-3. Four values are 
required for the calculation of the identification score: the ratio of matched peaks to the 
number of peaks in the unknown spectrum, the ratio of matched peaks to the number of peaks 
in the reference spectrum, a peak weight ranging from 0 to 100 indicating species specificity 
and the correlation factor of the matching peak intensities. A maximum of seventy of the 
most intensive peaks are taken into account in the standard identification method. The 
obtained score is then converted into a log score, where the highest score 1000 is represented 
by a log score of 3. According to the manufacturer’s recommendations, a log score <1.7 
indicates non-reliable identification, a log score between 1.7 to 2.0 indicates a reliable ID on 
genus-level, while a log score above 2.0 indicates species-level identification.(57) 
The general routine workflow proposed by Bruker Daltonics for the identification of 
microorganisms is displayed in Figure 4. The turn-around time for the displayed workflow 
can be as low as six minutes for a single isolate. However, due to the multiplexing of up to 96 
organisms on a single MALDI target plate, actual reporting times from receipt of the pre-
cultured plates are between 1-2hrs. 
The success of this technology is due to the fact that these commercialised systems were 
demonstrated to give comparable or even superior results to conventional biochemical 
identification systems such as Vitek or API® (bioMerieux) in a number of validation 
studies.(58-61) Combined with short reporting times, these systems are able to reduce the 
average turnover time in clinical microbiology laboratories by about one day (24hrs). In 
addition, analysis costs are a fraction of those of conventional techniques once the instrument 
is installed.(61,62) For the majority of bacterial cells, MALDI analysis can be directly 
performed on intact cells and is providing excellent identification results. However, short 
additional extraction steps significantly increase the identification accuracy, especially in 
case of yeasts and Gram-positive bacteria.(58,63) Misclassifications usually occur due to 
missing database entries, insufficient data quality, mixed cultures, or too close taxonomical 
relationships.(58-61) Spectral databases are continuously improved and the Bruker database 
now includes 4,613 reference entries (version 3.3.1.0). Custom database entries can be 
included into a local database and were often shown to further improve identification results 
for under-represented species.(64-66) 
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In the past, relatively little work was performed on viruses, due to their high molecular 
weight (>20kDa) and limited number of expected proteins for a given virus. In addition, there 
is no sample preparation protocol of similar simplicity as for bacteria since viruses require a 
cell substrate to be cultivated in vitro which requires separation of viral proteins from 
substrate proteins once the cells are lysed.(67) 
One major drawback of the routine MALDI-TOF-MS protocols involving bacterial protein 
profiling is that the method is not directly applicable to human samples as the extensive 
human protein background and low bacterial counts complicate bacterial detection. However, 
extensive research is performed to develop direct “on sample” applications and successful 
attempts were reported for samples such as positive blood culture bottles, urine, and cerebro-
spinal fluids. In healthy individuals, these are considered sterile samples and a large 
proportion of infections in such samples are caused by a single organism, which facilitates 
detection by MALDI-TOF-MS as the components of bacterial mixtures currently cannot be 
reliably identified. All these protocols involve a range of lysis and centrifugation steps to lyse 
the interfering human cells and separate and concentrate the bacterial cells for further 
analysis.(68-71) The largest impact on clinical practice can probably be obtained in case of 
sepsis, where earlier detection of the pathogen was shown to significantly improve survival 
rates.(72) Ferroni et al. developed a protocol that leads to possible identification of the 
pathogen in 30 minutes from the point when the blood culture flags positive if the workflow 
is considered in case of a single sample only (longer times required when analysis is 
multiplexed).(73) 
Although the introduction of MALDI-TOF-MS for bacterial identification made a huge 
impact on clinical microbiology routine, there are still areas where the approach of profiling 
bacterial protein patterns does not give the desired results as in case of bacterial mixtures, or 
sub-species typing such as serotyping or ribotyping. In some cases, tandem mass 
spectrometry (MS/MS) can be utilised to complement the direct MS analysis of intact 
proteins for the detection and identification of bacteria.(74-76) In case of the top-down 
proteomics approach the intact biomarker protein is fragmented to provide sequence-specific 
fragment ions. In a following homology search, the MS/MS spectrum is compared to spectra 
generated in silico from all the proteins sequences stored in a database whose masses match 
the observed m/z value. This way the unknown microorganism is identified based on the 
identification of an individual biomarker. Using this approach, the individual components of 
a mixture of two Bacillus spores could be successfully identified.(77) This example also 
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exemplifies that tandem MS may be particularly advantageous when only a few protein 
biomarkers are present in a regular mass spectrum by providing further specificity. However, 
as MALDI ionisation leads to predominantly singly charged ions, obtained fragmentation 
spectra generally lead to comparatively low protein sequence coverage due to lower 
fragmentation efficiency. 
In case of a bottom-up proteomics approach, proteins fractionated from lysed cells are 
cleaved to peptides which are fragmented and analysed in a MS/MS experiment. Identified 
peptides provide identification of proteins and, in turn, proteins provide identification of the 
microorganism. This bottom-up approach requires residue-specific cleavage of biomarker 
proteins as an extra step carried out enzymatically or chemically in-situ. This strategy 
provides another practical solution to the challenges of mixtures of microorganisms, but 
works best in such samples exhibiting relatively low spectral complexity. Since this approach 
requires lengthy sample preparation, top-down proteomics is favoured in most of the cases. In 
addition, the probability of false matching of a potential microorganism is generally lower in 
case of a top-down approach.(75) In both cases, identification relies on the detection and 
identification of unique, strain-specific biomarker ions versus peaks that can be observed in 
all bacteria of a species or genus.(74) Using a bottom-up methodology, differentiation of 
Lactobacillus subspecies was successfully demonstrated with an approach termed shotgun 
mass mapping (SMM) by performing a tryptic digest of isolates and subsequently comparing 
the spectra to a home-built reference library.(78) 
1.2.2.2. Electrospray Ionisation Mass Spectrometry 
The most important application in the field of clinical microbiology using electrospray 
ionisation mass spectrometry is arguably rapid ESI-MS analysis of polymerase chain reaction 
(PCR) products. This is in sharp contrast with the typical several hour time-scale of a gel 
electrophoresis experiment. DNA sequence constitutes the most unique biomarker for each 
kind of organism, but DNA copy numbers per cell are low (typically one copy per cell) 
without amplification which complicates its detection. In 1996, Wunschel et al. were the first 
to report the ionisation and detection of a double stranded PCR product by ESI-MS.(48) The 
mass measurements using ESI-FTICR-MS matched the theoretical masses and were 
consistent with results obtained by gel electrophoresis. Based on this methodology, the 
TIGER approach was developed. TIGER stands for “triangulation identification for the 
genetic evaluation of risks” and combines nucleic acid amplification with high-resolution 
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ESI-MS detection.(79,80) The essential aspect of this approach is the use of PCR primers 
targeting broadly conserved regions of microbial genomes that flank variable regions, namely 
ribosomal and housekeeping protein genes. The PCR products are in the size range of 80‒140 
base pairs and can be measured using high resolution FTICR- or TOF-MS in a high-
throughput mode. The mass accuracy must be better than 20 ppm to confirm the correct base 
composition. The microorganisms are identified by comparison of the derived base 
composition with available genome sequences in databases. To enhance confidence, several 
genomic regions are analysed to identify the organism. The general workflow comprises 
extraction of the microbial DNA, broad-range PCR amplification, ESI-MS of the amplicons 
and computerised triangulation.(81) Besides bacteria, the approach is equally well suited to 
the identification and quantification of viruses, fungi, and protozoa directly from clinical 
samples.(15,79) This system was developed as Ibis T5000 by Ibis Biosciences Inc., and was 
succeeded by the PlexID system (Abbott Molecular Inc., IL, USA). However, due to high 
costs, large space requirements and the limited acceptance by the microbiology community, 
this system eventually got discontinued in September 2012.(15) Based on the same principle, 
Abbott recently launched the IRIDICA platform for the detection of >750 bacterial and 
Candida species, more than 200 species of fungi, and >130 viruses in less than 6hrs from 
receipt of the clinical sample according to the manufacturer. The process includes automated 
DNA extraction, PCR set-up, amplification and amplicon purification followed by ESI-TOF-
MS for amplicon identification. Its universality, especially for fastidious organisms, is a huge 
advantage compared to other diagnostic approaches, however, the instrumentation and cost 
per sample are comparably expensive and the instrument has very high space requirements.  
1.2.3. 2004 onwards: Ambient mass spectrometry techniques 
Ambient mass spectrometry is defined as mass spectrometric analysis performed without 
active sampling or sample preparation, while the object of interest is not removed from its 
ambient environment. The first ambient ionisation method was desorption electrospray 
ionisation mass spectrometry (DESI-MS) introduced in 2004.(82,83) Definition of ambient 
mass spectrometry implicates that samples of arbitrary shape can be analysed in their native 
state without introduction into the mass spectrometer vacuum system. In case of 
microbiological applications this means that bacteria can be analysed directly from the Petri-
dish. Many ambient ionisation methods furthermore are minimally invasive and hence 
particularly well suited for in-vivo studies. Due to its versatility and electrospray-like 
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ionisation characteristics, DESI still today is the most commonly used of these techniques, 
however, other techniques that are commonly used include Direct Analysis in Real-Time 
(DART)(84), Low-Temperature Plasma Ionisation (LTP)(85), Easy-Sonic Spray Ionisation 
(EASI)(86) and Laser Ablation Electrospray Ionisation (LAESI)(87). 
Until 2009 alone, more than 30 individual ambient ionisation methods have been 
published(88) and many of those were used for bacterial characterisation,(89) resulting in an 
ever increasing number of studies involving a wide range of emerging ionisation techniques 
that indicate the breadth of possible applications of these methods in microbiology. These 
applications include the analysis of bacterial metabolites and phospholipids in-vivo and 
directly from the Petri-dish using DESI(90) and liquid microjunction-electrospray 
setups.(91). Nanospray desorption electrospray ionisation (nano-DESI) is a surface liquid 
microjunction-electrospray approach, which was successfully applied to monitor intact 
molecular species at single colony-level and was further used in numerous studies 
demonstrating the power of networking algorithms for high-throughput identification and 
characterisation of molecules secreted into the surrounding medium by bacterial colonies. In 
addition, it is suited for the two-dimensional mapping of bacterial metabolites directly from 
the Petri dish as demonstrated in case of the spatially resolved detection of glycolipids and 
bacterial metabolites directly from living colonies and the study of interactions between 
neighbouring colonies and in mixed-species biofilms.(92-94) Methodologically similar to 
other liquid junction technologies, however, strictly speaking not an ambient ionisation 
method, ‘contact’ liquid extraction surface analysis (LESA) followed by nanospray ionisation 
(NSI) was used to identify bacterial proteins from Escherichia coli colonies directly off the 
Petri-dish using top-down proteomics.(95) This technique might allow monitoring of protein 
changes in response to environmental stimulants in real-time. Electrospray techniques are 
generally better suited for top-down proteomics compared to MALDI due to the multiple 
charge states of proteins leading to more information rich protein fragmentation spectra. 
Parsiegla et al. were using LAESI-MS to detect phycobilisomal antenna proteins in small 
cyanobacterial populations and were able to determine the ratio of phycocyanin and 
allophycocyanin in the antenna complex, the subunit composition of the phycobiliproteins, 
and the tentative identity of over 30 metabolites and lipids.(96) 
Direct analysis in real-time (DART) is the most commonly used plasma-based ambient 
ionisation technique and was used for direct profiling of fatty acid methyl esters (FAMEs) 
from whole bacterial cells, thus enabling fast FAMEs profiling without the need for 
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chromatographic separation.(97) The methodology is expected to give lower specificity than 
a chromatography-based approach; however, this might be circumvented using ion mobility 
to separate isobaric fatty acids. DART-MS was also applied to monitor production of 
prenylated indole alkaloids in the hyphae of Malbranchea graminicola fungus grown on agar 
plates which led to the detection of two novel chlorinated metabolites.(98) 
Most ambient mass spectrometric methods strongly favour the detection of low molecular 
weight species with m/z ratios of less than 2000 and thus are not well suited for the detection 
of proteins. However, a growing interest in lipidomics, and the advent of ambient ionisation 
techniques as an easy means to generate lipid profiles gave new momentum to lipid profile-
based identification of microorganisms. Many different ionisation techniques, including fast 
atom bombardment (FAB)(35), electrospray ionisation (ESI)(44,49,99), MALDI(100,101), 
desorption electrospray ionisation (DESI)(102,103) and paper spray(104) have been used 
among many others to demonstrate that different bacteria have species-specific phospholipid 
profiles. However, none of these methods have been shown to possess the specificity and 
robustness required to serve as the basis for a general lipid-based identification system.(89)  
1.2.3.1. Desorption Electrospray Ionisation Mass Spectrometry 
Desorption Electrospray Ionisation (DESI) was first described in 2004 and proved a landmark 
in mass spectrometry as the first ambient ionisation technique.(82,83) In DESI, a 
pneumatically-assisted electrospray is directed onto the sample from a short distance. Due to 
the impact of the primary electrospray droplets, a liquid film forms on the surface of the 
sample and dissolves the analyte molecules from the sample surface. Upon the impact of 
further primary droplets into this liquid film, secondary droplets get ejected and aspirated by 
an extended inlet capillary. This process is schematically depicted in Figure 5.  
Since 2004, DESI MS is commercialised by Prosolia Inc. (Indianapolis, IN, US) and found 
various applications as for the detection of explosives,(105,106) characterisation of 
pharmaceuticals,(107) screening of biological fluids for drugs and illicit drugs,(108,109) 
direct analysis of microorganisms(90,103,110) or hyphenation to solid phase 
extraction(111,112) and solid-phase microextraction techniques.(109,113) However, the most 
prominent application of DESI-MS is arguably metabolic tissue imaging where (after 
MALDI-MSI and SIMS-MSI) it constitutes the third most often used imaging 
technique.(114-118) Unlike other tissue imaging methods such as staining procedures (as 
haematoxylin and eosin staining, immunohistochemical stains or fluorescent microscopy), 
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mass spectrometry imaging (MSI) has the major advantage of being able to detect thousands 
of different molecular constituents in a single experiment in a spatially resolved fashion. It is 
an especially valuable tool when combined with high-resolution mass analysers which 
significantly increase the specificity of the methodology by resolving nominally isobaric 
compounds. Thousands of compounds present in a sample can hence be analysed and 
visualised without a priori knowledge.  
 
Figure 5. Schematic representation of Desorption Electrospray Ionisation. 
Since none of the MSI techniques include chromatographic separation, detection of certain 
analytes of interest is often impeded by ion suppression. Due to the histological variance of 
suppression effects, the MSI signal intensity distribution does not necessarily follow the 
actual concentration-distribution of the analyte. Due to this fact, mass spectrometric imaging 
experiments are at best semi-quantitative. For this reason, many mass spectrometry imaging 
studies rely on multivariate statistical pattern recognition algorithms to distinguish between 
tissue types rather than relying on the different distributions of univariate markers.(119-122) 
DESI imaging studies were performed for various tissue types as normal breast tissue and 
breast cancer,(120,123) lymph node metastasis,(124) colorectal cancer,(119) or drug and drug 
metabolite distribution studies.(117,125,126) 
Unlike other commonly applied techniques for tissue imaging such as MALDI or SIMS-MSI, 
DESI can be used without matrix-application and transfer of the samples into vacuum. 
However, ambient analysis in turn requires the samples to be stable at room temperature. 
Spectral resolution, although initially restricted to 200µm and still much lower than those 
reported for MALDI and SIMS-MSI, by now is comparable to commercially available 
standard MALDI sources (50-100µm). The smallest feature detected on rat brain using DESI 
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was determined to be 35µm(127) and further improvements in spatial resolution are to be 
expected by further decreasing solvent flow rates and nebulising gas pressures and optimising 
sprayer geometry, however, ultimately spatial resolution is limited by Coulombic repulsion of 
the charged primary droplets. 
1.2.3.2. Rapid Evaporative Ionisation Mass Spectrometry 
Rapid evaporative ionisation mass spectrometry (REIMS) was first reported in 2009 with the 
main rationale of intra-surgical tissue identification.(128) It allows near real-time 
characterisation of human tissue in-vivo by analysis of the aerosol (‘surgical smoke’) released 
during an electrosurgical dissection. Although ambient mass spectrometric techniques in 
general allow the analysis of samples in their native state and environment, none has been 
found applicable for in-vivo applications directly on patients yet. REIMS is efficiently closing 
this gap using electrosurgical instruments as ion sources. This coupling and its application for 
intra-surgical tissue identification is known as the intelligent knife (iKnife). 
Two major groups of electrosurgical tools are used in clinical practice which follow a 
monopolar or bipolar principle as depicted in Figure 6. In case of monopolar electrosurgical 
tools, dissection is made using a sharp handheld electrode while the sample (or patient) is 
lying on a large surface counter electrode (see Figure 6A). This setup is employed in most 
open surgeries where the electrosurgical knife is used to dissect tissues and to cauterise blood 
vessels. In case of bipolar electrosurgery, both electrodes are handheld following a forceps-
like configuration (Figure 6B and C). This setup allows more accurate and less invasive 
operation and is predominantly used for surgical interventions on the brain. 
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Figure 6. Schematic representation of REIMS instrumentation and data collection. A) monopolar and b) 
bipolar surgical ion source and ion transfer setups for REIMS experiments. C) Aerosol aspiration using 
commercially available bipolar forceps. From Ref. (2). Reprinted with permission from AAAS. 
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Both setups are using radiofrequency alternating current to evaporate tissue material by Joule 
heating, which produces an aerosol containing tissue decomposition products. In clinical 
practice until today, this aerosol is largely regarded as potentially hazardous by-product of 
electrosurgical interventions. However, REIMS might induce a paradigm shift by using this 
formerly disregarded aerosol to derive histological tissue identification and asses tumour 
margins during surgical interventions.(129) This is accomplished by introducing the surgical 
aerosol into a mass spectrometer for analysis to obtain a tissue fingerprint that can then be 
compared to a database of REIMS spectra of different tissue types for identification.(130) 
This process can be completed in less than 0.5-2.5 seconds and thus offers an attractive 
alternative to intra-operative tissue histology commonly used during cancer resections. Intra-
surgical frozen section histology requires a minimum of 20-45 minutes in which the 
operation has to be paused while in parallel a large strain is posed on histopathology 
departments to process the specimens and determine whether the tumour was completely 
resected.(2,129) REIMS-based tissue identification has recently been demonstrated to give at 
least equivalent tissue identification accuracy as compared to frozen section histology on a 
set of 81 intra-operative interventions. In addition to intra-operative tissue ID, REIMS 
spectral profiles were shown to vary between distinct histological tumour types and also 
between primary and metastatic tumours.(2)  
 
Figure 7. Schematic representation of desorption mechanism in REIMS for the example of Gram-
negative bacterial cells. 
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No mechanistic studies on the REIMS mechanism have been published so far, however, the 
tentative rapid evaporative ionisation mechanism can be considered as heat-induced 
disruption of cells as depicted in Figure 7 for the cell wall of a Gram-negative bacterium. 
Upon exposure to the radiofrequency (RF) alternating current, the aqueous part inside any 
biological cellular material expands due to the high temperature. Water will evaporate and the 
cells will expand until they burst and lipid covered aqueous droplets are formed. The lipids 
originating from the cell membranes will form droplets due to their amphiphilic character. 
These droplets (molecular clusters) are aspirated by the mass spectrometer and subsequently 
undergo surface collisions inside the ion optics of the instrument where they form molecular 
ions. Due to the nature of the ionisation mechanism, ionisation of molecules is preferred if 
they are either charged prior to ionisation or highly polarised.  
The REIMS method shows high methodological resemblance to pyrolysis approaches, 
however, unlike pyrolysis systems, REIMS is working under ambient pressure and provides 
soft ionisation yielding predominantly molecular ions. The observed soft ionisation is 
tentatively associated with collisional cooling of the produced ions occurring under 
atmospheric conditions. 
1.3. Statistical methods for analysis of mass spectrometric profiling data 
1.3.1. Biomarker discovery using univariate statistical methods 
Biomarker discovery is usually performed using univariate tests in which m/z values in each 
sample are compared against each other in a one-by-one fashion. For a two class system that 
can be performed using traditional t-test, however, for multi-class systems, analysis of 
variance (ANOVA) is better suited. The result of a one-way ANOVA analysis is a p-value for 
each m/z feature and gives a measure of the probability of the observed difference being 
created by chance. A p-value of 0.05 refers to a false positive rate of 5% which is generally 
considered as significant.(131) However, even if there is a significant difference detected 
between the group means, there might be still be a considerable overlap between the 
individual data points which determines the diagnostic value of a biomarker. For this 
purpose, box-plots are supplied together with ANOVA results throughout this work to assess 
group overlap.  
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While ANOVA determines whether there is a significant difference between at least two of 
the different group means, it does not provide information about which group is significantly 
different. Thus, a post-hoc test such as the Tukey’s honest significant difference test (Tukey’s 
HSD test) is necessary in order to assign the observed difference to a certain group.  
1.3.2. Multivariate statistical methods 
Multivariate statistical analysis methods on the other hand are more suitable if groups are to 
be distinguished using correlated changes in relative abundance of several m/z features 
simultaneously. They are tools to identify correlations in high dimensionality datasets and 
reduce their complexity by identifying those features of discriminatory power. Multivariate 
statistical methods taking the relative distributions of several features simultaneously into 
account allow for finding similarity and differences in a dataset which cannot be captured by 
collection of individual biomarkers, but only by a combination of the distribution of a 
multitude of markers. This is particularly of use when analysing closely related biological 
specimens such as different bacterial subspecies, or different human cancer cell lines. In such 
cases, most metabolic (gene expression, protein expression, metabolite expression) 
constituents are expected to be present in most samples of the dataset in question, thus 
finding a single univariate biomarker to unambiguously identify every sample group is in 
many cases unlikely. Balog et al. found that for REIMS spectra of mammalian tissues, each 
m/z feature investigated was shared by >80% of individual samples analysed.(130) 
1.3.2.1. Principal component analysis 
Unsupervised statistical methods are used in order to identify the largest variance in a given 
dataset without introducing bias. Principal component analysis (PCA) is a dimensionality 
reduction technique aiming to reduce the number of variables (in case of mass spectrometry 
profiling data these equate to m/z features) while keeping the loss of information to a 
minimum by grouping variables with high covariance. A linear orthogonal transformation is 
performed in order to maximise variance. This results in orthogonal principal components 
(PCs) describing the variance observed in the dataset. The first principal component (PC1) 
describes the largest observed variance, while PC2 describes the next largest, PC3 the next 
largest and so forth.(131) The number of principal components to be visualised is either 
chosen by the user or determined by the amount of variance to be retained (for instance >95% 
of variance). Data after PCA is usually presented in the form of score plots (commonly 
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displayed as scatter plots), spectral loading plots and percentage of explained variance for a 
given component. The latter is of particular importance as it forms a measure for how much a 
given PC contributes to explaining the overall variance in the data. The loading plot contains 
the contribution to the overall explained variance as a function of m/z value for a given 
principal component. Contribution can be both positive and negative. However, the largest 
variance in the data is not necessarily related to differences between the individual sample 
cohorts in the data, but can also originate from other, biologically non-relevant factors such 
as systematic spectral variation introduced by sample preparation. In case of analysis of 
microorganisms, such factors can originate from different culturing conditions such as liquid 
versus solid culturing medium, culture age, culturing atmospheres, different culturing media 
or even different batches of culturing medium. Thus, using PCA is an excellent way to 
inspect the data for the presence of such factors that might introduce a bias into the dataset. 
Due to the applicability of PCA as a dimensionality reduction strategy, it is often applied as a 
data pre-processing method before the use of further downstream data analysis algorithms, 
such as supervised multivariate methods. By retaining only the components explaining the 
largest variance in the data, the assumption is that contribution to the variance by spectral 
noise is removed due to its uncorrelated nature. 
PCA has been applied to a variety of mass spectral profiling techniques and is commonly 
used for metabolomics approaches.(132) Most profiling studies cited in this work will contain 
data analysis using PCA, both for profiling of bacteria and other tissues using REIMS, DESI 
and MALDI(102,110,128,130,133,134) as well as for imaging mass spectrometry data 
sets(131) as it implies to the reader how suitable a certain methodology is for a given 
purpose. The larger the proportion of variance in the produced data is generated by the 
biological phenomenon in question, the better the presented methodology is suited for 
assessing this biological phenomenon. 
Data visualisation of multivariate datasets can be challenging. Principal component analysis 
is particularly well suited to analyse sample sets of high complexity containing several 
hundreds of data points using two- and three-dimensional scatter plots allowing simultaneous 
visualisation of two and three principal components, respectively. However, although 
principal components do not have to be consecutive components, no more than three 
components can be displayed at one time thus limiting the extend of the variability that can 
be visualised at a time. 
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1.3.2.2. Hierarchical cluster analysis 
Clustering methods such as hierarchical cluster analysis (HCA) are commonly used to assess 
the similarity of profiles produced. It is a common tool for displaying phylogenetic 
relationships in unicellular organisms based on their DNA(135) or 16S rRNA gene 
sequences(136), protein(137) or gene expression profiles(138), or metabolic 
profiles.(134,139) Similarity is displayed in a multi-level tree-like structure, a so-called 
dendrogram, where more similar profiles (samples/strains) are located on the same branch of 
the tree. Larger and smaller variation is explained by the different branching levels where 
clusters on one level are joined as clusters on the next level. To produce these dendrograms it 
requires the choice of a similarity measure and a ‘linkage’ calculation method. While the 
former determines the similarity between every pair of objects (here mass spectral profiles) in 
the data set, the latter determines how lower-level clusters are located on higher-order 
clusters by determining the proximity of objects to each other and grouping the closest pairs 
into binary clusters until all the data points are linked together in a hierarchical tree. The most 
common similarity measure is the determination of the Euclidean distance between the data 
objects. In a final step the data is partitioned by determining the number of clustering levels 
either by detecting natural groupings in the hierarchical tree or by arbitrary user-defined 
selection. 
Hierarchical cluster analysis is often performed after data normalisation and data reduction 
techniques in order to reduce the biologically non-relevant information such as spectral 
noise.(131) Several branching levels in a single diagram allow for better visualisation of 
multi-dimensionality in the data than three components might allow in PCA which makes 
HCA dendrograms an intuitive way to visualise similarity between data points. However, it is 
best suited for comparatively small numbers of individual data points as visualisation of 
dozens to hundreds of data points quickly gets challenging and removes the intuitive nature 
by overcrowding the dendrogram. 
1.3.2.3. Discriminant analysis 
Supervised statistical methods such as discriminant analysis (DA) take the user-defined group 
membership of the individual data points into account. Unlike unsupervised PCA,  DA will 
not search for the largest variance in the data in general, but it will instead search for the 
largest variance in the data explaining the group membership of the data points (thus it is 
called supervised). Linear discriminant analysis (LDA) attempts to find those linear 
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combinations of m/z features that discriminate between the different given groups (this can be 
two or more) by maximising the inter-class difference while simultaneously minimising intra-
class variability.(140) The loadings function will give information on those m/z features that 
contribute the most (both positively and negatively) to discriminating between the different 
groups. It is often used in combination with prior performed PCA thus only subjecting a 
certain number of principal components to LDA. However, this combination is based on the 
assumption that the variance between the different groups is also one of the main contributors 
to the overall variance in the data. The number of linear discriminant functions calculated is 
usually determined as the number of groups minus one. Thus, one linear discriminant 
function is used to distinguish between two groups, two discriminant functions are used to 
distinguish between three groups and so on. A discriminant model determined in this manner 
can then be used to classify new samples. For this purpose, often a training set and a test set 
are composed. The usually smaller training set is comprised of different samples from a given 
group system (for instance different species of bacteria or different human tissue types) from 
which a discriminant model is built and then used to classify unrelated samples into those 
groups it is built to distinguish. The quality of the model is then determined by the number of 
correct classifications of unknown samples. In such cases where there are not enough data 
points available per group to built independent training and test sets, often cross-validation 
methods are used instead. In leave-one-out cross-validation, each data point is left out of the 
model building process at a time and subsequently projected into the resulting model and 
classified. This can be performed sequentially for all data points or a subset of randomly 
selected data points only (for instance 10% of the overall data points). Model quality and 
robustness again is quantified based on the number of accurate classifications.  
A PCA-LDA combination has been previously used for most REIMS studies on mammalian 
tissue specimen. The 300-dimensional mass spectral data (m/z 600-900 at 1Da bin size) was 
subjected to PCA in order to reduce the data to the first 60 principal components. This data 
was then subjected to LDA for tissue classification experiments.(2,130) In one such study by 
Balog et al., 97% tissue identification accuracy was achieved using separate training and test 
sets. Although the method was proven sensitive to systematic data variation such as caused 
by age or different diets in rats, tissue identification capabilities were not impaired.(130) 
Maximum margin criterion (MMC) is another supervised multivariate algorithm that was 
initially developed for face analysis.(141) Unlike in LDA, its feature-extracting capacity does 
not depend on the nonsingularity of the within-class scatter matrix which is especially 
51 
 
advantageous in case of small sample sets. This methodology was adapted to a Recursive 
Maximum margin criterion (RMMC) by Veselkov et al. and shown to be applicable to 
lipidomics-based mass spectrometry imaging data.(122) Class-specific m/z signatures are 
derived based on weighted combinations of m/z feature patterns. Simultaneously, as in LDA, 
the ratio of inter-class to intra-class variability is maximised. However, while LDA 
maximises the distance between the individual group means, in RMMC the margin between 
individual groups is increased by maximising the distance between their most outer data 
points thus improving group separation.(122) The RMMC approach avoids selection of an 
optimal number of PCA-derived components before applying LDA and is therefore avoiding 
model over- or under-fitting. RMMC is used in this thesis alongside PCA-LDA as main 
supervised data analysis strategies. 
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2. Materials and Methods 
2.1. REIMS analysis of microorganisms 
2.1.1. Culturing of microorganisms 
All culturing of microorganisms was performed at the Department of Microbiology, Imperial 
College Healthcare NHS Trust, Charing Cross Hospital (London, UK). Clinical isolates were 
routinely collected from clinical microbiology work by trained NHS staff. Most of the 
microorganisms analysed during this study were previously isolated from blood cultures, 
identified using a Bruker Biotyper instrument, and stored on beads and in glycerol broth in a -
80°C freezer. For REIMS analysis, microorganisms were grown either form fresh cultures or 
from beads on a range of solid agar-based media commonly used in clinical microbiology 
settings. Media were purchased from Oxoid (Basingstoke, UK) or E&O Laboratories Ltd. 
(Bonnybridge, UK). The bacteria were incubated under appropriate atmospheric conditions at 
37°C before analysis. Atmospheric conditions included aerobic (plates stored in a hot room), 
anaerobic (plates stored in incubator), microaerophilic (plates stored in a jar containing 
microaerophilic conditions inside hot room), and aerobic conditions containing 5% CO2 
(plates stored in a humidified incubator). Microaerophilic conditions (5-10% oxygen, 8-10% 
CO2) were generated using a Whitley Jar Gassing System (Don Whitley Scientific Ltd., 
Shipley, UK).  
2.1.2. Rapid evaporative ionisation mass spectrometry 
The day before REIMS analysis was scheduled to take place, the instrument intended to be 
used was vented to perform a standard maintenance procedure aimed at cleaning possible 
sources of contamination inside the atmospheric pressure interface. In case of Thermo Fisher 
Scientific instruments (Orbitrap Discovery, LTQ XL and Exactive instrument) the 
atmospheric pressure interface housing was removed and inlet capillary, tube lens and 
skimmer were subjected to cleaning by immersion in a series of organic solvents starting with 
methanol/water (1:1 v/v), acetonitrile, acetone, dichloromethane and finally methanol in an 
ultrasonic bath for 5 minutes. In case of Waters instruments (Synapt G2, Xevo G2-S, Xevo 
G2-XS), the custom-made atmospheric pressure interfaces were removed and the collision 
53 
 
surface was wiped off using a cotton swab wetted with methanol. The inlet capillary was 
flushed using methanol and acetone. In addition, the Stepwave ion guide was removed and 
cleaned by immersion in methanol/water (3:1 v/v) for 5 minutes in an ultrasonic bath. 
Subsequently, the instruments were reassembled and pumped down. Orbitrap-based 
instruments were additionally baked out for 12hrs overnight. Each instrument was calibrated 
according to the manufacturer’s instructions before use utilising a home-built 
nanoelectrospray ionisation source. 
For REIMS analysis, two handheld electrodes in form of a forceps (termed bipolar forceps) 
were used as the sampling probe (Erbe Elektromedizin GmbH, Tübingen, Germany). A 
Valleylab Force EZc electrosurgical unit (Covidien, Dublin, Ireland) was used at 60W power 
setting in bipolar mode as RF alternating current power supply (470kHz, sinusoid alternating 
current). An approximately 1.5m long 1/8in. outer diameter, 1/16in. inner diameter PTFE 
tubing (Fluidflon PTFE tubing; LIQUID-scan GmbH Co. KG, Überlingen, Germany) was 
applied to connect the embedded fluid line of the bipolar forceps and the inlet capillary of the 
mass spectrometer. In each case the inherent vacuum system of the mass spectrometer was 
used for aspiration of the aerosol. This setup is shown in Figure 8 while instrumental settings 
are given in Table 1.  
 
Figure 8. Schematic representation of experimental REIMS setup using bipolar tool as applied for all 
instrumental platforms used in this study. Reprinted with permission from Ref. (142). Copyright 2014 
American Chemical Society. 
Mass spectrometric analysis of the microorganisms was performed directly from the solid 
culture medium (Figure 8). 0.1-1.5mg of microbial biomass was scraped off the agar surface 
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using one of the electrodes of the bipolar forceps. The two electrodes were subsequently 
brought into close proximity (i.e. by pinching the biomass between the tips of the forceps as 
indicated in Figure 9) and the RF power supply was triggered using a foot switch. The 
microbial biomass is rapidly heated up due to its non-zero impedance and an aerosol 
containing the analytes is produced and transferred directly into the mass spectrometer. 
Where possible, five individual measurements were performed for each strain and averaged 
as a database entry.  
 
Figure 9. Schematic representation depicting processes during bipolar REIMS ionisation. a) Microbial 
biomass is held between the two electrodes of the forceps, b) RF alternating current is applied, rapidly 
heating up the microbial biomass, c) aerosol is produced and aspirated into embedded fluid line. Adapted 
from Ref. (133) with permission from The Royal Society of Chemistry. 
To avoid any infection caused by aerosolised pathogenic bacteria, the analysis site was 
enclosed into a Class II safety level glove box compartment equipped with UV light source 
and HEPA filters. 
The device consists of three separate parts that are subject to potential blocking: a) the 
aspiration port inside the forceps, b) the polymer transfer line, c) the inlet capillary of the 
mass spectrometer. In practice, the only part that is observed to block regularly is the 
aspiration port within the forceps. Preventional cleaning is applied after on average every 50th 
individual measurement to avoid blocking. This was done by disconnecting the forceps from 
the transfer line and connecting it to a 20mL plastic syringe filled with 70% v/v ethanol to 
wash out eventual deposits. The aspiration line is then dried using nitrogen. The process of 
maintenance cleaning takes about 1-2 minutes. 
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Table 1. Instrumental parameters of Orbitrap Discovery and Xevo G2-S instruments used in this study. 
 Thermo Orbitrap Discovery Exactive Waters Xevo G2-S 
Parameter Setting Setting Parameter Setting 
Injection time 1000ms 1000ms Scan time 1000ms 
Microscans 1 1 Scan Mode Sensitivity 
Mass analyser FTMSa FTMSb Mass analyser TOF 
Ion mode negative Negative Ion mode negative 
Mass range 150-2000 150-2000 Mass range 150-2000 
Tube Lens Voltage -120V -160V Sampling Cone 30V 
Capillary Voltage -40V -50V Source Offset 80V 
Skimmer Voltage n/a -24V Source Temperature 150⁰C 
Capillary 
Temperature 
250⁰C 250⁰C   
Automatic Gain 
Control 
Off On (5x106)   
a: Orbitrap Discovery instrument is working at a resolution of 30,000 at m/z 400, b: Mass analyser was used at a resolution of 
50,000 (m/z 200) 
2.1.3. Determination of the amount of microbial wet weight needed for REIMS 
analysis 
For determination of the necessary amount of bacterial biomass, bacteria were picked up as 
for mass spectrometric analysis and  scraped off the sampling probe electrodes using a sterile 
cotton swab tip. The cotton swabs were transferred into a microcentrifuge tube and the tube 
weighed in triplicate using a Sartorius AG 180D (Göttingen, Germany) analytical balance. 
Microcentrifuge tube and cotton swab tip were additionally weighed in triplicate before 
taking up the bacterial biomass. Each five replicates were analysed per strain. Mean values 
for microcentrifuge tubes with and without bacterial biomass were calculated and substracted 
from each other to obtain the net amount of bacterial wet weight that was picked up using the 
bipolar sampling probe. 
2.1.4. Data analysis 
2.1.4.1. Determination of the number of peaks 
The amount of m/z signals observed using REIMS was assessed by randomly selecting a 
database entry for 28 of the most common bacterial pathogens (files sourced from dataset 
used for specificity assessment, Table 18). Each one file per species was peak picked in 
MATLAB environment (MathWorks, Natick, MA, USA) using the ‘mspeaks’ function. This 
function is part of the MATLAB suite and first applies smoothing to the mass spectral data 
followed by identification of putative peak location and intensity values and subsequent 
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application of post-filtering criteria. Height filter was chosen as a post-filtering criterion with 
a threshold of 200. Mass spectral features above this threshold were found to have a signal to 
noise ratio >3. 
2.1.4.2. Specificity assessment using multivariate statistical tools 
Raw mass spectrometric files were transcoded to mzML format by the ProteoWizard 
msconvert tool (version 3.0.4043)(143) and imzML format using imzML Converter (version 
1.0.5)(144) and imported into MATLAB for data pre-processing, pattern recognition analysis 
and visualisation. A typical total ion chromatogram as obtained during data acquisition for a 
database entry is shown in Figure 10. As REIMS is a pulsed ion source, individual 
measurements are represented by a sharp rise and subsequent fall in total ion current (TIC). 
The database file acquisition process takes on average 0.8-1.2 minutes with an individual 
measurement lasting for 3-6 seconds (see spikes in Figure 10). Constructed bacterial database 
contains mass spectrometric raw files grouped by bacterial species. For specificity 
assessment, an appropriate sub-set of files was chosen and converted to mzML format, 
followed by conversion to imzML format. All spectra acquired for an individual sample were 
extracted from the imzML format and subsequently summed up to lead to one sum spectrum 
per isolate. Spectra were chosen based on an average total ion current threshold of 120% as 
indicated by the blue line in Figure 10.  
 
Figure 10. Schematic representation for selection of spectra for downstream data analysis using a total 
ion count (TIC) threshold. Reprinted with permission from Ref. (142). Copyright 2014 American 
Chemical Society. 
All REIMS spectra were subsequently linearly interpolated to a common sampling interval of 
0.01Da. Since a binning strategy was used in this study, recursive segment-wise peak 
alignment was used to remove small mass shifts in peak positions across spectral 
profiles.(145) The aligned data were subjected to data normalisation (median-fold change or 
TIC normalisation as stated in text) to account for sample to sample variation in overall 
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signal intensity unrelated to molecular patterns.(146) Log-based transformation was 
subsequently applied to stabilise variance as a function of increased signal intensity (variance 
stabilisation normalisation) to ensure that the noise structure was consistent with the 
downstream application of multivariate statistical techniques.(146) A schematic 
representation of the applied data analysis strategy is shown in Figure 11 and was used unless 
stated otherwise. 
 
Figure 11. Data processing workflow for specificity assessment on different phylogenetic levels. 
Reproduced from Ref. (133) with permission from The Royal Society of Chemistry. 
Principal component analysis (PCA) was initially applied to map high-dimensional REIMS 
data into an uncorrelated set of components capturing the majority of variation in the dataset. 
Graphical representations of the first few generally most informative components were used 
to explore the overall similarities/differences in molecular ion composition between bacterial 
species. Unless stated otherwise, a supervised recursive maximum margin criterion 
algorithm(122,141) (RMMC) was subsequently applied to derive components with enhanced 
capacity for discriminating between bacterial types by taking the microbiological assignment 
of specimens into account. Alternatively, linear discriminant analysis (LDA) on the 
components derived from PCA was performed for supervised analyses. The final reduced set 
of discriminating components was equal to the number of bacterial species (classes) minus 
one. The discriminating models were validated using appropriate cross-validations (CV) as 
stated in text. 
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Hierarchical Cluster Analysis (HCA) shown in Figure 70 was performed using Euclidean 
pairwise distance calculation with a complete linkage metric. 3x3 strains of the original 
median-fold change normalised dataset shown in Figure 69A and B were averaged for each 
bacterial species to form the dataset which was then subjected to HCA. This step was 
undertaken in order to facilitate visualisation while still incorporating a maximum of the 
biological variance among strains of a certain species. 
2.1.4.3. Inter-platform data processing 
Thermo .raw files and Waters .raw folders were converted to .mzXML file format using 
MSConvert (ProteoWizard 3.0.4601). Intensity values of Exactive, Orbitrap and Xevo mass 
spectra were interpolated to a common mass range of m/z 200-2000 with 0.01Da mass 
resolution. Mass spectra originating from the same replicates were averaged and subjected to 
peak picking. Peak lists of averaged mass spectra were normalised to their unit vector and 
binned to a common mass range of m/z 200-2000 with 1Da mass resolution. Waters Xevo 
G2-S data was denoised by threshold detection according to Donoho and Johnstone.(147) 
Binned peak lists were then subjected to multivariate statistical analysis. 
2.1.5. Bacterial metabolite identification 
Bacterial metabolites were primarily identified based on exact mass measurements and 
literature references on compounds with the same exact mass that were found in the same or 
closely related bacterial species. Mass deviations were calculated using the following formula 
∆ = 	 	
 − 10
 
with m = mass deviation (in ppm) 
mexp = experimental exact mass, 4 decimal places accuracy 
mth = theoretical exact mass, 4 decimal places accuracy 
 
Mass accuracies of <3ppm were regarded as supporting the proposed the sum formula. 
Further structural identifications were only made by supporting literature references and 
confirmed by additional tandem mass spectrometry measurements if signal intensity was 
found sufficiently high and reference spectra were available. Fragmentation experiments 
were performed on either on a Thermo LTQ XL or Xevo G2-S/XS instrument and using 
collision induced dissociation as fragmentation mechanism.  
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2.2. Analysis of cell cultures using REIMS 
2.2.1. Culturing of cell lines 
All cells were supplied by the Research group of Dr Gergely Szakacs (Institute of 
Enzymology, Hungarian Academy of Sciences, Budapest, Hungary) as part of a collaboration 
with the research group of Prof Zoltan Takats at Imperial College London. The NCI60 cell 
panel was obtained from the DCTD Tumor Repository (National Cancer Institute, Frederick, 
MD, USA); HEK, HeLA and MES-SA cell lines were from the ATCC collection (Manassas, 
VA, USA). All cells were cultured in RPMI 1640 medium with the exception of HEK and 
HeLa cells in the Mycoplasma study which were cultured in Gibco DMEM medium 
(Invitrogen, Carlsbad, CA, USA). In all cases, media were supplemented with 10% (v/v) fetal 
bovine serum, 2mM glutamine, 100 units/mL penicillin, and 100mg/mL streptomycin 
(Invitrogen). Cells were incubated in 75cm2 tissue culture flasks under conditions of 
humidified 37°C, 5% carbon dioxide atmosphere. Cell lines were regularly screened for 
Mycoplasma contamination using the MycoAlertTM Mycoplasma Detection Kit (Lonza 
Group Ltd, Basel Switzerland).  
At 80-90% confluence, cells were rinsed with Phosphate Buffered Saline (PBS, pH: 7.2) and 
detached using 0.1% trypsin/EDTA for 10 minutes. The trypsin was subsequently neutralised 
with excess culture medium. The cell suspensions were centrifuged at 250×g for five 
minutes. After centrifugation the cells were re-suspended and washed two times in 10mL 
PBS. A third wash was performed in a microcentrifuge tube with only 1mL PBS. The cell 
pellets were frozen and stored at -80°C until further analysis. 
2.2.2. REIMS analysis of cell lines 
The REIMS experimental setup is identical to the setup used for the analysis of microbial 
cultures with the exception that analysis is performed from a microcentrifuge tube rather than 
a Petri dish (see Figure 12). Mass spectrometric analysis of the cell line biomass was 
performed directly on the thawed cell pellet without further sample pre-processing steps and 
cell biomass was picked up using one of the electrodes of the bipolar forceps. The two 
electrodes were subsequently brought into close proximity (i.e. by pinching the biomass 
between the tips of the forceps) and the RF power supply was triggered using a foot switch. 
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The produced aerosol was directly transferred into the mass spectrometer. Multiple technical 
replicates were recorded per cell line. 
 
Figure 12. Setup for REIMS analysis of cell line pellets. All analyses were performed on a Thermo 
Exactive instrument. Adapted with permission from Ref. (257). Copyright (2016) American Chemical 
Society. 
2.2.3. Data Analysis of REIMS cell line data 
2.2.3.1. Unsupervised multivariate statistics and cross-validations 
Raw mass spectrometric files were converted into mzML format using the MSConvert tool 
(part of the ProteoWizard suite, version 3.0.4043) and subsequently imported as imzML 
format into MATLAB (MathWorks) for data pre-processing.(142-144) All REIMS spectra 
were linearly interpolated to a common sampling interval of 0.01Da. Recursive segment-wise 
peak alignment was then used to remove small mass shifts in peak positions across spectral 
profiles.(148) The aligned data were subjected to total ion count (TIC) data normalisation and 
log-based transformation. Pattern recognition analysis and visualisation were performed 
either in MATLAB (MathWorks) or in RStudio (Boston, MA, USA, see also www.r-
project.com).(149) The mass range of m/z 150-1000 was used for data analysis in all studies. 
For self-identity experiments, the data set was filtered to keep a reduced set of m/z values: a 
m/z value was kept, if the difference between the available samples were significantly 
different at alpha=0.01 threshold level based on the Kruskal-Wallis test. For each cross-
validation run, a principal component analysis (PCA) transformation of the training data set 
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with pre-determined number of principal components (PCs) was calculated in R and 
prediction score was calculated for each test sample using the 3 nearest neighbor (3-NN) 
method. The training data in the 'spectral reproducibility set' was selected as follows: for each 
measurement day, a cell line with defined passage (p) and flask number (A/B) was kept as 
part of the training data (i. e. HeLa p4 A) if samples were available from at least two different 
biological replicates (i.e. A1-3). Such sets from each of the three cell lines were combined 
randomly to produce balanced training data where each cell line is represented by similar 
number of samples. All of the remaining samples constituted the test set. In the ‘NCI60 data 
set’, where applicable, one of the biological replicates was omitted while the remaining data 
constituted the training set. 
2.2.3.2. Correlation with gene expression data 
Gene expression data for the NCI60 cell line panel was sourced from the CellMiner 
website(150,151). For each available gene and filtered m/z value the gene expression and the 
binned signal intensity across the overlapping 58 cell lines was correlated using Pearson's 
correlation coefficient with 1000 iterations. The bootstrapped correlation value was defined 
as the lower 95% confidence interval level of the 1000 iterations, resulting in a total of 26065 
(genes) x 17878 (filtered m/z) = 465990070 values. 
2.2.3.3. Bootstrapped correlation analysis 
For each available gene and sufficiently varied binned m/z value a bootstrapped correlation 
coefficient was calculated, resulting in a total of 26065 x 5452 = 142106380 correlation 
values. In the case of each pair of gene expression and m/z value, the gene expression and the 
binned signal intensity across the overlapping 58 cell lines were correlated using Pearson's 
correlation coefficient with 1000 iterations. The bootstrapped correlation value was defined 
as the lower 95% confidence interval level of the 1000 iterations. 
2.3. Desorption Electrospray Ionisation Mass Spectrometry 
2.3.1. Desorption Electrospray Ionisation Setup 
A home-built automated DESI ion source as shown in Figure 13 was used for all DESI 
experiments in this study. This DESI stage involved a home-built sprayer assembly mounted 
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on a 3D rotating stage which in turn was mounted to a 3D moving stage allowing movement 
in x-, y- and z-direction.(119) Samples were mounted on an aluminium sample table using 
double-sided tape and subjected to DESI analysis. Collection of ions was performed by a 
home-built extended capillary inlet. 
 
Figure 13. Home-built DESI source mounted on Exactive instrument. Electrosonic sprayer (1) secured 
onto rotating stage (2) which in turn is mounted on 3D moving stage; (3)-(5) screws for adjustment in x-, 
y-, and z-direction; (6) sample table, movable in x-, y-, and z-direction; (7) gas supply; (8) high voltage 
supply; (9) solvent supply; (10) atmospheric inlet of mass spectrometer with extended bent inlet capillary 
(sniffer); (11) tissue section on glass slide. 
 
Figure 14. A) Schematic representation and B) photograph of a DESI sprayer assembly as used in this 
study. Reproduced from Ref. (152) with permission from The Royal Society of Chemistry. 
A schematic representation of the home-built DESI sprayer setup used in this study is shown 
in Figure 14 and employs a stainless steel (SS) Swagelok T element as sprayer body and 
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fused silica capillaries held in place by sleeves and ferrules to deliver gas and solvent, 
respectively.  
A 50µm ID, 150µm OD fused silica capillary was used to deliver the electrospray solvent and 
it was inserted into an approximately 1.5cm long 250µm ID, 363µm OD fused silica capillary 
delivering the nebulising gas. Since perfect coaxial orientation of the two fused silica 
capillaries proved difficult to achieve, the two capillaries were oriented with the inner 
capillary touching the outer capillary at its top edge when the sprayer is directed towards the 
sample (see Figure 15) at an angle up to 90°. This setup resulted in an elliptical spray point 
facing the inlet capillary of the mass spectrometer and an increased ion yield. The polyimide 
coating of both fused silica sprayer capillaries was removed to enable accurate shaping of the 
capillary tips using a ceramic wafer. This was found to be crucially important for obtaining a 
stable and symmetrical electrospray plume which in turn was found to be essential for image 
quality and ion yield. Best image quality was found with a spray head featuring the solvent 
capillary extruding approximately 0.5mm from the gas capillary.(152) 
  
Figure 15. Photograph of the DESI spray head used in this study showing relative position of gas and 
solvent capillaries; 5x magnification.Amended from Ref. (152) with permission from The Royal Society of 
Chemistry. 
2.3.2. Desorption Electrospray Ionisation Mass Spectrometry Imaging 
2.3.2.1. Sample collection 
Tissue specimens and related clinico-pathological data were collected between November 
2011 and September 2012 with informed and written consent from patients undergoing 
planned surgical resection for confirmed coloractal cancer (CRC) at a single cancer referral 
centre (St Mary’s Hospital (London, UK). Fresh tissue samples were harvested from centre of 
tumour, junction of tumour and healthy tissues, 5cm distance to tumour and 10cm distance to 
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tumour. Patients undergoing left sided or anterior resections were prepared using laxatives 
Senna and Citramag to clean the bowel before the intervention, while right-sided resection 
were performed without further pre-treatment. Tissue harvesting was performed in the 
pathology department by a single senior gastrointestinal pathologist (Prof Robert D. Goldin) 
and acquired samples were immediately transferred to a freezer at -80ºC prior to processing. 
This study was granted full ethical approval by the institutional review board at Imperial 
College Healthcare NHS Trust (REC reference number 07/H0712/112). 
2.3.2.2. Sample preparation 
Tissue samples were cryosectioned to 15µm thickness with either a Bright 5030 cryotome 
(Bright Instruments, Cambridgeshire, UK) or a Thermo Fisher Scientific HM550 cryotome. If 
samples were embedded to facilitate cryosectioning, 3% carboxy-methyl cellulose was used 
as embedding medium. However, the majority of samples were sectioned without any 
embedding medium. For this process, bulk tissue samples were fixed to a sample holder using 
a droplet of distilled water. Samples were cryosectioned at thicknesses ranging from 12-
15µm and subsequently thaw-mounted onto either plain glass slides or Superfrost glass slides 
and stored at -80°C until DESI-MS imaging analysis. 
2.3.2.3. DESI-MS imaging 
Tissue sections were subjected to DESI-MS imaging analysis using an Exactive mass 
spectrometer (Thermo Fisher Scientific Inc., Bremen, Germany). Exactive instrument 
parameters are listed in Table 2. A photo of the home-build automated DESI source is shown 
in Figure 13. 
Methanol/water (95:5 v/v) was used as the electrospray solvent at a flow-rate of 1.5L/min. 
Nitrogen N4.8 was used as nebulising gas at a pressure of 7bars. All solvents used were of 
LC-MS grade (Chromasolv, Sigma Aldrich, St Louis, MO, USA). The height distance 
between the DESI sprayer and the sample surface was set to 2mm with the distance between 
the sprayer and inlet capillary set to 14mm. The distance between the sample surface and the 
inlet capillary of the mass spectrometer was <<1mm. The angle between the sprayer tip and 
the sample surface was set at 80°. The collection angle between inlet capillary and sample 
was set to 10°.  
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Table 2. Thermo Exactive instrumental parameters used for DESI-MS imaging experiments. 
Parameter Setting. 
Polarity negative 
Resolution 100,000 
Mass range 200-1050 
Spray voltage - 4.5kV 
Capillary temperature 250°C 
Capillary voltage - 50V 
Tube lens voltage - 150V 
Skimmer Voltage - 24V 
Max. injection time 1000ms 
Microscans 1 
AGC target 5e6 
The general principle underlying imaging processes using DESI-MS is displayed in Figure 
16. Rather than point-by-point sampling, horizontal line scans are performed over the tissue 
surface by moving the automated sampling platform at a speed that covers the area 
determined as a pixel (spatial resolution) in the time the mass spectrometer requires to 
complete one scan (acquire one mass spectrum). This results in one file per row of the 
resulting image (number of rows determined by sample height divided by spatial resolution).  
 
Figure 16. Schematic representation displaying processes underlying DESI mass spectrometry imaging. 
Tissue sections are continuously sampled using horizontal line scans and followed by single ion image 
generation. 
2.3.2.4. Imaging data pre-processing 
For image analysis, individual horizontal line scans were converted into centroided .imzML 
files using the imzML Converter Version 1.1.4.5 (www.maldi-msi.org) and subsequently 
imported into MATLAB (MathwWorks) for pre-processing and multivariate analysis.(144) 
Molecular ion peaks within a m/z range smaller than the native accuracy of the mass 
spectrometer (<4ppm in this case) were assigned to the same molecular ion species uniformly 
for all pixels on a tissue section. The resulting sample-specific lists of m/z values were 
aligned between samples by means of a dynamic programming based peak-matching 
algorithm.(153) Median-fold change pixel-wise normalisation was used to remove overall 
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intensity variation between tissue spectra caused by technical factors. A log-based variance 
stabilising transformation was subsequently applied to account for intensity variation between 
small and large peaks.(154) 
2.3.2.5. Histological assignment and spectral pre-processing 
The same tissue sections that were used for DESI-MSI analysis were subsequently stained 
using hematoxylin and eosin (H&E) and a cover-slide was applied. Following staining, tissue 
sections were digitally scanned at high resolution using a NanoZoomer 2.0-HT digital slide 
scanner (Hamamatsu Corp., Japan).  
Histological and MSI features were optically aligned in a user-friendly MATLAB imaging 
toolbox using a rigid image-alignment algorithm.(154) Histological assignments were made 
by a single histopathologist (Abigail V. M. Speller) by choosing morphologically uniform 
regions-of-interest. Corresponding spectra were subsequently extracted and stored in a 
database for further down-stream analyses. 
2.3.3. Analysis of bacteria using DESI 
For analysis of microorganisms, bacterial biomass was scraped off the agar surface using a 
sterile cotton-swab and smeared onto the surface of a standard microscope glass slide. 
Subsequent spectral acquisition was performed in negative ion mode on a Thrmo Exactive 
instrument using the mass range m/z 150-2000 and other instrumental parameters as listed for 
DESI imaging experiments (see Table 2). Same DESI parameters were used as for imaging 
experiments with the exceptions of a solvent flow rate of 2.5µL/min, a shorter distance 
between sprayer and inlet capillary of 7mm and point-to-point rather than continuous 
movement. 
2.4. Determination of taxon-specific markers 
The general workflow applied for the identification of taxon-specific markers is displayed in 
Figure 17. All data was compiled and a representative subset of the overall >3,000 strains 
recorded on the Exactive instrument (see entire database entries in Appendix 2) was 
generated. This was followed by a peak-picking and peak-matching routine and an ANOVA-
based biomarker discovery to derive the taxon-specific markers. The overall workflow for 
detection of bacteria in DESI imaging sample sets is displayed in Figure 18. Once taxon-
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specific bacterial markers are derived, bacteria are subsequently detected in imaging datasets 
and displayed with the corresponding histological boundaries. 
2.4.1. Sample set 
A dataset was created comprising 228 different bacterial species belonging to 80 genera, 47 
families, 23 orders, 11 classes and 5 phyla (596 strains in total). A maximum of five to seven 
individual strains was used for calculations for badly represented genera, while a maximum 
of 3 strains per species was used for well represented genera (10 species per genus or more). 
A detailed sample set can be found in Appendix 4. Different culturing media, culturing ages 
and culturing atmospheres were included into the sample set where possible. 
2.4.2. Data analysis 
To derive taxon-specific markers, the data were processed in centroid rather than profile 
mode. For this, raw mass spectrometric files were transcoded to mzXML format by the 
ProteoWizard msconvert tool (version 3.0.4043)(143) and imported into MATLAB 
environment (MathWorks). 
 
Figure 17. Data analysis workflow used for the determination of taxon-specific markers. 
2.4.2.1.Peak-picking and peak-matching 
Peak picking was performed on individual spectra within each separate mzXML file, with 
processing being performed on each set of m/z values and corresponding intensity values. 
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Local maxima and peak boundaries were determined according to local minima or zero 
intensity values to either side of the maximum. Peak intensity is calculated as its sum 
between the two boundaries, with boundary intensities being halved (important only for un-
resolved peaks; resolved peak boundaries are 0). The peak’s ‘centre of mass’ is determined 
by means of an intensity-weighted average. After processing all spectra of a single mzXML 
file, the individual m/z and intensity vectors are aligned using a dynamic programming 
algorithm. The user specifies maximum peak shift (in ppm) that acts as the maximum 
distance over which peaks can be matched. If multiple files are to be compared, the peak-
matching algorithm is re-run using the same parameters. 
2.4.2.2. Biomarker discovery 
Each variable is analysed independently, initially by 1-way analysis of variance (ANOVA), 
to determine if there is a significant difference between the means of the defined groups 
(here, bacterial species). Significant differences (e.g. p<0.05) are further analysed by Tukey’s 
honestly significant difference (HSD) post-hoc method. HSD calculates the confidence 
intervals for differences between the mean of two groups and if this interval spans across zero 
then the difference between two means is regarded as insignificant. A difference for each 
variable between all groups is determined. Thus, a variable that differs significantly between 
one and all other groups is considered a likely biomarker candidate. Results for each variable 
are returned as the ANOVA p-value. The emphasis has been placed on variables that are 
significantly higher in one group than in others, rather than variables that are absent in all but 
one taxonomical group. This approach enables finding markers that would have otherwise 
been excluded in case of groups containing unrelated misclassified bacterial species which do 
not show the same spectral feature.  
For each taxonomical level, both a list of the top 20 most significant peaks per taxon and 150 
most significant peaks in the dataset were created and manually compiled into markers that 
are specific on different taxonomical levels. To further aid analysis, box-and-whisker plots 
were generated showing the 25th, 50th (median) and 75th percentiles of the marker in the taxon 
of question and other taxons at the same phylogenetic level. Whiskers indicate 1.5times the 
interquartile range. In a subsequent manual step, such markers were filtered out which were 
significantly increased for a certain bacterial species but were not specific enough to be used 
as univariate markers. As these imaging data sets were recorded using a mass range of m/z 
200-1000, determination of taxon-specific markers was restricted to the same mass range.  
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Figure 18. Workflow used for visualising taxon-specific markers in human colorectal tissue sections. A 
REIMS spectral database is generated and used to derive taxon-specific markers for bacteria. DESI 
imaging of tissue sections is performed and bacterial markers are visualised in DESI imaging datasets. 
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2.5. Detection of taxon-specific markers in human colorectal tissue 
specimens 
Each set of three tissue samples (center of tumour, 5cm distant and 10cm distant from 
tumour) from 16 colorectal cancer patients that underwent 16S rRNA sequencing-based 
community analysis were used to assess feasibility of detection of taxon-specific markers in 
human tissue specimen. This was performed by generating single ion images of the taxon-
specific markers given in Table 28 (page 199) and filtering said images for such structures 
that are not present in background and show no correlation of distribution with histological 
tissue types. 
RGB images were generated using MSiReader Version 0.05(155) with linear interpolation 
(order 1) and 0.01Da bin size. In-house processing of DESI imaging data files was performed 
as described in Ref. (122) and under Materials and Methods - Desorption Electrospray 
Ionisation Mass Spectrometry. To produce ion images of the previously derived taxon-
specific markers (TSM) containing outlines of histological tissues, first a binary segmentation 
method(156) was used to delineate the tissue object from the background pixels, which is 
shown by the thick grey line in Figure 18. In order to define the tissue type boundaries, a one-
against-all multivariate analysis was performed on a training set comprising a small subset 
(20-30 pixels) of pixels of the same tissue section which were previously annotated by a 
histopathologist as being morphologically homogenous. A probability for each pixel 
belonging to each class was determined. The tissue type boundaries, as depicted by the 
coloured lines, delineate those pixels with a probability of greater than 0.90 of belonging to 
that class. The one-against-all procedure makes it possible for a pixel to have more than one 
probability greater than 0.90, and pixels that are encompassed by multiple regions can be 
considered to be at the junction between two (or more) tissue types. Ion images were 
subsequently generated using a m/z window of 10ppm.  
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3. Method Development and 
Characterisation 
3.1. Experimental setup – Ion source 
3.1.1. Comparison of spectral content of REIMS and DESI datasets 
Desorption electrospray ionisation mass spectrometry (DESI-MS) has been reported in 
literature as a suitable tool to characterise and differentiate different types of 
bacteria.(90,103,110,157) For this reason, as a part of this study, the proposed REIMS 
methodology was compared to the more established DESI methodology in case of both 
bacterial and fungal analysis. Results were evaluated for spectral information content, ease of 
workflow and general applicability.  
Studies involving DESI published in literature were mostly performed by the research group 
of Prof R. Graham Cooks (Purdue University, IN, USA) and were focused on the analysis of 
E. coli, Salmonella spp., S. aureus, and Bacillus spp.. Bacteria were analysed both in negative 
and positive ion mode and from m/z 50-1600. Especially in the study presented by Zhang et 
al, good spectral diversity was observed for both Gram-positive and Gram-negative bacteria, 
however, analysis was not performed directly on the bacterial cells but on lysed cells after 
addition of 70% ethanol. In studies involving direct analysis of bacteria, significantly better 
signal intensity was observed for Gram-negative bacteria due to their thinner cell wall as 
compared to Gram-positive organisms. Comparatively poor phospholipid intensity was 
observed for S. aureus and B. subtilis and strong intensity signals could only be observed for 
extracellular metabolites such as the lipopolypeptide surfactin.(90,102) No studies were 
published on the analysis of yeasts.  
A range of bacterial reference strains for both Gram-positive and Gram-negative bacteria 
were analysed using both DESI and REIMS methodologies in-house. While analysis directly 
from the Petri-dish was possible in case of REIMS, in case of DESI very poor spectral quality 
was observed when the electrospray was directed onto bacteria growing on the agar surface. 
This was associated with significant deformations of the soft agar surface under the gas jet 
from the DESI spray caused by the pressure of the nitrogen stream. The deformations 
inflicted on the agar during analysis cause the sampling surface to lower relative to the height 
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of the extended MS capillary inlet hindering sampling of the secondary droplets produced 
during the DESI process as the droplets are unable to leave the deformation crater. As 
collection angles in DESI should ideally be close to zero degrees,(158) this effectively 
prevents generation of good quality spectral data. Thus, for DESI analyses of bacteria it was 
decided to instead deposit bacterial biomass on a solid glass surface using a cotton swab. 
Analysis was performed without further sample preparation and good spectral quality was 
obtained for several species such as Bacteroides fragilis or Fusobacterium necrophorum, 
Pseudomonas aeruginosa, Bacillus cereus, Microccoccus luteus, Streptococcus agalactiae, 
Stenotrophomonas maltophilia or Clostridium difficile, among others. This shows that good 
quality spectral data can be obtained both from Gram-positive and Gram-negative bacteria 
using both methodologies. However, while REIMS gives good quality data for all types of 
bacteria and yeasts, only comparably poor spectral quality were observed in case of the DESI 
analysis of certain Gram-positive species such as Staphylococcus aureus or all yeast species 
(C. krusei, C. albicans) which is tentatively associated with their cell wall properties. 
Interestingly, for some of those bacterial species that proved problematic using direct DESI 
analysis, particularly strong spectral intensity was observed using REIMS, such as 
Staphylococcus species.  
A comparison of spectral content reveals similar phospholipid profiles in the mass range m/z 
600-900 using both DESI and REIMS. Although relative signal intensities are varying 
between the two techniques, in general the same phospholipid species are visible. However, 
while DESI offers more mass spectral signals in the lower mass range of m/z 150-500, 
REIMS gives significantly more spectral constituents above m/z 1000, with clearly detectable 
mass spectral signals up to m/z 2000. Comparison of spectral profiles highlighting this 
difference between DESI and REIMS spectra of Bacteroides fragilis and Pseudomonas 
aeruginosa are shown in Figure 19 and Figure 20, respectively. A further complication of 
spray techniques as compared to REIMS is an increased spectral complexity as introduced by 
different adducts for the same molecular species as observed in case of ceramide species (m/z 
590, 604 and 618) in B. fragilis which are detected almost exclusively as [M+Cl]- adduct in 
case of REIMS while DESI spectra feature the same ion both as [M+Cl]- and [M-H]- (m/z 
554, 568 and 582).  
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Figure 19. Spectral profiles of same clinical isolate of Bacteroides fragilis obtained using REIMS (top) and 
DESI (bottom) using negative ion mode. 
A further advantage of REIMS compared to DESI is the lack of spray solvent peaks which 
greatly helps data analysis and partially explains the enhanced spectral content below m/z 500 
observed by DESI. The use of solvents during the ionisation process also enhances the 
chance of introducing spectral contaminants. Largely identical spectral features are observed 
for m/z 150-1000 in both DESI and REIMS, however, DESI largely favours ionisation of 
smaller more polar molecular constituents as visible in both Figure 19 and Figure 20 (bottom 
panel each). This in turn can lead to significant signal suppression of other analytes as shown 
in the example of Pseudomonas aeruginosa where small molecular weight quorum-sensing 
molecules suppress the phospholipid signal.  
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Figure 20. Comparison of spectral profiles of the same clinical isolate of Pseudomonas aeruginosa 
obtained using REIMS (top) and DESI (bottom). 
In earlier lipid characterisation studies of bacteria using DESI, the detection of high 
abundance lyso-phospholipids (both lyso-PEs and lyso-PGs) was reported for Escherichia 
coli K12 which were found to be the spectral base peaks. The reported spectral profile was 
found by the authors to be identical with spectra obtained using ESI-MS from cell extracts of 
the same strain (see Figure 21A and B).(103) However, these were found to be significantly 
lower for in-house performed DESI experiments as shown in Figure 21C, which suggests that 
the study reported by Zhang et al. involved instrument parameters that caused a high degree 
of fragmentation of intact phospholipid species. Neither lyso-PEs nor lyso-PGs were 
observed in REIMS spectra of Escherichia coli strains (see Figure 21D) suggesting 
comparably soft ionisation characteristics of the REIMS method.  
REIMS was found to give equally good spectral results for a variety of different bacterial and 
yeast species while being able to analyse bacteria directly from the Petri-dish without any 
further sample pre-treatment steps. In addition, significantly increased spectral variability and 
stability was observed for REIMS. Therefore, REIMS was chosen as preferred technique for 
large-scale database building. 
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Figure 21. Spectra obtained from Escherichia coli K12 derivatives using DESI-MS and REIMS. Data 
recorded using A) DESI-MS by Zhang et al., Purdue University, Ref. (103), B) ESI-MS by Zhang et al., C) 
DESI-MS performed at Imperial College London, D) REIMS performed at Imperial College London. A 
and B are reprinted from Ref. (103), with permission from Elsevier. 
3.2. REIMS Sampling Probe 
Different experimental setups following the scheme of monopolar and bipolar diathermy 
were tested for their suitability as ion sources. Both setups (shown in Figure 22) could 
generate mass spectral fingerprints of intact bacterial cells. For the monopolar setup, bacterial 
biomass is placed on a large surface area electrode and the electrical circuit is closed by 
touching the sample with the sharp, handheld counter electrode. Alternatively, the agar can be 
removed from the Petri-dish and placed on the counter electrode. The monopolar setup 
produces a very high electric current density in the proximity of the handheld electrode 
touching point, which results in high effective evaporation temperatures and excessive solid 
aerosol (soot) formation. In agreement with these observations, the spectral quality is poor in 
this case and spectra do not feature intensive signals above m/z 1000 (see Figure 24) This 
observation was tentatively associated with a high degree of charring and effective 
combustion of the sample which cannot be circumvented by decreasing the power output. In 
addition, the large amount of smoke produced (and aspirated by the instrument) results in 
significant contamination of the ion optics. In contrast, the bipolar setup uses a pair of 
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handheld electrodes in the form of forceps as the sampling probe and offers a more evenly 
distributed electrical current between the two electrodes (see Figure 23). This setup proved to 
be superior in comparison to the monopolar setup for the analysis of minor amounts of 
biomass.  
 
Figure 22. a) Monopolar and b) bipolar setups tested for the analysis of microorganisms using REIMS. 
Both setups were also tested with external transfer line. Reproduced from Ref. (133) with permission 
from The Royal Society of Chemistry. 
The bipolar setup provided esasier handling, almost complete elimination of memory effects 
and less frequent blocking of transfer devices. In addition, less fragmentation and better 
sensitivity for higher masses was observed using the bipolar tool. The most effective and 
reproducible aspiration of the produced aerosols was achieved using an electrode setup with 
an embedded aspiration line (as displayed in Figure 23B). The comparatively lower amount 
of aerosol produced by the bipolar tool is due to smaller amounts of biomass needed for 
analysis (higher sensitivity) and lower current density due to the parallel geometry of the 
electrodes. Secondary electrospray ionisation was tested using the experimental setup which 
was described earlier for the post-ionisation of surgical aerosols. In agreement with earlier 
studies, further increase in sensitivity was obtained only in positive ion mode.(159)  
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Figure 23. Schematic representation of experimental setup and electrical current density using A) a 
monopolar and B) a bipolar tool. Reprinted with permission from Ref. (142). Copyright 2014 American 
Chemical Society. 
 
Figure 24. Spectra of Staphylococcus aureus obtained using monopolar (top) and bipolar setup (bottom). 
The use of bipolar setups provides better handling and sensitivity and increased detection of high 
molecular weight lipid species. I=Intensity value at 100% relative abundance. Amended with permission 
from Ref. (142). Copyright 2014 American Chemical Society. 
The amount of biomass needed for sensitive REIMS analysis using the biopolar sampling 
tool with embedded aspiration line was determined using three strains of bacteria, 
Staphylococcus warneri, Pseudomonas aeruginosa and Haemophilus influenzae. These cover 
Gram-positive and Gram-negative bacteria, as well as bacteria that can be detached easily 
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from the agar surface and those which are more challenging to remove from the agar growth 
plate (P. aeruginosa). Gram positive S. warneri was found to be rather dense as compared to 
Gram-negatives P. aeruginosa and H. influenzae, with especially colonies of the latter 
looking very moist. Results of all five replicates are shown in Table 3 (for more details see 
Appendix 1). The amounts needed were found to be comparable in weight for all three 
bacterial strains analysed despite their different physical properties. For S. warneri, between 
0.2-0.9mg were needed, while for P. aeruginosa and H. influenzae 0.6-1.0mg and 0.2-0.6mg 
were required, respectively. 
Table 3. Results of experiment to determine amount of biomass needed for analysis. Each value was 
measured in triplicate and the mean calculated. Five replicates were performed for each strain. 
 Staphylococcus 
warneri 
Pseudomonas 
aeruginosa 
Haemophilus 
influenzae 
Replicate 1 0.5mg 1.0mg 0.3mg 
Replicate 2 0.9mg 0.6mg 0.4mg 
Replicate 3 0.2mg 0.9mg 0.6mg 
Replicate 4 0.7mg 0.7mg 0.3mg 
Replicate 5 0.6mg 0.7mg 0.2mg 
 
A major concern in case of direct bacterial REIMS analysis was the potential influence of the 
growth medium on the spectral content. This problem is obvious in case of bacterial growth 
media such as blood agar containing a significant amount of lipids itself. Growth medium 
alone was analysed using the bipolar sampling tool and the analysis has not produced any 
signals that could be attributed to the growth medium (see Figure 25). This observation was 
tentatively associated with the nature of the carbohydrate (agarose) matrix, which undergoes 
condensation reactions via water losses, resulting in extensive cross linking and eventually 
charring on heating which in turn will hinder the REIMS mechanism. Below, blank spectra of 
blood agar and Luria-Bertani agar are shown and show only polysiloxane instrument 
contaminants as indicated by the 78.0183 Da mass differences (measured using the Orbitrap 
mass analyser). Since the mass spectra otherwise do not contain any growth medium related 
mass spectral features and the agar surface was not disrupted while picking up the microbial 
biomass, clustering analysis in this study was generally performed excluding growth medium 
as a blank or quality control. 
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Figure 25. REIMS spectral profiles obtained for A) Luria-Bertani agar (Paul trap mass analyser) and B) 
blood agar (Orbitrap mass analyser). I=Intensity value at 100% relative abundance. 
3.3. Influence of the electrosurgical generator 
Throughout the entire study, different commercially available electrosurgical generators were 
used as radiofrequency power supplies. For most of the data presented, a Valleylab Force 
EZc generator from Covidien was used. This generator was working at 470kHz frequency 
(sinusoid) and – similarly to all other power supplies used – does only allow the adjustment 
of the output power. Based on the information from the manufacturer, the current densities 
are in the order of 104 A/m2 at the given power settings. Since the power supply is power 
controlled, the current does change with the amount of biomass between the electrode tips. 
This will most likely have an influence on the effective evaporation temperatures which in 
turn might affect spectral appearance. However, the evaporation event itself takes a few 
seconds only, which makes the measurement of the temperature challenging, taking into 
account the quick change of temperature, the boiling of the material and the few mm3 sample 
volume.  
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At the practical level, the appearance of the data did not show any significant dependence on 
RF frequency or evaporating power when the volumes were kept constant. Furthermore, the 
highly aqueous bacterial biomass cannot be heated freely above the boiling temperature of 
water, because as soon as there is no aqueous phase between the electrodes, the electric 
circuit opens. Instead of having higher temperature, the rate of evaporation will increase as 
the amount of sample is decreased. There is a given electrosurgical generator-dependent 
threshold power which is necessary to produce spectra, however, the spectral patterns do not 
show significant dependence on the power as shown in Figure 26. 
 
Figure 26. Dependence of spectral profile of Staphylococcus aureus ATCC 25923 on RF power setting of 
electrosurgical generator. I=Intensity value at 100% relative abundance. Data acquired using Thermo 
Exactive instrument. 
Two electrosurgical generators from two different manufacturers were additionally tested for 
their influence on spectral appearance: a Force Triad generator (Covidien, Dublin, Ireland) 
with very similar RF frequency to the Force EZc generator and an Erbe ICC300 (Erbe 
81 
 
Elektromedizin, Tubingen, Germany). A comparison of the technical details of both 
generators in bipolar mode is shown in Table 4.  
Table 4. Technical details of tested generators Covidien Force Triad and Erbe ICC300. 
Setting Force Triad Erbe ICC300 
RF frequency 472 kHz 330 kHz 
Waveform sinusoidal sinusoidal 
Peak-to-Peak Voltage 500 V 380 V 
Power setting 95 80 
Mode Bipolar, low Bipolar 
 
Five strains of three closely related bacterial species were analysed using either generator as 
RF power supply. Klebsiella pneumoniae (5 strains), Proteus mirabilis (4 strains) and 
Serratia marcescens (5 strains) are all part of the closely related Enterobacteriaceae family 
and frequently show misclassifications in cross-validation results. Each strain was 
sequentially analysed using either generator on a Thermo LTQ XL instrument and the 
resulting dataset (comprising 28 data points) subjected to principal components analysis 
(PCA) to assess the influence of the electrosurgical generator on the spectral profiles. A 
comparison of REIMS profiles for an identical strain of Proteus mirabilis using both power 
supplies is shown in Figure 27 and displays an overall very similar appearance. 
 
Figure 27. REIMS spectral profiles for a clinical isolate of Proteus mirabilis acquired using two different 
electrosurgical generators as power supply (top: Force Triad, bottom: Erbe ICC300). I=Intensity value at 
100% relative abundance. Data acquired on Paul trap instrument. 
The resulting PCA plot of the entire dataset is shown in Figure 28 and shows a clear 
separation of the three different bacterial species. No systematic variation can be observed 
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originating from the two different power supplies. These results indicate that an arbitrary 
electrosurgical generator with a bipolar application mode can be used as a power supply and 
will deliver spectral profiles comparable to those obtained by other models or brands. 
However, each generator requires optimisation with regard to power output to achieve 
optimal ionisation characteristics (minimal charring and an even and moderate power output 
for a large variety of bacterial species). The Force Triad generator generally led to higher 
signal intensities compared to the Erbe ICC300, however, the Erbe generator had better 
ionisation characteristics for a wider variety of bacterial species. 
 
Figure 28. Principal components analysis plot of dataset comprising three different bacterial species 
recorded using two different electrosurgical power supplies. 
3.4. Experimental setup - Instrumental parameters 
3.4.1. Comparison of positive and negative ion mode 
During the rapid evaporative ionisation processes, positively and negatively charged species 
are generated in equal amounts. However, as Figure 29 shows comparably poor signal 
intensity is observed for bacterial species when analysed in positive ion mode. REIMS 
predominantly ionises hydrophobic molecular species that are either present as ions in the 
sample material already or such species with very high tendency to form ionic adducts. 
Therefore the detection of complex lipid species is highly favoured in REIMS mechanism. 
Bacterial membranes of most bacterial species mostly consist of phosphatidylglycerols, 
phosphatidylethanolamines and cardiolipins which all undergo ionisation in negative ion 
mode. The poor signal intensity in positive ion mode is tentatively attributed to the low 
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abundance of lipid species in bacteria that would readily ionise in positive ion mode due to 
the absence of phosphatidylcholins and sphingomyelins in most bacteria.(1) Whereas 
negative ion mode gives strong intensity spectra for all bacterial and fungal species analysed, 
positive ion mode yields comparable spectral quality for only a limited number of species 
including P. aeruginosa, which features strong quorum-sensing molecule signals or B. 
fragilis, which contains high amounts of sphingolipids. Thus, for the generation of a robust 
identification method, negative ion mode was chosen due to its constantly high spectral 
quality for a wide variety of bacterial species.  
 
Figure 29. Comparison of REIMS profiles obtained in positive and negative ion mode for A) Escherichia 
coli, B) Pseudomonas aeruginosa, C) Staphylococcus aureus. I=Intensity. Amended with permission from 
Ref. (142). Copyright 2014 American Chemical Society. I=Intensity at 100% relative abundance. 
3.4.2. Optimisation of ion transfer and ion optical settings 
In a common capillary-skimmer-type atmospheric pressure interface (used by Thermo LTQ 
XL, Orbitrap Discovery and Exactive instruments), there are a small number of parameters 
that can be adjusted and have influence on spectral appearance. These are capillary voltage 
and temperature, tube lens (a lens surrounding the inlet capillary close to its internal opening) 
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voltage, and skimmer voltage. All these parameters were studied over their whole range in 
detail using Staphylococcus similans.  
No influence on spectral appearance and total ion current was observed in case of tube lens 
voltage and capillary voltage settings (see Figure 30A and D). Fluctuations in TIC were 
observed but were in line with analytical variations observed due to differences in amount of 
biomass sampled. However, significant effects on signal intensity and spectral appearance 
were observed in case of capillary temperature and skimmer voltage (see Figure 30B and C). 
The lack of effect in case of tube lens and capillary voltage is in accordance with earlier 
studies where no dependence on tube lens voltage was found in case of REIMS while strong 
dependence on tube lens voltage was observed for electrospray post-ionisation of REIMS 
aerosols.(159) The ionisation mechanism was investigated using rhodamine 6G pick-up 
experiments performed in-house on a Thermo Orbitrap Disovery instrument by depositing 
rhodamine 6G onto several potential collision surfaces inside the mass spectrometer (all ion 
guiding parts of the atmospheric pressure interface and the first square quadrupole ion guide) 
and determining its ionisation response during REIMS analysis. Highest rhodamine 6G 
abundance was found when the inner surface of the skimmer was studied, which suggests that 
collision of the clusters in the REIMS aerosol occurs predominantly at this position (E. A. 
Jones and O. Golf et al., data not published). This observation confirms that no desolvated 
molecular ions pass through the inlet capillary that could be affected by a change in either 
capillary voltage or tube lense voltage and the actual ion formation occurs in the proximity of 
the skimmer electrode.  
In agreement with this hypothesis, the skimmer potential setting was found to have a 
significant influence on both spectral appearance and ion yield. When decreasing skimmer 
voltages from 0 to -50V, mass spectra can be observed at all values, however, a clear onset 
value for efficient ion generation was observed at -15V. From then onwards, no influence on 
total ion current was observed by further increasing the skimmer voltage. However, skimmer 
voltage was further found to influence the spectral appearance over the entire range tested. 
Fragmentation was observed at very and high skimmer voltages low (<-5V, >-45V, see 
Figure 31, left) as indicated by changes in the abundance of a peak at m/z 241 which 
corresponds to fatty acid C15:0 which is part of all major phospholipids observed for 
Staphylococcus species (see Table 7). Furthermore, large molecular weight ions (m/z > 1000) 
were found to decrease in relative intensity for very high skimmer voltages.  
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Figure 30. Total ion current for repeated measurements of Staphylococcus similans as a function of A) 
capillary voltage, B) capillary temperature, C) skimmer voltage, and D) tube lens voltage. 
 
Figure 31. Spectral appearance in dependence on atmospheric pressure interface skimmer voltage (left) 
and capillary temperature (right). I=Intensity value at 100% relative abundance. 
Although the viscosity of aspirated air is increased at higher capillary temperatures resulting 
in a net drop of sample introduced, the observed signal intensities were found to be higher. 
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The temperature likely has an effect on the internal energy of molecular clusters, influencing 
the efficiency of desolvation on the surface collison event discussed above (see Figure 30B 
and Figure 32, right). Significantly higher signal intensities were observed for capillary 
temperatures above 100°C. The total ion current shows minimal further improvement and a 
plateau effect towards even higher capillary temperatures.  
 
Figure 32. Spectral appearance for three consecutive REIMS measurements of Staphylococcus similans 
recorded at 34°C capillary temperature. A) Spectrum obtained during washing of sampling probe using 
70% ethanol, B) spectrum obtained towards the end of an individual sampling event, C) highest TIC 
spectrum of a sampling event. D) Total ion count (TIC) trace of three consecutive sampling events. 
However, the capillary temperature was found to influence also the spectral appearance. For 
temperatures below 100°C, high variance of spectral profiles was observed during a single 
REIMS measurement as demonstrated in Figure 32. While for each individual measurement 
event the spectrum with highest TIC looks identical to those recorded at higher capillary 
temperatures, an additional set of peaks can be observed between m/z 800-900 towards the 
end of each measurement. The influence of these additional peaks disappears towards higher 
temperatures, and it is virtually absent from 250°C onwards. Very low capillary temperatures 
(< 100°C) cause the appearance of signals obtained during the cleaning procedure of the 
electrode tips (tips are wiped off using 70% ethanol after each analysis). This unfavourable 
effect is also disappearing towards higher capillary temperatures.  
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For these reasons, 250°C capillary temperature was found to constitute an optimum for stable 
spectral appearance, sensitivity and suitability for possibly thermally unstable analytes. 
3.4.3. Suitability of different mass analysers  
In order to assess reproducibility of REIMS profiles of microorganisms, the developed 
methodology was tested on different instrumental platforms. Overall six different mass 
spectrometers were tested comprising three different types of mass analysers (1x Paul trap, 2x 
Orbitrap, 2xToF, 1x IMS-ToF). Exemplary REIMS spectral profiles obtained for Escherichia 
coli strains using a Paul trap (B), Orbitrap (A) and time-of-flight (C) mass analyser are shown 
in Figure 33.  
All different instrument platforms and mass analysers were found applicable for the analysis 
of microorganisms using REIMS and were found to yield similar mass spectral profiles 
dominated by the same mass spectral features in the mass range m/z 600-800, and smaller 
peak groups at m/z 1200-1300, m/z 1350-1550, and m/z 1650-1750. Peaks at m/z 1200-1300 
are not visible in the mass spectrum obtained on the Paul trap, however, these are likely 
covered by the baseline noise. Abundant signals in the low mass region below m/z 500 are 
observed in the time-of-flight mass analyser, indicating a larger degree of fragmentation. 
However, the observed lipid fragmentation products are more likely to be generated by the 
different atmospheric pressure interfaces used (skimmer-type interface in ion trapping 
instruments, custom-built interface with inserted collision sphere in time-of-flight 
instruments). The effect of different interfaces between REIMS setup and mass analysers is 
further discussed under the point Experimental setup – Adaptation to Xevo G2-XS 
instrumental platform - Different atmospheric pressure interfaces. 
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Figure 33. Spectrum of Escherichia coli strains analysed on three different instruments with different 
mass analysers. A) Orbitrap-based mass analyser (Thermo Exactive), B) Paul trap mass analyser 
(Thermo LTQ XL), C) Time-of-Flight (TOF) mass analyser (Waters Xevo G2S). 
3.4.4. Instrument contamination 
In theory, every spectral feature detected using the presented direct infusion REIMS setup is 
originating from the sampled material as no other material (solvent or matrix) is introduced 
into the mass spectrometer than the produced aerosol. This greatly helps data analysis as 
compared to spray methods and matrix-assisted desorption methods that often require 
background-subtraction before further downstream data analysis methods could be applied.  
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Figure 34. REIMS spectra of Pseudomonas aeruginosa recorded on a Thermo Scientific Orbitrap 
Discovery XL hybrid instrument using the LTQ XL analyser without prior cleaning. Ultramark 1621 
contamination can be seen as polymeric structure ranging from m/z 1000-2000. Further contaminants 
include polysiloxanes at m/z < 400. 
However in practice, due to the ionisation mechanism involving surface collisions inside the 
mass spectrometer atmospheric pressure interface, contaminants are likely to be observed 
using REIMS. Commonly observed contaminants comprised C16:0 and C18:0 fatty acids, 
polysiloxane contaminants (m = 74) and such contaminants that were actively introduced 
into the instrument during REIMS analysis (bacterial metabolites) and during instrument 
calibration. Thermo instruments were calibrated using the commercially available Thermo 
Fisher Scientific PierceTM calibration mix which in negative ion mode consists of sodium 
dodecyl sulphate (SDS), taurocholic acid and polymeric Ultramark 1621. While no spectral 
contaminants were observed that originated from SDS and taurocholic acid, extensive 
contamination were observed due to Ultramark as displayed in Figure 34 showing the 
polymeric distribution with a distinct mass spacing of m = 100Da.  
To avoid detecting features originating from a contaminated atmospheric pressure interface, 
any instrumentation used in the presented work with a cold collision surface (this excludes 
the heated coil custom-made API used in conjunction with the Waters Xevo G2-XS 
instrument) was cleaned prior to REIMS analyses to ensure that the spectral influence of 
contaminants was negligible. Instrument contaminants are less critical in such methodologies 
where ions are generated outside of the instrument (such as ESI and DESI) and thus the 
instruments in those cases need less frequent cleaning.  
In case of the Thermo Scientific Exactive, LTQ XL and Orbitrap Discovery XL instruments, 
the instrument is vented and inlet capillary, tube lens and skimmer were cleaned to ensure all 
contaminants from previous experiments are removed. The skimmer was found to be the 
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main origin of contamination and was thus cleaned (together with the tube lens) by initially 
wiping off contaminants using a cotton swab and methanol before subjecting it to 
ultrasonication in five different solvents of increasing hydrophobicity. These were 
methanol/water (1:1 v/v), acetonitrile, acetone, dichloromethane and finally methanol. 
Sonicating the skimmer in a halogenated solvent was found to be essential to remove the 
perflourinated Ultramark polymer. The inlet capillary was ultrasonicated in a mixture of 
methanol/water/acetone (1:1:1 v/v/v). Other accessible surfaces of the atmospheric pressure 
interface were wiped off using a cotton swab and methanol before the API was reassembled 
and reinserted into the instrument, followed by a minimum of 12hrs bakeout to achieve 
sufficiently good vacuum for mass analysis. All FTMS instruments used during this study do 
require calibration after maintenance procedures to obtain sufficiently high mass accuracy. 
As calibration using the commercial HESI ion source led to returning Ultramark 
contaminations in the REIMS spectra, calibration was performed using nanospray ionisation 
devices. For this purpose, gold-coated nanospray needles with 5µm inner diameter tips were 
used (obtained from DNU-MS, Berlin, Germany). Spray durations were kept as short as 
possible (below 30s) and only the required ion mode was calibrated which was found to leave 
no significant contamination to the instrument.  
To reduce the effect of memory effects caused by compounds introduced during REIMS 
analysis, only a limited number of spectrally similar samples were analysed on a single day 
(max 45, depending on species) and were randomised with at least an equal number of a 
selection of taxonomically unrelated species. Such bacterial species that were empirically 
found to be producing metabolites that strongly contaminate the instrument were analysed in 
the end of the day in the order of increasing severity of induced contaminations. Only a 
limited number of database entries could be recorded per day in case of Bacteroides spp. 
(n<5, corresponding to 25 individual REIMS measurements) before carry-over of ceramide 
signals was observed, while only a single database entry of lipopeptides-producing Bacillus 
spp. (B. subtilis, B. licheniformis) could be recorded with as little as 3 individual REIMS 
measurements leading to persistent instrument contamination. While some cleaning success 
can be obtained without venting the instrument in case of time-of-flight analysers by 
introduction of hydrophobic solvents into the cooled atmospheric pressure interface, this is 
not an option for FTMS instruments as the evaporating solvent will destroy the ultrahigh 
vacuum.  
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Although contaminations introduced during calibration could be avoided by use of a 
customised calibration solution where Ultramark 1621 was replaced by compounds inducing 
less memory effects, the contamination to the skimmer surfaces during REIMS analysis by 
microbial species is a persisting problem that in case of the available skimmer-type Thermo 
Scientific instrumentation is very difficult to solve without substantial customisation of the 
atmospheric pressure interface and following ion transfer optics. Waters Corporation 
(Milford, MA, USA) instrumentation equipped with a StepwaveTM ion guide was found 
ideally suited for development of an atmospheric pressure interface as by default they do not 
contain any possible deposition and collision surfaces, they are equipped with a time-of-flight 
mass analyser requiring less stringent vacuum conditions, and any modifications of the 
atmospheric pressure interface can be made outside of the instrument without the need for 
major reconstruction.  
3.5. Experimental setup – Adaptation to Xevo G2-XS instrumental 
platform 
3.5.1. Different atmospheric pressure interfaces 
While no influence on spectral appearance and signal intensity was observed based on using 
different instruments and mass analysers per se, significant differences were observed related 
to the atmospheric pressure interfaces (API). A schematic of the four different types of APIs 
used in this study are shown in Figure 35 and include a) traditional commercial skimmer-
based API as used in Thermo Scientific instruments, b) commercial StepwaveTM-based 
interface as used in Waters Corporation instruments, c) customised API for Waters 
instruments comprising a cold sphere as collision surface and d) customised API for Waters 
instruments comprising a heated coil-shaped collision surface.  
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Figure 35. Different atmospheric pressure interfaces used in this study. A) Commercial skimmer interface 
of Thermo Exactive instrument, B) commercial Stepwave interface of Waters instruments, C) and D) 
custom-built atmospheric pressure interfaces for Waters instruments. Blue arrows indicate flight paths of 
neutral species while green arrows indicate the flight path of generated ionic species. 
The surface collision mechanism in the case of the default skimmer-type interface is 
displayed in Figure 35A. The actual surface collision involved in the REIMS ionisation 
mechanism were found not to occur on the outer conical surface of the skimmer but rather at 
the inner surface directly on front of further ion optical elements. This is due to the free-jet 
expansion that is occurring at the opening of the inlet capillary inside the first differential 
pumping stage (gas pressure approx. 1mbar). Due to this expansion, the trajectory of a small 
subset of molecular clusters generated during REIMS ionisation leads through the skimmer 
opening and collides with its inner surfaces from where the ions continue through the ion 
optics towards the mass analyser. This mechanism also implies that large parts of the actual 
molecular clusters are not undergoing this secondary ionisation step by not entering through 
the skimmer opening. Thus, a significant increase in sensitivity is expected if a larger part of 
the sampled aerosol could be induced to undergo surface collisions. 
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While the unmodified capillary-skimmer interface (Thermo Scientific instruments) allows the 
REIMS analysis of biological samples, the standard Stepwave-based API of the Waters 
instruments was found not to be suited for REIMS analysis because of a lack of mass spectral 
response. Both capillary-skimmer and Stepwave setups are meant to separate neutral from 
ionic species, however, while the skimmer eliminates neutrals by having them collide with its 
outer conical surface directly in between the opening of the inlet capillary and further ion 
optics, in the Stepwave ion guide charged particles are diverted from the straight flight path at 
a remote location from both further ion optics and inlet capillary. In this setup (shown in 
Figure 36), ions generated from surface collisions of large neutral clusters have no chance of 
following the flight path of pre-existing ionic species as possible surface collisions will occur 
at a large distance from any ion optical elements. The lack of REIMS signal observed in 
instruments deploying these commercially available interfaces again shows that the rapid 
evaporative ionisation process in itself does not create ions per se but that the ions are rather 
generated inside the mass spectrometer.  
 
Figure 36. Schematic representation of ion flow in Waters Stepwave ion guide (yellow: ions, blue: 
neutrals). Reprinted and modified with permission of Waters Corporation (Milford, MA, USA). 
This ionisation mechanism is further proven by the generation of ions upon introduction of a 
collision surface between the end of the inlet capillary and the front end of the Stepwave ion 
guide as depicted for two different setups in Figure 35C and D. Figure 35C depicts an 
atmospheric pressure interface with a spherical stainless steel collision surface mounted at 
6mm distance from the end of the inlet capillary. This setup was found to give identical 
spectral profiles to those obtained by the commercial skimmer-type API for a wide variety of 
bacterial species and thus enabling REIMS analysis on instruments using the Stepwave 
technology. However, this interface as well as the skimmer-type interface was found to suffer 
from severe carryover effects in case of the repeated measurements of certain analytes such 
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as sphingolipids or lipopolypeptides. As outlined in Method Development and 
Characterisation - Experimental setup - Instrumental parameters - Instrument contamination 
this could largely be avoided by cleaning the atmospheric pressure interface before analysis 
and by randomising different bacterial species during analysis of larger sample sets. 
However, these steps are not applicable for an unsupervised and ideally automated clinical 
microbiological setting.  
 
Figure 37. Spectral profiles of Bacteroides fragilis obtained using different atmospheric pressure 
interfaces depicted in Figure 35. A) Skimmer-type interface was recorded on Exactive instrument, while 
B) cold collision sphere and C) heated collision surface were recorded on Waters Xevo G2 instrument. 
I=Intensity at 100% relative abundance. 
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To avoid cross-contamination, a collision surface was tested that could be heated up to 
several hundreds °C. By heating the collision surface, any organic deposits will react with the 
oxygen introduced through the inlet capillary and be converted to CO2 and thus avoid 
contamination build-up. A coil-shaped collision surface was used instead of a stainless steel 
spherical collision surface as it was found to be the most beneficial configuration to ensure 
equal heat distribution when developed for intra-surgical applications. The coil-shaped 
collision element was manufactured out of Kanthal S, a heat-resistant iron-chromium-
aluminium (FeCrAl) alloy, allowing operating temperatures in the range of 700-800°C and 
supplied by the Waters Research Center (Budapest, Hungary). Using this heated collision 
surface, memory effects and thus the frequency of instrument cleaning procedure could be 
greatly reduced. Hundreds of database entries could be recorded without memory effects and 
even prolonged exposure to lipopolypeptides did not result in any observed carry-over.  
Nevertheless, spectral profiles recorded using this heated coil interface in some cases showed 
markedly different appearance compared to those recorded using cold collision surfaces as 
illustrated in Figure 37. This indicates that not all spectral constituents are thermally stable 
enough for this type of heated surface induced ionisation. The effect of the heated coil seems 
to be especially strong on phosphatidic acid (common in fungi such as C. albicans, Figure 
39) and some sphingolipid species (common in phylum Bacteroidetes, Figure 37) while 
generally little effect on spectral appearance can be observed for phosphatidylglycerol and 
phosphatidylethanolamines (main phospholipid species in Proteus mirabilis, Figure 40). The 
heated coil was also observed to lead to a loss of spectral information for Pseudomonas 
aeruginosa where the loss of low mass quorum-sensing molecules (important virulence 
factors) was observed.  
3.5.2. Aerosol pick up using isopropyl alcohol 
Further setups were tested that rely on introduction of isopropyl alcohol to aid ionisation by 
partially or fully solvating the analyte molecules and thus reducing intermolecular forces 
which would otherwise negatively affect ionisation hence reducing sensitivity. The 
introduction of isopropyl alcohol was first tested for the heated interface dedicated for intra-
surgical tissue identification which is using a Venturi pump for aerosol transfer from the 
monopolar sampling device to the inlet capillary of the mass spectrometer. Aerosol sampling 
by the mass spectrometer in this case occurs orthogonally to the outlet of the Venturi pump. 
For the bipolar forceps sampling probe, the application of a Venturi pump is disadvantageous 
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compared to the aspiration by the vacuum system of the instrument, since it leads to 
considerable dilution of the sampled aerosols and thus loss in sensitivity.  
In comparison to an API applying cold collision surface (skimmer-type API, custom-built 
interface as shown in Figure 35A and C), the heated collision surface was found to eliminate 
certain spectral features such as ceramides in Bacteroides fragilis (see Figure 37). 
Introduction of isopropanol into the sampled aerosol before entering the mass spectrometer 
was found to restore those spectral features and generate mass spectral fingerprints similar to 
those obtained by an atmospheric pressure interface with cold collision surface. In addition, 
the introduction of isopropanol to the aerosol led to similar or higher signal intensity as 
compared to direct aerosol introduction and thus theoretically enabled the use of a Venturi 
pump for aerosol transport. However, increases in sensitivity will be neutralised by the 
introduction of a Venturi setup. Thus, a further increase in sensitivity was expected for direct 
introduction of isopropanol into the aerosol line without applying additional nebulising 
setups. For this purpose, a T-piece was constructed as depicted in Figure 38. This T-piece 
was directly attached onto an extended mass spectrometer inlet capillary, thus still enabling 
sampling using the inherent vacuum system of the instrument. Increasing isopropanol flow 
rates were tested between 0-0.25mL/min and the optimum flow rate was determined to be 
0.1mL/min.  
 
Figure 38. Photograph of apparatus used for introduction of isopropanol using bipolar sampling probe 
and direct introduction into the mass spectrometer.  
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Figure 39. Spectral profiles for Candida albicans (yeast) using different experimental setups: heated coil 
with introduction of IPA, heated coil without IPA introduction, and cold collision sphere. All data 
recorded on Xevo G2XS instrument. 
 
Figure 40. Spectral profiles of Proteus mirabilis (Gram-negative) using different experimental setups: 
heated coil with introduction of IPA, heated coil without IPA introduction, and cold collision sphere. All 
data recorded on Xevo G2XS instrument. 
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The effect of the different setups on spectral appearance is shown for Candida albicans and 
Proteus mirabilis in Figure 39 and Figure 40, respectively. Both examples clearly 
demonstrate that using a heated instead of a cold interface results in significant changes of the 
spectral appearance with many spectral features in Candida albicans being significantly 
reduced in relative intensity or disappearing altogether. Introduction of isopropanol into the 
system helps to circumvent this problem and creates a spectrum more similar to cold collision 
surface interfaces. However, one observed disadvantage is the observation of a rising baseline 
towards lower masses effectively reducing signal-to-noise ratio. Additionally, the use of 
isopropanol results in significant loss of mass spectral information above m/z 1000 as clearly 
visible in case of Proteus mirabilis (Figure 40). 
 
Figure 41. REIMS spectra obtained for Bacteroides fragilis using IPA mediated aerosol pick-up setup 
operated with different IPA flow rates. Zoom into mass range of m/z 500-900 covering phospholipid 
region. 
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The effect on spectral appearance for different isopropanol flow rates was determined for 
Bacteroides fragilis and is displayed in Figure 41 and Figure 42. A direct effect of the 
isopropanol being present is detectable from 0.02mL/min upwards as clearly visible based in 
case of the appearance of m/z 590 (ceramide species) and m/z 752 (α-Galactosylceramide). 
These species were found to increase in their relative abundance with increasing isopropanol 
flow rates. As soon as the appearance of m/z 590 and 752 sets in, peaks in the very high mass 
region m/z >2000 were found to disappear (see Figure 42) thus indicating a negative 
influence on heavier spectral features.  
 
Figure 42. REIMS spectra obtained for Bacteroides fragilis using aerosol pick-up setup operated with 
different isopropanol flow rates. Zoom into mass range of m/z 2000-2500 showing effect on very high mass 
ions. 
While a heated atmospheric pressure interface utilising isopropanol and a Venturi air jet 
pump is the method of choice in case of intra-surgical applications, this setup is not suited for 
the identification of bacteria. This is due to strong limitations in spectral content originating 
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from the use of a heated collision surface, which leads to the exclusion of thermally labile 
compounds, loss in sensitivity (due to dilution occurring because of the Venturi pump), and 
loss of high mass features and reproducibility due to the introduction of isopropanol. Thus, 
the optimum setup for a commercial platform for the identification of bacteria would be a 
setup utilising direct introduction of the aerosol and a cold collision surface. In order to avoid 
cross-contamination, this collision surface should be exposed to short periods of heating 
between mass spectral analyses rather than being constantly heated up in order to obtain 
optimum spectral quality in an unsupervised clinical microbiology setting.  
3.6. Characterisation of spectral reproducibility 
The inter-species variance of data has to be larger than intra-species variance for any 
microbial identification tool. The biological variance introduced to the overall spectral 
appearance by different culturing media, different culturing atmospheres and different strains 
of the same species was assessed and the results are shown in Figure 43, Figure 44 and Figure 
45, respectively for the three most common and most extensively studied pathogenic species 
encountered in clinical microbiology, Pseudomonas aeruginosa, Staphylococcus aureus and 
Escherichia coli. 
Figure 43 shows REIMS spectral profiles obtained for five different clinical isolates of the 
same bacterial species cultured under the same conditions. Excellent pattern stability can be 
observed for S. aureus, while more variability was observed for P. aeruginosa and E. coli. In 
case of the latter, some changes in relative signal intensity were observed between major 
phosphatidylglycerol species in the mass range m/z 600-800 while a very high degree of 
similarity was observed for the high mass range. In case of P. aeruginosa, three of five 
strains exhibit production of extracellular metabolites such as quorum-sensing molecules and 
rhamnolipids in the mass range of m/z 200-350 and m/z 500-680, respectively. Furthermore, 
the same strains exhibit a group of signals in the range of m/z 900-1100. However, the 
phospholipid region between m/z 680-800 and masses above m/z 1100 show good agreement 
between all five clinical isolates. These three bacterial species represent three very different 
behaviours, with S. aureus displaying very stable profiles, E. coli showing slight changes in 
phospholipid signal distributions and P. aeuruginosa showing presence or absence of entire 
compound classes.  
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Figure 43. REIMS spectral profiles for each five different clinical isolates of Staphylococcus aureus (top), 
Pseudomonas aeruginosa (middle) and Escherichia coli (bottom) cultured on Columbia blood agar. 
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Figure 44. REIMS spectral profiles obtained for Staphylococcus aureus ATCC 25923, Pseudomonas 
aeruginosa ATCC 27853 and Escherichia coli ATCC 25922, each grown on five different solid growth 
media. From front to back: Brain-heart infusion agar (BHI), Columbia horse blood agar (CBA), 
chocolate agar (CHOC), Mueller-Hinton agar (MH), Trypticase soy agar (TSA). Amended with 
permission from Ref. (142). Copyright 2014 American Chemical Society. 
103 
 
 
Figure 45. REIMS spectral profiles obtained for Staphylococcus aureus ATCC 25923, Pseudomonas 
aeruginosa ATCC 27853 and Escherichia coli ATCC 25922, each grown on Columbia blood agar for 
48hrs at 37°C under different atmospheres. From front to back: aerobic, aerobic containing 5% CO2, 
microaerophilic, anaerobic.  
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However, in all cases it is apparent that large parts of the spectral information remains 
conserved, especially for masses above m/z 1100. This highly conserved nature of signals at 
m/z >1000 has been largely ignored by other lipid based studies, which predominantly 
focused on the mass range below m/z 1000. This might be due to difficulties in detection of 
those higher mass compounds for technologies such as DESI and a limited knowledge on the 
chemical nature of these heavy bacterial lipid species. 
Similar spectral behaviour was observed if a single bacterial strain was cultured on five 
different commonly used nutrient-rich solid growth media (see Figure 44). In this case, very 
similar mass spectral profiles were obtained within all three species, with very limited 
variance for S. aureus, different quorum-sensing expression profiles for P. aeruginosa as well 
as slight changes for the lipid species at m/z 900-1100, while in case of E. coli slight 
variations of the major phosphatidylglycerols species were observed. However, none of the 
organisms is fastidious and all growth media are rich in nutrients providing the bacterium 
with all necessary nutrients to achieve optimum membrane lipid composition. Changes in 
production of extracellular metabolites in case of P. aeruginosa was additionally observed for 
different colony morphologies. Single colonies of P. aeruginosa generally did not display 
large amounts of quorum-sensing molecules and rhamnolipids while the same strain grown as 
a lawn would greatly exhibit signals originating from these molecules. This is tentatively 
associated with production of both types of molecules being cell density-regulated.(160) This 
highlights the need for standardised culturing and sampling conditions if studies are aimed at 
the differences in expression of extracellular metabolites in correlation with proteomic or 
genomic information. 
All three bacterial species are facultative anaerobes and can thus survive and grow under a 
variety of different atmospheric compositions. Figure 45 shows the REIMS profiles obtained 
after culturing the bacteria under the four most commonly used atmospheric compositions. P. 
aeruginosa and E. coli show similar mass spectral features when cultured under all four 
different conditions. However, significant changes were observed in the spectral profile of S. 
aureus grown under anaerobic conditions with a strong shift of spectral features towards 
higher molecular weight species, both for the low mass range of m/z 650-800 as for higher 
mass species in the range of m/z 1300-1700. This effect is more clearly visualised in the 
zoomed mass spectral regions in Figure 46. This can be explained by results obtained in a 
study analysing the fatty acid composition of S. aureus grown under aerobic and anaerobic 
conditions using gas chromatography.  
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Figure 46. Regions of mass spectra of S. aureus grown under aerobic and anaerobic conditions. A) m/z 
650-800, aerobic, B) m/z 650-800, anaerobic, C) m/z 1250-1750, aerobic, and D) m/z 1250-1750, anaerobic. 
I=Intensity value at 100% relative abundance. 
While under aerobic conditions, fatty acids with 15, 18, and 20 carbon atoms account for 
40.86%, 3.7%, and 21.84% of the overall fatty acid content, under anaerobic conditions these 
numbers change to 16.26%, 22.38% and 37.65%, respectively.(161) This was associated with 
the membrane-bound electron transport system being inactive under anaerobic conditions. As 
S. aureus was found to contain less than 1% free fatty acids, these fatty acids are 
predominantly built into membrane lipid species and thus lead to a significant increase in 
heavier phospholipid species which can also be observed using REIMS, both for 
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phosphatidylglycerol species in the mass range of m/z 650-800, and for cardiolipins and other 
heavy molecular weight species in the mass range of m/z 1250-1750 (see Figure 46). 
3.7. Analysis of liquid cultures 
For many applications in research, diagnostics or biotechnology, liquid cultures are preferred 
over solid cultures due to their higher degree of homogeneity regarding concentration of 
nutrients and cell density. In addition, liquid culturing conditions resemble more the 
conditions bacteria experience in the human body. The bipolar setup with incorporated 
aspiration port as used for solid cultures is little suited for the analysis of liquid cultures. 
Simple immersion of the electrodes into the liquid medium leads to aspiration of liquid 
culturing medium into the mass spectrometer which in turn leads to impaired vacuum 
conditions and instrument contamination as the aspration port is too closely situated to the 
electrode tips. An external aspiration port could also be used to circumvent the aspiration of 
liquid into the instrument; however, limitations to the efficiency of the aerosolisation process 
prevail as the aerosolisation temperature is limited due to the excess of water in the sample. 
This, together with dilution of cells by the culturing medium considerably limits sensitivity. 
However, the technique could be adapted to the analysis of liquid cultures by spinning the 
microbial liquid cultures in a centrifuge and discarding the supernatant.  
For most bacterial species, a centrifugation step of 10mins at 3500g is sufficient to form a 
cell pellet suitable for REIMS analysis. However, certain bacterial species sucha as Klebsiella 
pneumoniae or Pseudomonas aeruginosa need to be centrifuged under more rigorous 
conditions such as 10mins at 12500g to allow effective removal of the supernatant. This was 
tentatively associated with the mucoid nature of these cultures. The remaining pellet after 
centrifugation can directly be analysed by taking up microbial biomass from the pellet 
between the electrodes of the sampling probe as shown in Figure 9. If the obtained microbial 
pellet contains only small amounts of biomass or excess liquid, better sensitivity can be 
obtained if the microbial biomass is instead analysed from a solid support material such as 
the tip of a cotton swab. To achieve this, some of the microbial biomass is picked up from the 
cell pellet using the swab and parts of the wetted swab were squeezed between the electrodes 
of the sampling probe for REIMS analysis. As Figure 47 shows, largely identical spectral 
profiles were obtained using either direct analysis or REIMS analysis aided by a solid 
support. No spectral features originating from the cellulose of the cotton were observed 
although the cotton underwent significant carbonisation. This effect is similar to the one 
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observed for the agar matrix, which was reasoned to undergo extensive charring without 
producing any mass spectral signals in the studied mass range. Since both cellulose and 
agarose are linear polysaccharides, this effect is likely to be of similar origin. 
 
Figure 47. REIMS spectral profiles obtained for clinical isolate of Proteus mirabilis with and without solid 
support. Spectra obtained from ionisation from the bipolar forceps electrodes (bottom, direct) and 
analysing samples from the surface of a cotton swab (top, from solid support). I=Intensity value at 100% 
relative abundance. 
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4. Analysis of microorganisms 
4.1. Building of REIMS spectral database 
A large scale spectral database was built with the intention to produce a spectral library 
comprising entries for the 100 most common pathogenic species and with an overall size of 
approx. 5,000 entries. Spectral acquisition was distributed over several instruments in order 
to be able to test robustness and reproducibility of the proposed methodology more 
comprehensively. All strains were analysed using settings as described in Materials and 
Methods - REIMS analysis of microorganisms. An overview of the numbers of strains 
acquired on each instrumental platform is shown in Table 5. The largest database for testing 
specificity on different phylogenetic levels was based on data recorded on the Thermo 
Exactive instrument and eventually comprised 3,308 entries of 263 bacterial and fungal 
species belonging to 95 genera (as determined on 14.01.2015) at the end of the project. A 
comprehensive list of individual species of bacteria and yeast and respective number of 
entries that were part of this database are given in Appendix 2 and Appendix 3. The database 
comprised 43 reference and type strains that were either sourced from the quality control 
organisms at the clinical microbiology laboratory (Charing Cross Hospital, London, UK), 
through a collaboration with Dr Anne McCartney (Food and Nutritional Sciences, University 
of Reading, UK) and Dr Lesley Hoyles (University of Westminster and Imperial College 
London), or cultured from Culti-loops (Oxoid, Basingstoke, UK) or Vitroids (Sigma Aldrich, 
St Louis, MO, USA). The vast majority of other strains featured in the database were 
obtained from the routine work of the clinical microbiology laboratory and were identified 
using the MALDI Biotyper instrument. The majority of yeasts (210 strains) were sourced 
from an internal study of the Clinical Microbiology Laboratory that assessed the robustness 
of the MALDI Biotyper for yeast speciation and were confirmed using pyrosequencing if 
discrepancies were found between MALDI and conventional identification results.  
Spectral database entries for an overall number of 221 bacterial species were recorded on the 
Exactive instrumental platform, however, only a small proportion of these database entries 
can be used for specificity assessment using multivariate statistical models such as PCA and 
LDA as these methods require multiple datapoints per data group or class. 77 bacterial 
species were represented by a single database entry only while 154 species were represented 
by <5 database entries. Overall, 55 (24.9%) bacterial species were represented by >10 
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database entries. Thus, only the most common pathogenic species that were represented with 
sufficient amount of database entries were used for specificity assessment by multivariate 
statistical methods.  
Table 5. Size of spectral database acquired as part of the presented study as determined on 14.01.2015 
 
Intrument used for analysis 
 
Thermo Exactive 
Thermo Orbitrap 
Discovery XL 
Waters Xevo G2-S Waters Synapt G2 
Bacteria 
no of strains 3054 704 662 252 
no of genera 85 23 42 11 
no of species 221 39 90 13 
Yeasts 
no of strains 254 5 76 0 
no of genera 10 2 5 0 
no of species 42 3 17 0 
Total no of strains (database entries):                             5,007 
 
4.2. Characterisation of REIMS spectral content 
The number of mass spectrometric features observed using REIMS was determined for 28 of 
the most commonly detected bacterial pathogens. For this purpose, REIMS spectra were peak 
picked as described in Materials and Methods - Data analysis -  Determination of the number 
of peaks. No spectral deconvolution was performed as all signals detected were singly 
charged. Isotope signals were not removed to keep the nature of a profiling mass 
spectrometric method. Results are shown in Table 6. The smallest number of m/z features was 
detected in case of E. coli (434 features) while the highest number of features detected in K. 
oxytoca (1590 features). This leads to a range of approximately 400-1600 m/z signals 
detected in REIMS measurements with the average amount of m/z signals being around 900. 
Within the Staphylococcus genus, spectral appearance is comparatively similar, however, the 
amount of m/z features detected varies between 783 for S. capitis and 1481 for S. 
haemolyticus. This suggests differences in number of features detected to be correlated with 
general quality of the REIMS measurement and signal to noise ratios. While comparatively 
small number of high abundance mass spectrometric signals (400-500 features) determine the 
overall appearance, approximately 1000 low abundance signals can be detected if favourable 
signal to noise levels are obtained. This large variance in the number of detected m/z signals 
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might pose a difficulty for data analysis using multivariate statistical methods as it might lead 
to increased intra-species variance. 
Table 6. Number of spectral features detected for 28 of the most common clinical pathogens. 
Bacterial Species Number of m/z signals 
Bacteroides fragilis 1076 
Burkholderia cepacia complex 871 
Citrobacter koseri 897 
Clostridium difficile 545 
Enterobacter cloacae 1156 
Enterococcus faecalis 994 
Enterococcus faecium 1196 
Escherichia coli 434 
Haemophilus influenzae 535 
Klebsiella oxytoca 1590 
Klebsiella pneumoniae 966 
Micrococcus luteus 587 
Moraxella catarrhalis 677 
Morganella morganii 408 
Neisseria gonorrhoeae 1141 
Proteus mirabilis 817 
Pseudomonas aeruginosa 451 
Serratia marcescens 1148 
Staphylococcus aureus 1047 
Staphylococcus capitis 783 
Staphylococcus epidermidis 1337 
Staphylococcus haemolyticus 1481 
Staphylococcus hominis 1059 
Stenotrophomonas maltophilia 1108 
Streptococcus agalactiae 709 
Streptococcus pneumoniae 772 
Streptococcus pyogenes 851 
 
The REIMS ionisation mechanism strongly favours the detection of compounds undergoing 
ionic dissociation in aqueous media. Most signals that have previously been reported using 
REIMS were limited to the mass range of m/ 600-900 and were originating from phosphatidic 
acids (PAs), phosphatidylethanolamines (PEs), phopsohatidylglycerols (PGs), 
phosphatidylinositols (PIs), phosphatidylserines (PSs), sphingomyelins (SMs), 
phosphatidylcholines (PCs), diacylglycerols (DAG-H2O) and triacylglycerols 
(TAGs).(128,159) These compounds were found to originate mostly from the lipid bilayer of 
the cell membranes. The detection of polar lipids is highly favoured compared to other 
compounds present in the sample, similarly to other ionisation methods. This is associated 
with the combination of hydrophobic acyl-chains and ionic head groups making desorption 
ionisation energetically favourable. 
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The chemical nature of the vast majority of REIMS signals was found to be deprotonated, 
quasi-molecular [M-H]- species. However, [M+Cl]- adducts and in some cases [M-H2O]- for 
phosphatidylglycerol species were also observed. [M+Cl]- adducts were frequently observed 
for sphingolipid species where the [M-H]- signal was negligible. Water loss was observed in 
case of high abundance phosphatidylglycerol species, as observed in Staphylococcus species. 
However, these features were detected with low spectral intensity as compared to the intact 
[M-H]- species (<5% relative abundance as compared to parent ion).  
4.2.1. Bacterial glycerophospholipids detected using REIMS 
 
Figure 48. Overlaid REIMS spectral profiles as obtained for nine different bacterial species for m/z 500-
1900 and m/z 600-900 in zoom. Adapted from Ref. (133) with permission from The Royal Society of 
Chemistry. 
The majority of spectral profiles obtained from biological samples using REIMS are 
dominated by intact phospholipid species as shown in Figure 48 that can be ascribed to PAs, 
PEs and PGs. This can clearly be seen in Table 7, which shows the qualitative phospholipid 
distribution as obtained for nine different bacterial pathogenic species using exact mass 
measurements and tandem mass spectrometric data acquired during REIMS 
experiments.(133) Only high abundance signals (>5% relative abundance) were included. 
Distinct peak patterns can be obtained for all bacterial species, even for those that are closely 
related such as different Streptococcus spp. or members of the Enterobactereaceae family (E. 
coli, C. koseri, K. pneumoniae, S. marcescens, P. mirabilis). Most spectral patterns for both 
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Gram-negative and Gram-positive species are dominated by high abundance deprotonated 
phosphatidylglycerol (PG) signals.  
Table 7. Identified phospholipids detected in the mass range m/z 600-900 for all analysed species. Only 
phospholipids with relative abundances >5% and only the most abundant acyl chain combination were 
included. Solid growth media on which bacteria were grown is given in parentheses. ID based solely on 
exact mass when lipid composition given as sum carbon number rather than individual acyl chains. 
Reproduced from Ref. (133) with permission from The Royal Society of Chemistry. 
Nominal 
mass 
C. koseri E. coli 
K. 
pneumoniae 
P. mirabilis P. aeruginosa S. marascens S. aureus S. agalactiae S. pyogenes 
m/z (CBA) (CBA) (LB) (MCC) (LB) (MCC) (CBA) (CBA) (CBA) 
645         PA(32:1)* 
659   PA(16:0/17:1) PA(16:0/17:1)  PA(16:0/17:1)    
661       PA(33:0)*   
665         PG(12:0/16:0) 
671         PA(34:2)* 
673    PA(16:0/18:1) PA(16:0/18:1)    PA(16:0/18:1)* 
675       
PG(15:0/15:0-
H2O) 
 PG(30:0-H2O)* 
688 PE(16:1/16:0)   PE(16:1/16:0)      
691         PG(14:0/16:1) 
693 PG(16:0/14:0)  PG(16:0/14:0)    PG(15:0/15:0) PG(15:0/15:0) PG(14:0/16:0) 
697         PA(36:3)* 
699         PA(18:1/18:1)* 
701        PG(32:1)-H2O* PG(32:1)-H2O* 
702 PE(16:0/17:1) PE(16:0/17:1) PE(16:0/17:1) PE(16:0/17:1)  PE(16:0/17:1)    
707       PG(15:0/16:0)   
716 PE(18:1/16:0)   PE(18:1/16:0) PE(18:1/16:0) PE(17:0/17:1)    
717        PG(32:2)* PG(16:1/16:1) 
719 PG(16:1/16:0) PG(16:1/16:0) PG(16:0/16:1) PG(16:0/16:1) PG(16:0/16:1) PG(16:0/16:1)  PG(16:0/16:1) PG(16:0/16:1) 
721       PG(15:0/17:0) PG(15:0/17:0) PG(16:0/16:0) 
725         PA(16:1/18:2) 
727         PG(16:1/18:1)-H2O 
729        
PG(16:0/18:1)-
H2O* 
PG(16:0/18:1)-H2O 
730    PE(16:0/19:1)      
733 PG(16:0/17:1) PG(16:0/17:1) PG(16:0/17:1) PG(16:0/17:1) PG(16:0/17:1) PG(16:0/17:1)    
735       PG(15:0/18:0)   
743        PG(16:0/18:3) PG(16:1/18:2) 
745 PG(16:1/18:1) PG(16:1/18:1) PG(16:1/18:1)  PG(16:1/18:1) PG(16:1/18:1)  PG(16:0/18:2)* PG(16:1/18:1) 
747 PG(16:0/18:1) PG(16:0/18:1) PG(16:0/18:1) PG(16:0/18:1) PG(16:0/18:1) PG(16:0/18:1)  PG(16:0/18:1) PG(16:0/18:1) 
749       PG(15:0/19:0) PG(15:0/19:0) PG(16:0/18:1)* 
752          
759  PG(17:1/18:1) PG(17:1/18:1)  PG(17:1/18:1) PG(17:1/18:1)    
761  PG(16:0/19:1) PG(16:0/19:1) PG(16:0/19:1) PG(16:0/19:1) PG(16:0/19:1)    
763       PG(15:0/20:0)   
770         PE(38:2)* 
771        PG(36:3)* PG(18:1/18:1)* 
773 PG(18:1/18:1) PG(18:1/18:1) PG(17:1/19:1)  PG(17:1/19:1) PG(18:1/18:1)  PG(36:2)* PG(18:1/18:1) 
775        PG(36:1)* PG(18:0/18:1) 
787   PG(18:1/19:1)       
801   PG(19:1/19:1)       
* Signal intensity not sufficient to obtain meaningful MS/MS data; Abbreviations: PG = phosphatidylglycerol, PE = 
phosphatidylethanolamine, CBA = Columbia blood agar, LB = Luria-Bertani agar, MCC = McConkey agar. 
 
Generally, Gram-negative species display a higher percentage of unsaturated phospholipid 
species and a higher relative amount of PEs. This is in good agreement with literature on the 
bacterial phospholipid composition.(1) Staphylococcus aureus (and other Staphylococcus 
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spp.) are clearly distinguished from other bacterial species by the fact that they exclusively 
show signals arising from saturated phospholipid species.  
These differences in phospholipid composition are mirrored in the multivariate statistical 
plots as shown in Figure 49.(133) Gram-positive and Gram-negative bacterial species are 
separated from each other along the first principal component. S. aureus is further separated 
from other Gram-positive species by their markedly different phospholipid profile.  
 
Figure 49. A) PCA plot, and B) RMMC plot of the processed dataset, mass range m/z 500-1,900. 
Reproduced from Ref. (133) with permission from The Royal Society of Chemistry. 
Phospholipid composition of E. coli cells in their exponential growth phase were reported to 
consist of 75% phosphatidylethanolamines (PEs), 20% phosphatidylglycerols (PGs), and 5% 
cardiolipins (CLs).(162) Although identical phospholipid species regarding class and carbon 
chain length of lipids were detected using REIMS, the relative abundances of the 
corresponding signals do not reflect the amounts detected using chromatographic methods. 
While based on Ref. (162), PEs would be expected to be the dominant lipid class in REIMS 
spectra of E. coli, in practice phosphatidylglycerol and cardiolipins prove to be the most 
abundant spectral features for the vast majority of bacteria as it is shown in Figure 48 and 
Table 7 for nine common bacterial pathogens including E. coli. This data suggests a 
favourable ionisation behaviour for phosphatidylglycerols as compared to 
phosphatidylethanolamines.  
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In addition to regular glycerophospholipid species, high spectral abundance PE and PG 
plasmalogen species have also been detected in REIMS spectra of anaerobic bacteria such as 
Clostridium spp., Fusobacterium spp., and Veillonella spp.. While plasmalogens are major 
constituents of the cell wall of many anaerobic bacteria, they are absent in aerobic or 
facultatively anaerobic bacteria. They are also rarely found in fungi although they are widely 
distributed among mammalian species.(163)  
 
Figure 50. Full REIMS spectrum of Staphylococcus epidermidis ATCC 1228 cultured for 48hrs on BHI 
agar. Zoomed region shows cardiolipin region. Asterixes indicate those species that were confirmed by 
MS/MS measurements. I=Intensity at 100% relative abundance. 
Cardiolipins (1,3-bis(sn-3′-phosphatidyl)-sn-glycerols) are complex diphosphatidylglycerol 
lipids containing four fatty acid chains that can differ in length and degree of unsaturation. In 
bacteria, they are predominantly found in the plasma membranes and although there is 
significant potential for complexity in cardiolipin structure considering the presence of four 
fatty acyl chains, the cardiolipin profiles are generally found to be simple and 
reproducible.(164) Bacterial cardiolipins predominantly exhibit shorter carbon chain lengths 
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with mostly saturated or mono-unsaturated fatty acids. In contrast, eukaryotic cells feature 
predominantly longer chain polyunsaturated fatty acids as building blocks of their 
cardiolipins. Using REIMS, cardiolipins were detected and identified in a wide range of both 
Gram-positive and Gram-negative bacteria, based on exact mass measurements. They were 
typically detected in the mass range between m/z 1300-1450 which corresponds to overall 
chain lengths of CL(60:0)-CL(72:0).  
Figure 50 shows the overall spectral profile and the cardiolipins region in particular for 
Staphylococcus epidermidis ATCC 12228. For this strain, the presence of cardiolipins was 
further confirmed using tandem mass spectrometric fragmentation patterns. For this purpose, 
the strain was cultured on BHI medium which was found to increase the relative spectral 
intensity for cardiolipins as compared to horse blood agar. Representative fragmentation 
spectra are shown in Figure 51. Detected fragmentation patterns are in good agreement with 
those reported for mammalian cardiolipins of higher molecular weight.(165)  
 
Figure 51. Fragmentation spectra for cardiolipins at A) m/z 1352, B) m/z 1394 and C) m/z 1423 from 
Staphylococcus epidermidis ATCC12228. Peak identifications as listed inTable 8. 
In good agreement with the acylation pattern of phosphatidylglycerol species, (see Table 7), 
only cardiolipins with saturated fatty acyl groups were detected in case of the Staphylococcus 
genus (see Table 8). This is expected as phosphatidylglycerols moieties form the building 
blocks of cardiolipins.  
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Table 8. Cardiolipin species that were identified for Staphylococcus epidermidis ATCC 12228. 
Compound 
Sum 
formula 
Exact mass 
[M-H]- 
Exp. mass 
Mass 
Deviation 
CL(62:0) C71H138O17P2 1323.9335 1323.9268 5.0 ppm 
CL(63:0) C72H140O17P2 1337.9492 1337.9426 4.9 ppm 
CL(64:0) C73H142O17P2 1351.9649 1351.9601 3.6 ppm 
CL(65:0) C74H144O17P2 1365.9806 1365.9758 3.5 ppm 
CL(66:0) C75H146O17P2 1379.9962 1379.9913 3.5 ppm 
CL(67:0) C76H148O17P2 1394.0119 1394.0070 3.5 ppm 
CL(68:0) C77H150O17P2 1408.0275 1408.0238 2.6 ppm 
CL(69:0) C78H152O17P2 1422.0432 1422.0400 2.3 ppm 
CL(70:0) C79H154O17P2 1436.0588 1436.0561 1.9 ppm 
CL(71:0) C80H156O17P2 1450.0745 1450.0748 0.2 ppm 
CL(72:0) C81H158O17P2 1464.0900 1464.0970 4.8 ppm 
4.2.2. Mycolic acids in Corynebacterinaceae suborder 
The suborder Corynebacterineae forms a large group of actinomycete species characterised 
by the presence of mycolic acids. Mycolic acids are complex lipids composed of a longer 
beta-hydroxy chain (meromycolate chain) and shorter alpha-alkyl side chain (α-branch, see 
Figure 52). The variability of their chain lengths and the complexity of their structures 
contribute to the definition of the genera, from the simplest corynomycolic acids of 
Corynebacterium to the most complex mycolic acids of the Mycobacterium genus.(166) The 
number of carbon atoms and the degree of desaturation (refers to the number of double bonds 
and/or cyclopropane rings) of main and side chains vary according to the taxonomical 
classification of bacteria.  
 
Figure 52. A) Structure of Corynomycolic acid, a short-chain mycolic acid found in Corynebacterium and 
Rhodococcus spp., B) Collision-induced dissociation fragmentation pathway observed in negative ion 
mode. Fragmentation by neutral loss of meromycolate chain as aldehyde. 
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Figure 53. REIMS spectral profiles for Corynebacterium afermentans (clinical isolate), Rhodococcus equi 
(ATCC 6939), Nocardia asteroides (ATCC 19247) and Mycobacterium avium (clinical isolate). 
Figure 53 displays REIMS spectral profiles that were obtained for members of the four most 
common genera of the Corynebacterineae suborder as encountered in clinical microbiolgy. In 
their REIMS spectra, Corynebacterium spp. display mycolic acids of chain lengths ranging 
from C28 to C36, whereas C28 to C39, C48 to C60 and C77 to C81 were found in 
Rhodococcus spp., Nocardia spp., and Mycobacterium spp., respectively. 
4.2.2.1. Corynebacterium spp. 
Species identification within the Corynebacterium genus can be challenging using existing 
methods. Partial 16S rRNA gene sequencing does not lead to sufficient specificity (ideally 
the less commonly used full sequence is needed), the API Coryne system (bioMerieux, 
Durham, NC) takes 24hrs and may yield unreliable results and they further have very similar 
protein patterns in the Biotyper database.(167,168)  
Corynebacteria contain mycolic acids with the shortest overall chain lengths of 22-38 carbon 
atoms. Mycolic acids in Corynebacterium spp. are composed of an even number of carbon 
atoms with the degree of desaturations reported to be between 0 and 2.(169) Results obtained 
using REIMS are in good agreement with these findings with only even carbon numbered 
mycolic acids being present in the REIMS spectra showing the expected range of 
unsaturations (see Table 9). 
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Figure 54. Zoom into REIMS profile for five different Corynebacterium species reveals different mycolic 
acid patterns; spectra normalised to base peak. I=Intensity at 100% relative abundance. 
De Briel et al. proposed a HPLC-based mycolic acid profiling method for speciation within 
the Corynebacterium genus.(170) Distinctively different mycolic acid patterns showing good 
correlation with taxonomic classification were obtained also using REIMS (see Figure 54). 
Corynebacterium amycolatum, an emerging opportunistic pathogen, can be easily 
distinguished by its absence of mycolic acid signals. Mycolic acid patterns obtained using 
REIMS might therefore offer a promising approach to identify Corynebacterium species. 
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Table 9. Identified mycolic acids as detected in different Corynebacterium species. 
Compound 
Sum 
formula 
Exact mass 
[M-H]- 
Exp. mass 
Mass 
Deviation 
Mycolic acid C28:0 C28H55O3 439.415669 439.4159 0.5 ppm 
Mycolic acid C30:0 C30H59O3 467.446969 467.4473 0.7 ppm 
Mycolic acid C32:1 C32H61O3 493.462619 493.4634 1.6 ppm 
Mycolic acid C32:0 C32H63O3 495.478269 495.4786 0.7 ppm 
Mycolic acid C34:2 C34H63O3 519.478269 519.4788 1.0 ppm 
Mycolic acid C34:1 C34H65O3 521.493919 521.4942 0.5 ppm 
Mycolic acid C36:2 C36H67O3 547.509569 547.5102 1.2 ppm 
 
Using collision induced dissociation, mycolic acids fragment at the bond between the 
meromycolate chain and the α-branch (see Figure 52B). While the meromycolate chain forms 
an aldehyde and leaves the parent ion as a neutral entity, the α-branch of the mycolic acid 
forms a negatively charged carboxylate ion, allowing the structural assignment of the parent 
ion.(171) Fragment ions observed (see Table 9) were in good agreement with those reported 
in literature for C. glutamicum and confirmed chemical assignment.(171) All detected 
mycolic acids could be assigned to alpha- (or alpha’-) mycolic acids based on exact mass 
measurements. However, no further assignments were made than overall number of carbons 
as mycolic acids were frequently observed to be mixtures of several isobaric compounds and 
fatty acid composition derived from a single strain is likely insufficient to reflect composition 
within the whole genus.  
 
Figure 55. Tandem mass spectra obtained for an isolate of Corynebacterium striatum, A) m/z 467, B) m/z 
495 and C) m/z 547. Signals were attributed to mycolic acids as listed in Table 9. 
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4.2.2.2. Rhodococcus spp. 
Mycolic acids constituents were determined for Rhodococcus equi ATCC 6939. According to 
Nishiuchi et al,(172) Rhodococcus spp. contain mycolic acids between 30 and 54 carbon 
chain lengths and 0-2 unsaturations. For the analysed Rhodococcus strain, mycolic acids with 
overall chain length of 28-39 were found with 0-3 unsaturations. The overall chain length for 
this particular strain is in good agreement for R. equi species as reported in literature.(172) 
However, a higher amount of unsaturations were found in the presented study (see Table 10).  
Table 10. Identified mycolic acids as detected in Rhodococcus species. 
Compound Sum formula 
Exact mass 
[M-H]- 
Exp. mass 
Mass 
Deviation 
Mycolic acid C28:0 C28H56O3 439.4157 439.4159 0.5 ppm 
Mycolic acid C30:1 C30H58O3 465.4313 465.4315 0.4 ppm 
Mycolic acid C30:0 C30H60O3 467.4470 467.4472 0.4 ppm 
Mycolic acid C31:1 C31H60O3 479.4470 479.4473 0.6 ppm 
Mycolic acid C31:0 C31H62O3 481.4626 481.4630 0.8 ppm 
Mycolic acid C32:2 C32H60O3 491.4470 491.4475 1.0 ppm 
Mycolic acid C32:1 C32H62O3 493.4626 493.4634 1.6 ppm 
Mycolic acid C32:0 C32H64O3 495.4783 495.4786 0.6 ppm 
Mycolic acid C33:2 C33H62O3 505.4626 505.4630 0.8 ppm 
Mycolic acid C33:1 C33H64O3 507.4783 507.4785 0.4 ppm 
Mycolic acid C33:0 C33H66O3 509.4939 509.4943 0.8 ppm 
Mycolic acid C34:3 C34H62O3 517.4626 517.4632 1.2 ppm 
Mycolic acid C34:2 C34H64O3 519.4783 519.4788 1.0 ppm 
Mycolic acid C34:1 C34H66O3 521.4939 521.4944 1.0 ppm 
Mycolic acid C34:0 C34H68O3 523.5096 523.5100 0.8 ppm 
Mycolic acid C35:3 C35H64O3 531.4783 531.4784 0.2 ppm 
Mycolic acid C35:2 C35H66O3 533.4939 533.4946 1.3 ppm 
Mycolic acid C35:1 C35H68O3 535.5096 535.5100 0.7 ppm 
Mycolic acid C35:0 C35H70O3 537.5252 537.5259 1.3 ppm 
Mycolic acid C36:3 C36H66O3 545.4939 545.4944 0.9 ppm 
Mycolic acid C36:2 C36H68O3 547.5096 547.5102 1.1 ppm 
Mycolic acid C36:1 C36H70O3 549.5252 549.5260 1.5 ppm 
Mycolic acid C36:0 C36H72O3 551.5409 551.5424 2.7 ppm 
Mycolic acid C37:3 C37H68O3 559.5096 559.5102 1.1 ppm 
Mycolic acid C37:2 C37H70O3 561.5252 561.5257 0.9 ppm 
Mycolic acid C37:1 C37H72O3 563.5409 563.5418 1.6 ppm 
Mycolic acid C37:0 C37H74O3 565.5565 565.5573 1.4 ppm 
Mycolic acid C38:4 C38H74O3 571.5096 571.5098 0.3 ppm 
Mycolic acid C38:3 C38H74O3 573.5252 573.5261 1.6 ppm 
Mycolic acid C38:2 C38H74O3 575.5409 575.5415 1.0 ppm 
Mycolic acid C38:1 C38H74O3 577.5565 577.5579 2.4 ppm 
Mycolic acid C39:2 C38H76O3 589.5565 589.5578 2.2 ppm 
This might be due to a lack of sensitivity in the cited literature source as these highly 
unsaturated species detected in the REIMS spectra are of low spectral intensity. All ionic 
species in Table 10 could be assigned to alpha- (or alpha’-) mycolic acids based on exact 
mass measurements. 
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4.2.2.3. Nocardia spp. 
In literature sources, Nocardia spp. were reported to contain mycolic acids with chain lengths 
between 48 and 60 carbon atoms with a degree of unsaturation between 0 and 3.(169,173) 
These findings could be confirmed for a Nocardia sp. isolated from a sample of respiratory 
origin and type-strain Nocardia asteroides ATCC 19247. Detected mycolic acid species are 
listed in Table 11 and could be assigned to alpha- (or alpha’-) mycolic acids based on exact 
mass measurements. 
Table 11. Identified mycolic acids as detected in Nocardia species. 
Compound Sum formula 
Exact mass 
[M-H]- 
Exp. mass 
Mass 
Deviation 
Mycolic acid C48:3 C48H90O3 713.6817 713.6797 2.8 ppm 
Mycolic acid C48:2 C48H92O3 715.6974 715.6959 2.1 ppm 
Mycolic acid C50:3 C50H94O3 741.7130 741.7114 2.2 ppm 
Mycolic acid C50:2 C50H96O3 743.7287 743.7285 0.3 ppm 
Mycolic acid C52:3 C52H94O3 769.7443 769.7430 1.7 ppm 
Mycolic acid C52:2 C52H96O3 771.7600 771.7588 1.6 ppm 
Mycolic acid C53:3 C53H96O3 783.7600 783.7596 0.5 ppm 
Mycolic acid C53:2 C53H94O3 785.7756 785.7754 0.3 ppm 
Mycolic acid C54:4 C54H96O3 795.7600 795.7594 0.8 ppm 
Mycolic acid C54:3 C54H98O3 797.7756 797.7739 2.1 ppm 
Mycolic acid C54:2 C54H100O3 799.7913 799.7902 1.4 ppm 
Mycolic acid C55:4 C54H102O3 809.7756 809.7748 1.0 ppm 
Mycolic acid C55:3 C54H104O3 811.7913 811.7907 0.7 ppm 
Mycolic acid C55:2 C54H106O3 813.8069 813.8061 1.0 ppm 
Mycolic acid C56:5 C56H102O3 821.7756 821.7748 1.0 ppm 
Mycolic acid C56:4 C56H104O3 823.7913 823.7907 0.7 ppm 
Mycolic acid C56:3 C56H106O3 825.8069 825.8053 1.9 ppm 
Mycolic acid C56:2 C56H108O3 827.8226 827.8213 1.6 ppm 
Mycolic acid C57:4 C57H106O3 837.8069 837.8050 2.3 ppm 
Mycolic acid C57:3 C57H108O3 839.8226 839.8215 1.3 ppm 
Mycolic acid C58:5 C58H106O3 849.8069 849.8068 0.1 ppm 
Mycolic acid C58:4 C58H108O3 851.8226 851.8218 0.9 ppm 
Mycolic acid C58:3 C58H110O3 853.8382 853.8375 0.8 ppm 
Mycolic acid C59:3 C59H112O3 867.8539 867.8537 0.2 ppm 
Mycolic acid C60:4 C60H112O3 879.8539 879.8537 0.2 ppm 
Mycolic acid C60:3 C60H114O3 881.8695 881.8683 1.4 ppm 
 
Representative fragmentation spectra for different chain length mycolic acids produced by 
Nocardia asteroides ATCC19247 are shown in Figure 56. Observed mycolic acid α-branch 
fragments are of same length as observed in case of the shorter mycolic acids of the 
Corynebacterium and Rhodococcus genera, indicating that major changes in length and 
number of unsaturations of aliphatic chains predominantly takes place in the meromycolate 
chain. 
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Figure 56. Tandem mass spectra obtained for Nocardia asteroides ATCC19247, A) m/z 853, B) m/z 797 
and C) m/z 743. Signals were attributed to mycolic acids as listed in Table 11. 
4.2.2.4. Mycobacterium spp. 
One isolate of Mycobacterium avium, M. fortuitum and M. peregrium were obtained from 
clinical respiratory specimens and analysed using REIMS. The detected mycolic acid species 
are listed in Table 12. Mycobacteria are reported to contain mycolic acids with chain lengths 
between 60 and 90 carbon atoms and 1-2 unsaturations. While other members of the 
Corynebacterineae suborder mainly contain unfunctionalised mycolic acids, there is a larger 
structural variability in Mycobacteria ranging from unfunctionalised alpha-mycolic acids to 
methoxy-, keto- and epoxy-functionalities as part of the beta-hydroxy side chain. Apart from 
Segniliparus spp., no other member of the Corynebacterineae suborder contains similarly 
long mycolic acids. However, while lower chain length mycolic acids were found with high 
intensity, mycolic acids in case of Mycobacterium spp. were found with comparably low 
spectral intensity (see Figure 53). This might either be due to lower general abundance in the 
membrane of Mycobacteria as compared to other genera or more likely decreasing ionisation 
efficiency with increasing mycolic acid chain lengths. Mycolic acids of at least two different 
classes were detected (see Table 12), however, further discrimination could not be made 
based on exact mass measurements only. Tandem mass spectra could not be recorded as 
signal intensity was not sufficient for fragmentation analysis. 
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Table 12. Identified mycolic acids as detected in different Mycobacterium species. 
Compound 
Sum 
formula 
Exact mass 
[M-H]- 
Exp. mass 
Mass 
Deviation 
α/α’-Mycolic acid C77:2 C77H150O3 1122.1512 1122.1525 1.2 ppm 
α/α’-Mycolic acid C78:2 C78H152O3 1136.1669 1136.1684 1.3 ppm 
α/α’-Mycolic acid C79:2 C79H154O3 1150.1825 1150.1833 0.7 ppm 
Epoxy/keto-Mycolic acid C79:1 or  
Methoxy-Mycolic acid C79:2 
C79H154O4 1166.1774 1166.1769 0.4 ppm 
Epoxy/keto-Mycolic acid C80:1 or  
Methoxy-Mycolic acid C80:2 
C80H156O4 1180.1931 1180.1897 2.9 ppm 
Epoxy/keto-Mycolic acid C81:1 or  
Methoxy-Mycolic acid C81:2 
C81H158O3 1194.2087 1194.2102 1.3 ppm 
 
Based on exact mass measurements the extact type of mycolic acid cannot be determined as 
α- and α’-mycolic acids as well as epoxy-, keto- and methoxy-mycolic acids respectively do 
have the same exact mass. All mycolic acids in case of Corynebacterium, Rhodococcus and 
Nocardia spp. were found to be of the α- or α’-type respectively, while Mycobacterium 
species showed a wider variety of mycolic acids as shown in Table 12. 
4.2.3. Sphingolipids in the phylum Bacteroidetes 
Sphingolipids are a class of lipids built around a sphingosine backbone with a long-chain 
amino alcohol and an amide-linked fatty acid attached to it. Sphingolipids are ubiquitous 
among eukaryotes and serve as structural and signalling components in both mammalian and 
yeast cells.(174,175) However, sphingolipid production is present in only a few bacterial 
genera.(176) Species of the Gram-negative bacterial phylum Bacteroidetes are unusual in that 
they produce sphingolipids with up to 40-70% of their total membrane phospholipid 
content.(177) Genera within the phylum Bacteroidetes include Bacteroides, Parabacteroides, 
Prevotella, Tannerella and Porphyromonas. In eukaryotes, sphingolipids serve also as 
signaling molecules that play a key role in modulating cell differentiation, gene expression 
regulation and cell apoptosis.(174,175) Although structurally similar, bacterial sphingolipids 
are differing from eukaryotic sphingolipid species regarding acyl chain lengths (mammalians 
are typically 18-20 carbon vs. maximum 19 carbons in bacterial sphingolipids), acyl chain 
nature (bacterial chains often branched), degree of saturation (mammalian lipids typically 
contain an unsaturated amino alcohol moiety, while in bacteria often saturated), and 
sphingolipid headgroup (mammalian cells typically contain phosphocholine while this 
headgroup is absent in bacteria).(24,178) Spingolipids that were described in literature and 
identified in REIMS spectra of members of the phylum Bacteroidetes include free ceramides, 
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phosphoethanolamine dihydroceramides, as well as substituted and unsubstituted 
phosphoglycerol dihydroceramides.(179-181) An overview of these detected compounds is 
given in Table 13. It was recently shown that Bacteroides fragilis NCTC 9343 additionally 
produces an isoform of α-galactosylceramides, a sponge-derived sphingolipid that serves as 
ligand for the host immune receptor CD1d.(181) These compounds were found in REIMS 
spectra of B. fragilis strains at m/z 752, 766 and 780 and were not found in any other analysed 
species within the Bacteroidetes class.  
Table 13. Identified sphingolipid species in members of the Bacteroidetes phylum. 
Formula 
Experimental 
mass 
Exact mass 
Mass 
Deviation 
Observed in 
Ceramide Phosphorylethanolamine/Phosphoethanolamine Dihydroceramides (PE-DHC) 
C36H74N2O7P- 677.5253 677.5239 2.0 
B. fragilis, B. ovatus, B. thetaiotaomicron, B. 
uniformis, B. vulgatus, P. bivia, P. distonasis 
C37H76N2O7P- 691.5411 691.5396 2.2 
C38H78N2O7P- 705.5569 705.5552 2.4 
Free ceramides 
C34H69NO4Cl- 590.4934a 590.4921 2.2 
B. fragilis, B. ovatus, B. thetaiotaomicron, B. 
uniformis, B. vulgatus, P. bivia, P. distonasis 
C35H71NO4Cl- 604.5090 604.5077 2.1 
C36H73NO4Cl- 618.5246 618.5234 1.9 
Bacteroides fragilis α-Galactosylceramides 
C40H79NO9Cl- 752.5465 752.5449 2.1 
B. fragilis C41H81NO9Cl- 766.5623 766.5605 2.3 
C42H83NO9Cl- 780.5781 780.5762 2.4 
C15:0 substituted Phosphoglycerol Dihydroceramides (subPG-DHC) 
C50H100O10NP 904.7007 904.7028 2.3 
B. fragilis, B. ovatus, B. thetaiotaomicron, B. 
uniformis, B. vulgatus, P. distonasis 
C51H102O10NP 918.7163 918.7185 2.4 
C52H104O10NP 932.7324b 932.7337 1.4 
C53H106O10NP 946.7481b 946.7484 0.3 
C54H108O10NP 960.7637b 960.7624 1.3 
Unsubstituted Phosphoglycerol Dihydroceramides (unPG-DHC) 
C37H76O9NP 708.5184 708.5199 2.1 
P. distonasis 
C39H80O9NP 736.5497 736.5484 1.8 
 a: see Fragmentation spectra in Figure 57. b: see fragmentation spectra in Figure 59 
 
Free ceramides were not observed to be identical with those observed for samples of 
mammalian origin but were found to contain an additional oxygen molecule; a tentative 
fragmentation mechanism of the [M+Cl]- ion at m/z 590 is shown in Figure 57 explaining the 
two major fragments observed from collision induced dissociation of the parent ion.  
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Figure 57. Fragmentation spectrum and tentative scheme of fragmentation for oxidised ceramide signal 
at m/z 590 obtained from B. fragilis. Reprinted with permission from Ref. (142). Copyright 2014 
American Chemical Society. 
Figure 58 shows tandem mass spectra obtained for ceramide phosphorylethanolamine [M-H]-
ions that are observed at m/z 677, 691 and 705 within members of the Bacteroidetes class. In 
agreement with literature spectra, these compounds show a characteristic fragment at m/z 140 
which corresponds to the phosphoethanolamine headgroup,(182) as well as a ion 
corresponding to PO3- at m/z 79. All three parent ions furthermore show a fragment at m/z 
241 corresponding to a common fatty acid residue with 15 carbons and a neutral loss of m = 
268. 
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Figure 58. Fragmentation spectra obtained for peaks at A) m/z 705, B) m/z 691 and C) m/z 677 from 
Bacteroides fragilis assigned as ceramide phosphorylethanolamines. 
 
Figure 59. Fragmentation spectra obtained for peaks at m/z 932, 946 and 960 from Parabacteroides 
distonasis assigned as C15:0 substituted phosphoglycerol dihydroceramides (subPG-DHC). 
Figure 59 shows fragmentation spectra obtained for [M-H]- ions of C15:0 substituted 
phosphoglycerol dihydroceramides that were detected in members of the Parabacteroides 
genus. Main fragments at m/z 153 and 171 can be ascribed to the glycerolphosphate 
headgroup while m/z 241 can be attributed to C15:0 acyl chains. A neutral loss of 242Da 
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form the parent ion can additionally be ascribed to the C15:0 acyl chain. These compounds 
have been described in literature for Porphyromonas gingivalis (not part of the present 
database) and thus seem specific for the Porphyromonadaceae family.(180) These 
compounds were reported to penetrate into human tissues and were found in blood, vascular 
tissues and brain.(180) 
4.2.4. Lipid A in H. pylori 
Lipopolysaccharides (LPS) are a major component of the outer membrane of Gram-negative 
bacteria and generally consist of three structural elements, the O-antigen, a core (both 
consisting of polysaccharide chains) and lipophilic Lipid A (also called endotoxin). Lipid A 
anchors the lipopolysaccharide in the outer bacterial cell membrane and consists of a usually 
phosphorylated glucosamine disaccharide unit which acts as a backbone and is substituted 
with fatty acid residues via either ester or amide linkers. Some of these acyl chains are β-
hydroxylated and can carry a further acyl residue attached to the β-hydroxyl group. 
 
Figure 60. Structures of the endotoxin Lipid A for Escherichia coli (left) and Helicobacter pylori (right). 
Considerable structural variations can be found for different bacterial species, especially in 
the nature and number of the fatty acid residues attached to the disaccharide backbone. While 
Lipid A of E. coli consists of two carbohydrates, each bearing a phosphate group and six fatty 
acid residues with chain lengths of 12-14 carbons, Helicobacter pylori Lipid A generally 
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consists of a phosphorylethanolamine group linked to the disaccharide backbone which 
contains four further acyl substituents with chain lengths of 16-18 carbons (see Figure 60). In 
the human body, Lipid A binds to the Toll-like receptor 4 (TLR4) complex where it can 
trigger a potent reaction by the innate immune system. Lipid A is thus a potent virulence 
factor and absence or modulation of any of its structural components can lead to significant 
loss in virulence.(183) 
H. pylori is the most predominant cause of gastritis and peptic ulcers in humans. The degree 
of the pro-inflammatory cytokine response to the presence of H. pylori is reported to be 
dependent on the Lipid A acylation patterns. The most abundant form of H. pylori Lipid A is 
shown in Figure 60 and comprises one 3-hydroxyhexadecanoic, two octadecanoic and one 3-
hydroxyoctadecanoic fatty acids substituents.(184) This Lipid A variant was detected using 
REIMS as shown in Figure 61 and confirmed by exact mass measurements with a mass 
deviation from the theoretical mass of 1.8ppm. Lipid A is the major component of the 
bacterial outer membrane and would thus be expected as a highly abundant signal in REIMS 
spectra. Instead, it is detected at intensities below 10% relative abundance. This discrepancy 
is tentatively associated with its large molecular weight (MW = 1547 g/mol) and associated 
low ionisation efficiency. 
 
Figure 61. REIMS spectrum obtained from a clinical isolate of Helicobacter pylori. Corresponding m/z 
signal highlighted in spectrum. Mass deviation of theoretical and experimental mass determined as 
1.8ppm. 
Some bacteria were found to modify their Lipid A structures in response to environmental 
conditions such as magnesium deficiency or such conditions as present during infection of a 
mammalian host.(185) These structural modifications are necessary in order to maintain outer 
cell membrane integrity and can lead to significant change in LPS mediated recognition by 
the host. It was shown that Pseudomonas aeruginosa is synthesising structurally different 
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Lipid A variants depending on the stage of cystic fibrosis (CF) infection. While strains 
isolated from non-cystic fibrosis show a predominantly a penta-acylated β-(1,6)-glucosamine 
disacchararide structure, a hexa-acylated Lipid A that contains palmitate and aminoarabinose 
is observed in CF patients, while a hepta-acylated Lipid A was isolated from CF patients with 
acute pulmonary disease.(185-187) Since REIMS is principally able to detect Lipid A as 
shown in case of H. pylori, it offers a unique opportunity to identify a bacterial isolate while 
simultaneously allowing the structural determination of a main virulence factor in a single 
analysis.  
4.2.5. Quorum-sensing molecules in P. aeruginosa 
Cell-to-cell communication via so-called quorum-sensing (QS) mechanisms is ubiquitous in 
the bacterial world. These QS systems rely on synthesis of small molecules that diffuse in and 
out of cells where they promote collective behaviour by modulating gene expression.(188) 
These molecules are also called autoinducers as among others they also promote expression 
of genes that lead to their own synthesis. QS molecules are also known to influence the 
behaviour of eukaryotic cells in order to facilitate bacterial survival.(189) Several chemically 
distinct molecular families of QS molecules have been described of which the N-
acylhomoserine lactone (AHL) family in Gram-negative bacteria have arguably been best 
studied. P. aeruginosa is known to employ both AHL and a more unique system which is 
biochemically linked to the first and which utilises 2-heptyl-3-hydroxy-4(1H)-quinolone as 
main functional entity (Pseudomonas quinolone signal, PQS). PQS and structurally similar 
derivatives are known to regulate the production of virulence determinants such as elastase, 
rhamnolipids, the galactophilic lectin, and the pigment pyocyanin. It was further reported to 
influence biofilm development and maturation.(190) Fifty-six 4-hydroxy-a-alkylquinolines 
and related compounds were detected in the culture supernatant of P. aeruginosa and 
structurally assigned by Lepine et al. using HPLC-MS/MS.(191) 
Abundant signals were observed in REIMS spectra of P. aeruginosa that correlate with the 
PQS-based quorum-sensing system. These were found in different abundances and 
compositions based on the type of culturing medium, culture age, growth mode and strain. 
An example for different growth modes observed in a number of P. aeruginosa strains is 
given in Figure 62 and shows spectra of cells of the same strain grown on the same plate in 
small single colonies (<1mm diameter) and as a lawn. While no signals corresponding to QS 
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molecules were observed in case of spectra obtained from single colonies, abundant QS 
molecules were observed for those cells grown in a lawn pattern. Production of QS molecules 
and resulting gene expression is known to be depending on cell density and was found 
increased in biofilms of P. aeruginosa(192); the observed findings were thus correlated with 
this cell density-correlated effect. The same effect was observed in case of rhamnolipid 
production (see next point). 
 
Figure 62. A clinical isolate of Pseudomonas aeruginosa grown as a lawn (top) and as single colonies 
(bottom) showing markedly different REIMS profiles. I=Intensity value at 100% relative abundance. 
Table 14. Identified quorum-sensing molecules in Psuedomonas aeruginosa. 
Compound Sum formula Exact mass Exp. mass Mass Deviation 
2-Heptylquinoline-4(1H)-one C16H21NO [M-H]- = 242.1550 242.1552 -0.8 ppm 
2-Heptyl-3-hydroxy-4(1H)-quinolone 
(PQS) 
C16H21NO2 [M-H]- = 258.1499 258.1502 -1.2 ppm 
Hydroxynonenylquinoline C18H23NO [M-H]- = 268.1707 268.1711 -1.5 ppm 
Hydroxynonylquinoline C18H25NO [M-H]- = 270.1863 270.1868 -1.9 ppm 
Hydroxyundecenylquinoline C20H26NO [M-H]- = 296.2020 296.2023 -1.0 ppm 
 
Compounds 2-heptylquinoline-4(1H)-one and 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS) 
have been confirmed by comparison with tandem mass spectra of standard compounds (see 
Figure 63). Hydroxynonenylquinoline (m/z 268), hydroxynonylquinoline (m/z 270) and 
hydroxyundecenylquinoline (m/z 296) show similar fragmentation patterns and can thus be 
ascribed to structurally similar compounds. Common fragments include m/z 143, 157 and 
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170. Tandem mass spectra of these compounds featured in the literature are only reported for 
the [M+H]+ ion. However, the fragments observed in negative ion mode (m/z 157 and 170) 
seem to correlate with the fragments observed in positive ion mode (m/z 159 and 172) and are 
indicative of 4-hydroxy-2-alkylquinolines.(191)  
 
Figure 63. Tandem mass spectra of quorum-sensing molecules produced by P. aeruginosa. A) m/z 242, B) 
2-Heptylquinoline-4(1H)-one standard, C) m/z 258, D) 2-Heptyl-3-hydroxy-4(1H)-quinolone (PQS). 
Fragments for PQS (m/z 258) are all showing a mass shift of 16Da as compared to this 
common set of fragments which can be explained by the additional hydroxyl group attached 
to the quinoline moiety. Structurally confirmed quorum-sensing molecules are listed in Table 
14. Furthermore, m/z signals at 306 and 332 show fragments at m/z 270 and 296 (and a 
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common fragment at m/z 157), respectively (loss of 36Da) and a isotopic pattern indicative of 
[M+Cl]- adducts of hydroxynonylquinoline and hydroxyundecenylquinoline. 
4.2.6. Rhamnolipids in P. aeruginosa 
Microorganisms like bacteria, yeasts, and fungi are known to produce various types of 
biosurfactants. Rhamnolipids are a class of surface-active glycolipids containing one or two 
3-hydroxy fatty acids of various lengths, linked to a mono- or dirhamnose (Rha) moiety. 
They can be found in different concentrations and composition patterns in a variety of 
Pseudomonas species. Some Burkholderia spp. have also been shown to produce 
rhamnolipids with longer alkyl chains than those produced by P. aeruginosa.(193) 
Rhamnolipid production could be linked to physiological functions such as biofilm 
formation, uptake and biodegradation of poorly soluble substrates, surface motility, 
displaying antimicrobial activity against both Gram-negative and Gram-positive species as 
well as a range of fungal species.(194) Rhamnolipids probably also contribute to the 
inflammation-related tissue damage observed in the lungs of CF patients. In fact, rhamnolipid 
concentrations in CF patients are high: up to 8µg/mL rhamnolipid concentration was found in 
sputum samples obtained from P. aeruginosa colonised CF patients(195) and as much as 
65µg/mL were found in secretions of a lung removed from a CF patient.(196)  
Although initially described as a mixture of four congeners, the development of more 
sensitive analytical techniques has led to the further discovery of about 60 rhamnolipids 
homologues.(193) A typical rhamnolipid profile as obtained from Pseudomonas aeruginosa 
isolates is shown in Figure 64. Identified rhamnolipid species are listed in Table 15. Overall 
spectral intensity of rhamnolipids depends on a number of factors, e.g. single colonies were 
observed to display less rhamnolipids than when the same bacterial strain was grown as a 
lawn (this effect was correlated with the detection and production of QS molecules, see 
previous point). Rhamnolipid production is linked to the QS apparatus, a fact that can be 
observed in REIMS spectra of P. aeruginosa as high abundance of rhamnolipids are usually 
accompanied by abundant QS signals as shown in Figure 63. Rhamnolipid intensity was also 
seen to increase significantly with increasing age of the culture. However, not all of the 
analysed P. aeruginosa strains were observed to produce measurable amounts of 
rhamnolipids even under favourable conditions.  
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Figure 64. Rhamnolipid species commonly produced by P. aeruginosa strains. Reprinted with permission 
from Ref. (142). Copyright 2014 American Chemical Society. 
Table 15. Rhamnolipid species commonly produced by P. aeruginosa strains. 
Compound Sum formula Exact mass 
[M-H]- 
Exp. mass Mass 
Deviation 
Rha-C20 C26H48O9 503.3225 503.3224 0.2 ppm 
Rha-C22:1 C28H50O9 529.3382 529.3384 -0.4 ppm 
Rha-C22 C28H52O9 531.3539 531.3538 0.2 ppm 
Rha-Rha-C20 C32H58O13 649.3805 649.3804 0.2 ppm 
Rha-Rha-C22 C34H62O13 677.4118 677.4116 -0.3 ppm 
Rha-Rha-C22:1 C34H60O13 675.3961 675.3965 -0.6 ppm 
 
Figure 65. Fragmentation spectra for rhamnolipids species detected in Pseudomonas aeruginosa recorded 
using a Thermo LTQ XL ion trap instrument using collision induced dissociation at collision energy 
setting of 25. 
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Fragmentation spectra of rhamnolipids species listed in Table 15 is shown in Figure 65. 
Rhamnolipids at m/z 503 and m/z 649 were confirmed by comparison to tandem mass spectra 
published in literature.(197,198) Other rhamnolipids were assigned based on similar 
fragmentation patterns such as the loss of rhamnose moieties and the loss of one of the acyl 
chains and exact mass measurements. 
Rhamnolipids have several potential biotechnological applications, especially as 
biodegradable surfactants for use in industry or medicine or as a possible alternative for 
production of rhamnose.(199,200) Therefore, a REIMS-based rhamnolipid screening method 
could be applied for the identification of optimal rhamnolipid producers. 
4.2.7. Lipopolypeptides in Bacillus species 
Bacillus spp. are important Gram-positive model organisms that produce a variety of 
antibiotics of which the most important are lipopolypeptides such as the lipoheptapeptide 
surfactin (C13H27HCO|CH2CO-Glu-Leu-D-Leu-Val-Asp-D-Leu-Leu|, where the symbols ‘|’ 
represent the cyclic bonding sites) and its homologues. Surfactins are produced by strains of 
Bacillus subtilis and Bacillus pumilus, while structurally closely related lichenysins are 
produced by Bacillus licheniformis. Due to their hydrophobic side chains, these compounds 
can be incorporated into the phospholipid bilayer where they induce permeabilisation and 
perturbation of the cell membranes by reorienting the lipid headgroups towards the cell 
membrane interior.(201) They showed a variety of properties such as anticoagulating and 
immunosuppressing activity.(202) The various polar functional groups of the surfactin 
molecule allow straightforward ionisation in both positive and negative ion modes. REIMS 
spectra obtained in negative ion mode for B. subtilis, B. pumilus and B. licheniformis are 
shown in Figure 66. Surfactin production was observed both in B. subtilis and B. pumilis, 
however, the acyl-chain lengths were markedly different. While B. subtilis produced shorter 
chain length surfactins with side chains containing 13-16 carbon atoms (highest abundance 
for surfactin(C15), B. pumilus produced longer chain length surfactins with 14-18 carbon 
atoms (highest abundance surfactin(C16)). Other minor related antibiotic compounds 
produced by B. subtilis include fengycin and iturin, however, these compounds were not 
observed in the REIMS spectra, presumably due to concentrations below the limit of 
detection in the tested strains. 
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Bacillus subtilis mass spectra are dominated by species clustering around m/z 1034 in 
negative ion mode and m/z 1059 in positive ion mode. This cluster can be ascribed to 
[Surfactin(C15)-H]- and [Surfactin(C15)+Na]+ and C13 and C14 homologues, respectively, 
as shown in Table 16. The protonated quasi-molecular ions corresponding to [M+H]+ adducts 
were not observed in positive ion mode. This is due to the high affinity of surfactin for 
sodium cations and high abundance of sodium in living organisms and the culturing medium. 
The same surfactin species although with different relative abundances are found in strains of 
B. pumilus. 
 
Figure 66. Mass spectra obtained from lipopolypeptide producing strains of the Bacillus genus recorded 
using REIMS. 
Table 16. Surfactin species detected in positive and negative ion mode for Bacillus subtilis and Bacillus 
pumilus. 
 Negative ion mode Positive ion mode 
Compound Exp. mass 
Exact mass 
[M-H]- 
ppm Exp. mass 
Exact mass 
[M+Na]+ 
ppm 
Surfactin(C13) 1006.6453 1006.6440 1.3 1030.6389 1030.6416 2.6 
Surfactin(C14) 1020.6604 1020.6597 0.7 1044.6545 1044.6573 2.7 
Surfactin(C15) 1034.6754 1034.6753 0.1 1058.6702 1058.6729 2.6 
Surfactin(C16) 1048.6912 1048.6910 0.2 
   
Surfactin(C17) 1062.7061 1062.7066 0.4 
   
Surfactin(C18) 1076.7216 1076.7222 0.6 
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Doubly charged negative ions of surfactin species (as reported in literature in case of DESI-
MS) were not observed using REIMS.(102) This underlines the strong tendency of REIMS to 
produce singly charged ionic species. Furthermore, significantly higher amounts of 
phospholipids were detected using REIMS than in a comparable DESI study,(102) indicating 
better cell disruption and less influence of ion suppression observed in REIMS. The presence 
of surfactin and its homologues was further confirmed by tandem mass spectrometry 
measurements. Fragmentation patterns observed in negative ion mode (see Figure 67) 
correspond well with fragmentation patterns reported in literature.(102) Fragments can be 
assigned to water loss from the [M-H]- parent ion, neutral loss of the cyclic polypeptide 
moiety (fragment at m/z 241), and partial peptide losses. 
 
Figure 67. REIMS fragmentation spectrum of m/z 1034 corresponding to Surfactin(C15). Red asterix 
indicates fragments reported in Ref. (102) for same compound. 
Lichenysin was observed with alkyl chain lengths of 13-16 carbon atoms with the most 
abundant species being Lichenysin(C15). Detected compounds are listed in Table 17 for 
negative ion mode. Detection of lipopolypeptides surfactin and lichenysin suggests that 
REIMS ionisation mechanism extends to peptide-like structures if compounds possess 
sufficient amphiphilic properties. In conclusion, REIMS offers a rapid and specific 
identification for the Bacillus subtilis complex of organisms which are otherwise challenging 
to differentiate based on traditional phenotypic tests and phylogenetic analysis of the 16S 
rRNA sequences.(203) 
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Table 17. Lichenysin compounds detected in Bacillus licheniformis. 
Compound Exp. mass 
Exact mass 
[M-H]- 
ppm 
Lichenysin (C13) 1005.6594 1005.6600 0.6 
Lichenysin (C14) 1019.6748 1019.6756 0.8 
Lichenysin (C15) 1033.6906 1033.6913 0.7 
Lichenysin (C16) 1047.7055 1047.7070 1.4 
4.2.8. Polyhydroxyalkanoate polymers detected using REIMS 
Polyhydroxyalkanoates (PHAs) are linear polyesters produced naturally by bacterial 
fermentation of sugar or lipids, usually under a shortage of a non-carbonous nutrient, e.g. 
nitrogen. They are produced by the bacteria to store carbon and energy. These polyesters are 
biodegradeable and are used in the production of bioplastics. The simplest and most 
commonly occurring form of PHA is poly-β-hydroxybutyrate (poly-3-hydroxybutyrate, 
P3HB). However, more than 100 different monomers have been reported as PHA 
constituents. Generally, PHAs are classified into three different classes according to 
monomer carbon chain length: short (C3-C5), medium (C6-C14) and long (C>14) chain 
PHAs.(204) More than 90 genera of archea and eubacteria (both Gram-positive and Gram-
negative) have been reported to produce PHAs.(205) 
 
Figure 68. REIMS spectral profile of a clinical isolate of Bacillus cereus displaying polyhydroxybutyrate 
production. I=Intensity value at 100% relative abundance. 
138 
 
All polymers detected using REIMS were consisting of C4H6O2 (polyhydroxybutyrate) 
monomers, however, the exact nature of polymer (P3HB or P4HB) could not be determined 
based on exact mass measurements only. These polymers were found in different amounts in 
strains of Bacillus cereus (see Figure 68), Delftia acidovorans, Burkholderia cepacia 
complex and Achromobacter xylosoxidans.  
The ability of REIMS to detect biopolymer production in several bacterial species offers an 
opportunity for biotechnological applications to rapidly screen organisms for successful 
production of these polymers, average polymer chain lengths and modifications and/or best 
polymer producers. This is equally true for production of biosurfactants as shown in case of 
lipopolypeptides and rhamnolipids.  
4.3. Specificity assessment of REIMS-based microbial ID method 
4.3.1. Specificity on different taxonomic levels 
Suitability of the proposed REIMS method for bacterial identification requires that inter-
species spectral variance needs to be larger than the intra-species variance for different strains 
and phenotypes of the same species. In order to investigate whether this basic condition is 
fulfilled, a dataset was created comprising 15 different clinical isolates for each of 28 
different bacterial species (see Table 18). 
Results of multivariate statistical analyses of the generated dataset are given in Figure 69A 
and B, respectively. Generally the plots resulting from the supervised and unsupervised 
analysis of REIMS data show high similarity. This is due to the fact that REIMS features 
exclusively signals originating from the sample (i.e. not from any chemical background). 
This is an advantage compared to DESI- or MALDI-MS where solvent- and matrix-related 
signals significantly contribute to the overall spectral content.  
Gram-positive and Gram-negative species are separated along the first multivariate 
component in both PCA and RMMC analysis (Figure 69A and B). Compared to Gram-
negative species, Gram-positive bacteria generally show a higher amount of saturated 
phospholipid species and lower relative abundance of phosphatidylethanolamines. These 
observations are in agreement with the bacterial cell membrane composition reported in 
literature.(1)  
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Table 18. Dataset used to assess the specificity of a REIMS-based identification system. 15 clinical isolates 
were used per species. Reprinted with permission from Ref. (142). Copyright 2014 American Chemical 
Society. 
Gram-stain Family Genus Species Growth conditions 
negative Pseudomonadaceae Pseudomonas aeruginosa CBA, aerobic 
Enterobacteriaceae Citrobacter koseri CBA, aerobic 
Enterobacter aerogenes 
cloacae 
CBA, aerobic 
CBA, aerobic 
Klebsiella oxytoca 
pneumoniae 
CBA, aerobic 
CBA, aerobic 
Escherichia coli CBA, aerobic 
Proteus mirabilis CBA, aerobic 
Morganella morganii CBA, aerobic 
Serratia marcescens CBA, aerobic 
Pasteurellaceae Haemophilus influenzae CHOC, aerobic (5 % CO2) 
Burkholderiaceae Burkholderia cepacia complex CBA, aerobic (5 % CO2) 
Xanthomonadaceae Stenotrophomonas maltophilia CBA, aerobic 
Bacteroidaceae Bacteroides fragilis CBA, anaerobic 
Moraxellaceae Moraxella catarrhalis CBA, aerobic 
Neisseriaceae Neisseria gonorrhoeae CBA, aerobic (5 % CO2) 
positive Staphylococcaceae Staphylococcus aureus 
epidermidis 
capitis 
haemolyticus 
hominis 
CBA, aerobic 
CBA, aerobic 
CBA, aerobic 
CBA, aerobic 
CBA, aerobic 
Enterococcaceae Enterococcus faecalis 
faecium 
CBA, aerobic (5 % CO2) 
CBA, aerobic (5 % CO2) 
Clostridiaceae Clostidium difficile CBA, anaerobic 
Micrococcaceae Micrococcus luteus CBA, aerobic 
Streptococcaceae Streptococcus agalactiae 
pyogenes 
pneumoniae 
CBA, aerobic(5 % CO2) 
CBA, aerobic (5 % CO2) 
CBA, aerobic (5 % CO2) 
 
Hierarchical cluster analysis was performed (HCA) in order to investigate how well the 
REIMS spectral profiles follow the bacterial taxonomy as determined by 16S rRNA gene 
sequences. HCA was implemented using Euclidean pairwise distance calculation with a 
complete linkage metric. Three sets of each three strains of the original dataset shown in 
Figure 69A and B were averaged for each bacterial species to form the dataset which was 
subjected to HCA. This step was undertaken in order to facilitate visualisation while still 
incorporating a maximum of the biological variance among strains of a certain species. 
Figure 70 shows that spectral profiles of closely related bacterial species are grouped closely 
together while rather unrelated bacterial species group separately. For the Gram-positive 
species this is visible for each the Staphylococcus spp. (S. aureus, S. capitis, S. epidermidis, 
S. hominis and S. haemolyticus), Streptococcus spp. (S. agalactiae, S. pneumoniae, S. 
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pyogenes) and two Enterococcus spp. (E. faecalis and E. faecium). Streptococcus and 
Enterococcus spp. which both belong to the Lactobacillales order are further situated on the 
same cluster in the HCA.  
 
Figure 69. Pseudo-2-dimensional A) PCA and B) RMMC plots of model comprising 28 different clinically 
relevant bacterial species. Gram-positives are indicated by circles (o), Gram-negatives are represented by 
squares (□). C) and D) are showing PCA plots for only the Gram-positive and Gram-negative species, 
respectively. Reprinted with permission from Ref. (142). Copyright 2014 American Chemical Society. 
Regarding Gram-negative species, all members of the Enterobacteriaceae family (members 
of the genera Escherichia, Citrobacter, Enterobacter, Proteus, Morganella, Klebsiella and 
Serratia) grouped closely together. Furthermore, Pseudomonas aeruginosa, Moraxella 
catarrhalis and Burkholderia cepacia complex strains are all located together in a separate 
cluster when compared to the other Gram-negative species. Pseudomonas spp. and Moraxella 
spp. are both part of the Pseudomonadales order. Although Burkholderia cepacia complex 
strains belong to β-Proteobacteria today, they were previously classified into the 
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Pseudomonas genus(206), thus indicating a high phenotypic similarity between Pseudomonas 
spp. and Burkholderia spp. which explains their proximity on the HCA dendrogram (see 
Figure 70). The same trends were observed in the PCA plots for Gram-positive and Gram-
negative-species only (see Figure 69C and D). Similarly to HCA, these results demonstrate 
that REIMS spectral profiles largely follow taxonomical trends. The overall agreement with 
the bacterial taxonomy is expected to increase with larger coverage of bacterial diversity 
among different phyla, classes and orders. 
 
Figure 70. Hierarchical cluster analysis (HCA) of the dataset shown in Table 18 and Figure 69. Reprinted 
with permission from Ref. (142). Copyright 2014 American Chemical Society. 
The presented RMMC model (Figure 69B) was cross-validated in order to assess the 
specificity of the REIMS method on Gram-, genus- and species-level. Cross-validation was 
performed using leave-one-out cross-validation and three nearest neighbours as classifier. In 
leave-one-out cross-validation, each data point is left out from the supervised model once and 
then projected into the generated data space and classified according to a given criterion (here 
according to its 3 nearest neighbours). Therefore, this type of cross-validation shows 
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similarity with blind identification tests and is applied here to assess the specificity of the 
method. However, for Gram-level cross-validation an entire bacterial species was left out at a 
time. Cross-validation results yield 95.9%, 97.8% and 100% correct classification at species-, 
genus- and Gram-level, respectively. Misclassifications were only observed for closely 
related bacterial species and comprised three misclassifications within the Staphylococcus 
genus, five misclassifications within the Enterococcus genus and nine misclassifications 
within the Enterobacteriaceae family. Misclassifications are defined in comparison to 
identifications provided by a commercial MALDI-TOF-MS instrument as obtained during 
routine clinical work. The correct identification statistics is therefore not expected to be better 
than those reported in literature for commercial MALDI MS systems.  
4.3.2. Dependence of the correct identification performance on spectral resolution 
In order to assess the mass resolution required to reliably distinguish between the different 
bacterial species as shown in Figure 69, the original data were binned using varying bin sizes. 
Aligned raw data were normalised to the total ion count (TIC) and log-transformed for each 
bin size individually before unsupervised and supervised multivariate analyses were carried 
out (for respective PCA plots obtained for bin sizes 0.01, 0.1 and 1Da see Figure 72A, B and 
C, respectively). The minimum resolution required for accurate classification using REIMS 
was assessed by comparing the results of cross-validations for each bin size. As for the model 
shown in Figure 69, leave-one-out cross-validation was used at species- and genus-level, 
whereas leave-species-out cross-validation was performed at Gram-stain-level. 
 
Figure 71. Cross-validation results for the dataset shown in Figure 69 as a function of the bin size on 
species-, genus-, and Gram stain-level. Reprinted with permission from Ref. (142). Copyright 2014 
American Chemical Society. 
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Figure 72. Results of unsupervised (left) and supervised (right) analysis for the dataset shown in Figure 
69 using A) 0.01Da, B) 0.1Da, and C) 1Da bin size. Reprinted with permission from Ref. (142). Copyright 
2014 American Chemical Society. 
The results given in Figure 71 show that no considerable loss in identification accuracy was 
observed neither at species-, genus- nor Gram-stain-level for different bin sizes between 0.01 
and 1Da. These data strongly suggests that a mass analyser working at unit resolution would 
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be sufficient for the routine identification of unknown bacteria. Even a bin size of 5Da does 
not result in a significant loss of identification accuracy, clearly indicating the presence of 
major spectral differences even between closely related species.  
Nevertheless, performing analysis on a high resolution mass spectrometer facilitates 
identification of unknown spectral features by exact mass measurements. In addition, using 
high-resolution data leads to more compact data groups in PCA and improved information 
recovery as can be seen in case of Lactobacillales in Figure 72, where separation of the S. 
agalactiae group from other Streptococcus spp. gets less pronounced towards higher bin 
sizes. Similarly, S. maltophilia and B. fragilis are observed to move towards the group of 
Gram-negative bacteria suggesting a loss of significant features towards larger bin sizes. 
To test how well the REIMS spectra are following the phylogenetic tree of bacteria on a more 
comprehensive dataset, a reduced dataset was created from the entire database listed in Table 
5 containing only one strain for each of the 217 bacterial species listed in Appendix 4 to 
enable visualisation using multivariate statistical methods.  
PCA was applied to initially assess the similarity between REIMS spectral profiles of 
bacterial species on different higher taxonomical levels such as Gram-, phylum-, class- and 
order-level. HCA analysis is traditionally more commonly used for this purpose; however, 
PCA is better suited for a more intuitive visualisation of large datasets as the one presented 
here. In Figure 73A, all 217 species are coloured based on their Gram-stain behaviour. Figure 
73B and C each show the same PCA plot, however, the labelling is according to phylum (B) 
and class (C) of the phylogenetic tree and are intended to facilitate the visualisation of the 
clustering on different taxonomic levels. In Figure 73A, an overall good separation can be 
observed for Gram-positive and Gram-negative species along the first principal component. 
However, Gram-negative species are clearly separated into two distinct clusters while Gram-
positive species show a tentative separation into three different clusters. For Gram-negative 
species this separation can be attributed to the different phyla Proteobacteria and 
Bacteroidetes (see Figure 73B). Bacteroidetes are clearly separated from all other bacterial 
species along the second principal component indicating their very special membrane lipid 
composition containing large amounts of otherwise rare sphingolipids. Furthermore, 
Flavobacteria and Bacteroidetes show a good separation on class-level along the second 
principal component in the plot displayed in Figure 73D for Gram-negative species only. 
Although further trends are visible for separation of Fusobacteria and Alpha-Proteobacteria, 
no further distinct separation is visible along the first two principal components in Figure 
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73D indicating a large amount of heterogeneity among the different bacterial species and 
making it unlikely to find specific biomarkers at high taxonomic levels such as phylum, class 
and order for non-Bacteroidetes species. 
 
Figure 73. Principal components analysis plots from a dataset comprising 217 bacterial species different 
phylogenetic levels. A) Gram-level, B) phylum-level, C) Class-level, D) Class-level, Gram-negative species 
only, E) Class-level, Gram-positive species only, F) Order-level, Gram-positive species only. 
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Unlike in case of Gram-negative bacteria, the separation among Gram-positive bacteria 
cannot be correlated with systematic spectral differences on phylum-level. The members of 
the Negativicutes class are outliers from the centre of the Gram-positive cluster and are 
located next to members of the Gram-negative phylum Proteobacteria, suggesting a markedly 
different lipid composition from their Gram-positive counterparts. In fact, although 
Negativicutes are a class of firmicute bacteria, due to their peculiar cell wall composition 
their Gram-staining behaviour is negative. Negativicutes are the only diderm members of the 
Firmicutes phylum and as such possess inner and outer membranes in the same way as Gram-
negative bacteria. Nevertheless, although phylogenetic analysis based on DNA sequences 
reveals significant heterogeneity within the Firmicutes phylum, no close relationship was 
found between Negativicutes and Proteobacteria.(207) No further separation is visible when 
investigating Gram-positive classes only. However, if strains are labelled according to 
bacterial order (Figure 73F), more clear clustering is visible within the different phyla. The 
class of Bacilli separates into the two orders of Bacillales and Lactobacillales. Bacillales are 
forming a cluster with Micrococcales, all of which were observed to contain large amounts of 
saturated phospholipid species in their REIMS spectral profiles.  
The clustering results based on REIMS spectral profiles do not exactly match those expected 
based on 16S rRNA sequences, but rather as shown earlier in this study follow phenotypic 
characteristics which are rather determined by the environmental niche a bacterium lives in. 
Significant heterogeneity is observed especially among the very large phyla Proteobacteria, 
Actinobacteria and Firmicutes. However, better clustering results are obtained on lower 
taxonomic levels (order, family, genus). These results suggest that a general identification 
algorithm based on a decision-tree of phylogenetic relationships between bacteria is not likely 
to yield reliable identification results.  
The appearance of occasional outliers is expected as the strains used to build this dataset were 
clinical isolates identified only based on their MALDI-TOF-MS results on the Bruker 
BioTyper instrument and were not further validated using molecular methods. MALDI-TOF-
MS was performed on bacterial samples that were prepared using the direct smear technique 
which further reduces the correct identification rates.(208) 
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4.3.3. Inter-platform comparison 
An independent set of clinical isolates for blind identification tests was cultured on various 
different growth media (see Table 19 for details) and subsequently analysed using an 
Orbitrap Discovery or a Xevo G2-S Q-TOF instrument (the latter being equipped with a 
modified atmospheric interface). In all cases, a minimum of two different culturing media 
were used per species. Only enriched (blood containing) media were investigated in case of 
N. gonorrhoeae and S. agalactiae due to limitations in growth on other media. However, 
chocolated/non-chocolated and selective agars were included in this study.  
Acquired spectra (full mass range) were classified based on a subset of nine different species 
of the previously generated model shown in Figure 69 which were all cultured on Columbia 
horse blood agar. Since a 1Da sampling interval proved sufficiently specific, these blind 
identification tests were performed at a common bin size of 1Da. This further compensates 
for the differences in mass resolution of the different instruments. 
Table 19. Details of sample set analysed in the cross-platform comparison (Figure 74). Reprinted with 
permission from Ref. (142). Copyright 2014 American Chemical Society. 
Gram-stain Family Genus Species Growth mediaa 
negative Pseudomonadaceae Pseudomonas aeruginosa CBA, BAB, CHOC, LB, MCC, ISO, MH, 
MH+B, TS 
Enterobacteriaceae Escherichia coli BHI, BAB, CBA, CHOC, ISO, MH+B, MH, TS 
Moraxellaceae Moraxella catarrhalis BHI, CBA, CHOC, MH, MH+B, TS 
Neisseriaceae Neisseria gonorrhoeae CBA, CHOC, VCAT, ISON 
Xanthomonadaceae Stenotrophomonas maltophilia BHI, CBA, CHOC, MH, MH+B, TS 
positive Staphylococcaceae Staphylococcus aureus AZT, BAB, BHI, CBA, ISO, LB, MH, TS 
Streptococcaceae Streptococcus agalactiae CBA, ISON 
Clostridiaceae Clostridium difficile CBA, Braziers 
Micrococcaceae Micrococcus luteus CHOC, BHI, TS, CBA, MH+B, BAB, MH 
Abbreviations: LB = Luria-Bertani agar, BAB = Blood agar base, MCC = McConkey agar, CBA = Columbia horse blood agar, BHI = Brain-heart 
infusion agar, TS = Trypticase soy agar, CHOC = Chocolate agar, ISO = Iso-sensitest agar (for antimicrobial susceptibility testing), MH = 
Mueller-Hinton agar, MH+B = Mueller-Hinton agar containing horse blood, ISON = Iso-sensitest agar with blood and NAD, Braziers = 
Braziers Clostridium difficile selective agar, AZT = Aztreonam blood agar (selective agar for Gram-positives), VCAT = Chocolate agar 
including Vancomycin, Colistin, Amphotericin and Trimethoprim (selective for N. gonorrhoeae) 
 
The described experiment yielded 100% correct blind identification results for strains 
acquired on the Orbitrap instrument (same mass analyser as training set) and 97.8% correct 
identification for the files acquired using the Xevo Q-TOF instrument (see confusion matrix 
in Table 20). The two misclassifications are tentatively attributed to the differences in noise 
structure between the different mass analysers used for training and test set. In addition, as 
the RMMC plot shown in Figure 74 demonstrates, very little separation originating from the 
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different instruments and or mass analysers is shown in case of supervised analysis and the 
inter-species variance clearly dominates the plot. This demonstrates that the spectral profiles 
obtained using REIMS are highly reproducible, even considering the conceptually different 
atmospheric pressure interfaces of the two different types of mass analysers.  
 
Figure 74. RMMC plot showing the combined data acquired on three different instruments (Exactive, 
Orbitrap, and Xevo). Bin size 1Da, m/z 200-2000. Confusion matrices for cross-platform blind 
identification results are given in Table 20. Reprinted with permission from Ref. (142). Copyright 2014 
American Chemical Society. 
Table 20. Confusion matrices for blind identification tests using different experimental platforms. Both 
Orbitrap and Xevo data was classified based on the model recorded on the Exactive instrument. 
Reprinted with permission from Ref. (142). Copyright 2014 American Chemical Society. 
T
a
rg
e
t 
C
la
ss
, 
E
xa
ct
iv
e
 
C. difficile  10 0 0 0 0 0 0 0 0   10 0 0 0 0 0 0 0 0 
E. coli  0 10 0 0 0 0 0 0 0   0 10 0 0 0 0 0 0 0 
M. catarrhalis  0 0 10 0 0 0 0 0 0   0 0 10 0 0 0 0 0 0 
M. luteus  0 0 0 10 0 0 0 0 0   0 0 0 10 0 0 0 0 0 
N. 
gonorrhoeae  
0 0 0 0 10 0 0 0 0   0 0 0 0 10 0 0 0 0 
P. aeruginosa  0 0 0 0 0 10 0 0 0   0 0 0 0 0 10 0 0 0 
S. agalactiae  0 0 0 0 0 0 10 0 0   0 0 0 0 0 0 10 0 0 
S. aureus  0 0 0 0 0 0 0 10 0   0 0 0 0 0 0 0 10 0 
S. maltophilia  0 0 0 2 0 0 0 0 8   0 0 0 0 0 0 0 0 10 
  
C
. 
d
if
fi
ci
le
 
E
. 
co
li
 
M
. 
ca
ta
rr
h
a
li
s 
M
. 
lu
te
u
s 
N
. 
g
o
n
o
rr
h
o
e
a
e
 
P
. 
a
e
ru
g
in
o
sa
 
S
. 
a
g
a
la
ct
ia
e
 
S
. 
a
u
re
u
s 
S
. 
m
a
lt
o
p
h
il
ia
 
 
C
. 
d
if
fi
ci
le
 
E
. 
co
li
 
M
. 
ca
ta
rr
h
a
li
s 
M
. 
lu
te
u
s 
N
. 
g
o
n
o
rr
h
o
e
a
e
 
P
. 
a
e
ru
g
in
o
sa
 
S
. 
a
g
a
la
ct
ia
e
 
S
. 
a
u
re
u
s 
S
. 
m
a
lt
o
p
h
il
ia
 
  
Predicted Class, Xevo 
 
Predicted Class, Orbitrap 
  
149 
 
4.3.4. Comparison of spectral profiles for bacteria cultured on liquid and solid 
culturing medium 
In routine clinical microbiology settings the vast majority of strains are isolated and cultured 
on solid agar-based culturing medium. Solid culturing medium has several advantages 
compared to liquid culturing media, of which the most important is the visual information 
that can be obtained by observing colony size and morphology, swarming behaviour, colony 
colour or discolouration in the agar surface by lysis of agar constituents or by excretion of 
coloured secondary metabolites. It also facilitates the detection of possible contaminants and 
enables standardised antibiotic sensitivity testing. Advantages of liquid culturing medium on 
the other hand include more homogenous nutrient distribution and better reproducibility of 
culturing conditions. The long-term goal of a REIMS-based microbial identification tool 
however is the development of a method that is applicable to the direct analysis of clinical 
samples such as blood, urine, sputum or pus – all of which more closely resemble liquid 
culturing conditions. 
To assess the influence of the two different culturing modes, 15 bacterial species were 
cultured both in liquid (5mL volume in 25mL flask) and solid brain-heart-infusion medium 
(standard 9cm Petri-dishes; both commercially available from E&O Laboratories Ltd.). The 
detailed sample set is listed in Table 21. All strains were incubated for 48 hours at 37°C. 
Liquid cultures were grown on a static shelf due to restrictions imposed by working within a 
clinical microbiology laboratory handling patient samples. The lids of the liquid culturing 
flasks were only loosely attached to avoid contaminations, but enable gas exchange by 
diffusion. B. fragilis and C. difficile were grown under anaerobic conditions, S. pneumoniae 
and S. agalactiae as well as E. faecium and E. faecalis were grown aerobically in an 
atmosphere containing 5% CO2. All other isolates were cultured under standard aerobic 
conditions. Although 10 individual strains were prepared per bacterial species in each liquid 
and solid medium, the actual numbers of isolates per species deviate from this number. This 
is due to exclusion of contaminated specimens or a lack in growth or availability. In case of 
S. pneumoniae no growth was observed on all ten solid cultures while good growth was 
observed in liquid culture medium. Numbers of isolates of >10 include back-up strains which 
were cultured and analysed to replace other strains that fail to achieve necessary quality. 
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Table 21. Sample set compiled to investigate the effect of liquid and solid culturing medium. 
Gram-stain Family Genus Species 
number of strains 
liquid culture solid culture 
negative Pseudomonadaceae Pseudomonas aeruginosa 9 10 
 Moraxella catarrhalis 9 9 
Bacteroidaceae Bacteroides fragilis 5 9 
Enterobacteriaceae Escherichia coli 9 11 
Enterobacter cloacae 9 10 
Klebsiella pneumoniae 10 9 
Proteus mirabilis 11 10 
positive Staphylococcaceae Staphylococcus aureus 10 11 
  hominis 6 10 
  epidermidis 9 11 
Streptococcaceae Streptococcus agalactiae 7 10 
  pneumoniae 6 - 
 Enterococcus faecalis 10 10 
 Enterococcus faecium 10 13 
Clostridiaceae Clostridium difficile 10 9 
 
Direct analysis of liquid cultures resulted in poor spectral quality due to the restrictions 
imposed on evaporation temperature and the dilution of bacterial cells by the culturing 
medium. Thus, bacterial cultures were centrifuged at 12500g for 10 minutes prior to analysis 
and the supernatant discarded. No further sample preparation was performed and the cell 
pellets were directly subjected to REIMS analysis. The observed spectral profiles were 
visually assessed for major spectral differences and subsequently subjected to multivariate 
statistical analysis. 
For about half of the bacterial species analysed (P. aeruginosa, all members of the 
Enterobacteriacae family, Moraxella catarrhalis, and Streptococcus agalactiae.), no 
systematic variation in the spectral profiles associated with the culturing mode was observed. 
However, in the rest of the cases clear differences could be observed originating from 
differential relative signal intensity of certain phospholipid species. Figure 75 and Figure 76 
display the two different cases of largely identical spectral profiles in case of P. aeruginosa 
and major changes to spectral appearance in case of Staphylococcus aureus.  
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Figure 75. REIMS spectral profiles obtained from a clinical isolate of P. aeruginosa grown in solid (top) 
and liquid (bottom) culturing medium. 
 
Figure 76. REIMS spectral profiles obtained from Staphylococcus aureus ATCC 6538 grown in solid (top) 
and liquid (bottom) culturing medium. 
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In case of all Staphylococcus species, liquid culturing conditions were often observed to 
result in a relative increase of saturated phosphatidylglycerol species of longer chain lengths 
and an increase in relative intensity of cardiolipins. A very similar behaviour was observed 
when S. aureus strains were grown on solid medium under anaerobic conditions (see 
Characterisation of spectral reproducibility, Figure 45). This suggests the possibility of 
reduced oxygen availability in liquid culture (especially considering that culture was 
performed on a static shelf) as origin of the spectral changes rather than the actual fact that 
culturing was performed in liquid medium.  
However, no general assumptions can be deducted regarding the bacterial phenotypes 
expressed under different culturing conditions since each bacterial species showed 
characteristic spectral differences. In addition, biological variations were also observed 
between different strains of the same bacterial species. Thus, principal component analysis 
was used to further investigate whether the extent of changes in spectral appearance is 
exceeding the spectral variance between different bacterial species.  
 
Figure 77. PCA plots of datasets comprising A) only solid cultures, B) only liquid cultures and C) both. 
The resulting PCA score plots are shown in Figure 77 for bacteria cultured on solid medium 
(A), liquid medium (B) and both datasets combined (C). Differences in the score plots can be 
observed for liquid and solid cultures regarding the compactness of groups and their distance 
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from each other. In addition, slight differences can also be observed in relative positioning of 
the groups. This is particularly clear in case of data points corresponding to C. difficile, M. 
catarrhalis and P. aeruginosa. C. difficile datapoints observed from solid culture form a very 
distinctive cluster located equally distant from all other datapoints (apart from single isolate 
which clusters with Enterobacteriaceae and is therefore most likely a contaminant) while in 
liquid culture they are closely located to the Streptococcus spp. data points. Similarly, M. 
catarrhalis and P. aeruginosa (both Pseudomonadaceae) are located close to Gram-negative 
Enterobacteriaceae when grown on solid culturing medium while they are closer located to 
Steptococcaceae when grown on liquid medium. However, overall the similarity between 
both PCA plots is high and suggests no significant changes of spectral profiles but conserved 
spectral features that differ in relative intensities. This is further demonstrated by the PCA 
plot of the resulting combined data set which shows an overall very similar appearance to the 
previous two PCA plots and clearly shows that the same closely related bacterial species 
continue to cluster together while unrelated strains show greater distance to each other. 
Figure 77C suggests that spectral differences are negligible in case of P. aeruginosa, M. 
catarrhalis and members of the Enterobacteriaceae family while there are are systematic 
intra-species changes in case of C. difficile, B. fragilis and Enterococcus and Staphylococcus 
spp. which while still clustering close to each other show two distinct data clusters for those 
strains grown on solid and on liquid culturing medium. 
These results indicate that there are effects on the spectral profiles if culturing is performed in 
liquid culturing medium rather than on solid medium. As most biological fluids and tissues 
have to be regarded as liquid rather than solid medium, it is thus important to include bacteria 
grown on liquid medium into the database for future direct on-sample applications. 
4.3.5. Testing of sensitivity and specificity at sub-species level 
4.3.5.1. Strain-level specificity 
A set of seven standard E. coli laboratory strains (NCM3722, MG1655, MC1000, MC4100, 
DH5α, C600, and OP50) was analysed in order to test whether the specificity of the presented 
method goes beyond genus- and species-level and allows the identification of bacteria at 
strain-level. Strains NCM3722, MG1655, MC1000, MC4100, DH5α and C600 are all derived 
from the K-12 parent strain, whereas OP50 is a B-strain derivative. The effect of culture 
conditions was further investigated by forming a dataset including the strains grown to 
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different culture ages (1-4 days, on Luria-Bertani agar) and on five different solid culture 
media (Luria-Bertani agar, blood agar base, brain-heart infusion agar, trypticase soy agar, 
MacConkey agar). Data acquisition was performed using the linear ion trap of the LTQ 
Orbitrap Discovery instrument working at unit resolution. Data was TIC normalised and 
reduced to the mass range of m/z 600-900 which was found to improve identification 
performance. While no significant changes in spectra could be observed for different culture 
ages between 1-4 days, changes in relative phospholipid signal ratios were observed for 
different culturing media.  
 
Figure 78. A) PCA-LDA model of seven different E. coli strains. Data was TIC normalised and reduced to 
m/z 600-900. B) Cross-validation results CV=87.3%. Data points classified as outliers if located outside 3x 
the standard deviation from the group mean. 
Application of a supervised PCA-LDA classification algorithm leads to 87.3% accurate 
identification results using leave-one-out cross-validation (LDA plot shown in Figure 78A). 
As Figure 78 shows, OP50 as only B-strain is clearly separated from the K-12 derivatives 
along the first principal component. The RMMC algorithm in this case was found to be 
inferior to the PCA-LDA approach, only yielding 85.3% correct cross-validation results. This 
observation (together with the reduction of mass range) suggests that different identification 
algorithms used at different levels of identification (subspecies-level vs. higher taxonomical 
levels) might further improve the identification performance. Figure 78B shows the confusion 
matrix of the cross-validation results obtained from the model shown in Figure 78A. The 
majority of misclassifications occured between two strains (MC1000 and MC4100). 
Therefore, the 5 of 7 analysed strains self-identify largely correctly despite being cultured on 
different media and for different durations. This suggests that REIMS generally can deliver 
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strain-level specificity, with likely better identification outcomes if culturing was performed 
under standardised conditions. 
4.3.5.2. Serotyping of Streptococcus pneumoniae 
Streptococcus pneumoniae is a Gram-positive bacterium that causes diseases such as 
bacteraemia, meningitis and infections of the respiratory tract, especially in young children 
and the elderly with most cases occurring in the developing world. Streptococcus 
pneumoniae cells are covered with layers of polysaccharides forming a capsule which acts as 
an essential factor in virulence. 93 distinct pneumococcal serotypes have been identified, 
however, only a comparably small number of these serotypes are accounting for most cases 
of infection. Vaccines are available for this pathogen, but for guiding vaccine composition 
development, epidemiological information on serotypes causing infectious outbreaks is 
critically important.(209) Identification of S. pneumoniae serotypes is most commonly 
performed using the Quellung reaction which involves adding an antibody solution to a broth 
of S. pneumoniae and observing a positive reaction indicated by “swelling” of the bacterial 
cells which is observed using a light microscope. This test is laborious and time-consuming 
and consists of a range of subsequent individual tests until a serotype is unambiguously 
identified. Usually antibody solutions are added in mixtures of several antibodies at a time to 
reduce amount of tests necessary.(210) Molecular serotyping methods involving PCR tests 
were found to be more cost-effective, however, are still comparably laborious and time-
consuming.(211) Therefore, a straightforward way to distinguish between different 
pneumococcal serotypes without the need to introduce further sample processing steps 
besides those needed for species-level identification would have a huge impact on daily 
microbiological practice. 
A collaboration was established with Dr. Irene Burkhardt, a consultant microbiologist from 
the Universitatsklinikum Heidelberg, Germany who kindly agreed to send a set of each 10 
strains of three different serotypes for analysis using REIMS. Strains were grown on horse 
blood agar for 48hrs under an atmosphere containing 5% CO2 and subsequently analysed 
using a Thermo Exactive instrument. Results of multivariate statistical methods applied to the 
dataset are shown in Figure 79. Trends toward separation can be seen in the PCA plot and 
better separation is visible for the supervised PLS analysis. Cross-validation results for the 
obtained dataset give 77.8% correct classification into the three different serotypes. The 
confusion matrix shown in Figure 79 shows that while there are 3 misclassifications between 
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serotype 19A and each serotype 14A and 3, there are no misclassifications observed between 
serotypes 14 and 3. These results suggest that there is some information concerning serotypes 
in the lipid-based REIMS spectral data which in turn suggests that the bacterium makes slight 
modifications in membrane lipid composition to accomodate different polysaccharide 
moieties. Targeted improvements in sampling and data analysis procedures as well as 
increasing the size of the dataset might lead to improvements on classification. Further 
experiments using a larger number of strains and serotypes will be required to fully assess 
specificity and investigate the origin of the larger difference between serotypes 14 and 3 in 
comparison to serotype 19A. Alternative chromatography-based profiling of the saccharide 
moieties and correlation with gene/protein analyses can additionally be used to further assess 
this phenomenon. 
 
 
Figure 79. PCA (top left) and PLS (top right) plot for three different S. pneumoniae serotypes. Cross-
validation results are 77.8% (bottom). 
4.3.5.3. Ribotyping of C. difficile 
Clostridium difficile is a Gram-positive anaerobic bacterium and infections are often 
nosocomially acquired after broad-band antibiotic treatment, which allows excessive growth 
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of this hardy spore-forming species. More than 300 PCR ribotypes are recognised, however, 
in routine clinical microbiology, severe C. difficile outbreaks are often associated with certain 
ribotypes such as ribotype 027 or 078 which are thought to be particularly pathogenic. 
Therefore it is especially interesting for clinical microbiology laboratories to establish 
whether an infection was acquired during the hospital stay (nosocomial – all patients would 
be expected to have been infected by a strain of the same ribotype) or whether the infection 
was caused by a strain acquired before entering the hospital. 
Ribotyping of C. difficile is routinely performed by isolating C. difficile on species-specific 
media (such as Braziers medium), DNA extraction and subsequently performing PCR 
amplification of the 16S-23S intergenic spacer region to determine the ribotype pattern. This 
process is very time consuming and labour intensive, thus, the specificity of the REIMS 
technique was investigated for this particular problem.  
Each 10 strains of three different ribotypes of C. difficile were cultured on Columbia horse 
blood agar for 24hrs under anaerobic conditions. The ribotypes included 002 and 014 which 
are regarded to be less pathogenic and the more pathogenic ribotype 078. Strains were 
analysed on the Thermo Exactive instrument under standard conditions in a randomised 
fashion. C. difficile strains were further randomised with unrelated bacterial species. Data 
was subsequently subjected to multivariate statistical analysis. 
 
Figure 80. PCA (left) and RMMC (right) multivariate statistical plots for three different ribotypes of C. 
difficile. Overall classification accuracy is 90%.  
Both in supervised and unsupervised analysis, clear separation trends were observed between 
the less (002 and 014) and the more pathogenic ribotype (078) along the first principal 
component (see Figure 80). When performing cross-validations of the supervised RMMC 
model, no misclassifications are obtained between more and less pathogenic strains, but the 
only misclassifications observed are between the less pathogenic 002 and 014 ribotypes. 
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Overall cross-validation accuracy is 90%. These results sugges that C. difficile does show 
different lipid profiles, especially between those ribotypes that show differences with regard 
to pathogenicity. However, further experiments including larger numbers of ribotypes are 
required to validate this separation. 
4.3.5.4. Antibiotic resistance in K. pneumoniae 
Antibiotic resistance of microorganisms is a global problem of increasing significance that 
often complicates treatment of infections. The protein profiles that are acquired during 
routine MALDI-TOF-MS analysis do not deliver sufficient information on the antibiotic 
resistance pattern.(212) This means that although MALDI-TOF-MS allows the rapid 
identification of an organism in clinical settings, the determination of antibiotic sensitivity 
still has to be performed separately using conventional culturing-based methods. For this 
purpose, bacteria are streaked in a film onto one to three agar plates and an array of 5-15 
antibiotic discs will be placed on top of the agar surface. Antibiotic susceptibility is 
determined based on the size of the inhibition zone around the antibiotic disk. This process is 
expensive in terms of personnel and consumables and usually requires incubation for another 
24-48hrs based on the organism. Numerous MALDI-based technique were developed over 
the last 15 years,(212) and the detection of β-lactamase activity is arguably the most 
developed method. This method is applicable to β-lactam antibiotics such as ampicillin, 
piperacillin, cefotaxime, ceftazidime, ertapenem, imipenem, and meropenem. The bacterium 
is placed into liquid growth medium containing low concentrations of the antibiotic. 
Subsequently, not the protein profile of the bacterium is analysed, but the bacterial hydrolysis 
product in the culture supernatant that is produced from a resistant organism.(213) Usually 2-
6 hours of incubation are sufficient to detect the drug metabolite due to the high turn-over 
rate of β-lactamases which results in resistance information being available the same day as 
the MALDI organism identity. This methodology did not gain approval for clinical use yet 
and requires the MALDI instrument to be used under non-routine settings, does require a 
non-routinely performed liquid culturing step and only works for a single antibiotic (or group 
of related antibiotics) at a time.  
The possible application of a REIMS-based test to determine antibiotic sensitivity patterns 
was assessed in case of carbapenemase-producing Klebsiella pneumoniae, an emerging group 
of pathogens that show resistence to carbapenem antibiotics. Carbapenems are members of 
the β-lactam class and frequently used to treat infections known or suspected to be caused by 
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multidrug-resistant bacteria. Although it was originally detected in K. pneumoniae and 
thought to be genus-specific, production of carbapenemase is an important resistance 
mechanism for an increasing number of Gram-negative bacteria and poses significant 
challenges to clinicians due to limited number of antibiotics available for treatment of 
affected patients. Although carbapenemase-production is not the only mechanism inducing 
carbapenem-resistance,it is of particular interest, since it is is commonly missed by routine 
antibiotic sensitivity testing and it may induce resistance to virtually all β-lactam antibiotics 
and thus it is associated with high mortality rates.(214) 
A test to determine carbapenemase production using MALDI-TOF-MS was demonstrated to 
identify producers of NDM-1, VIM-1, KPC, OXA-48 and OXA-162 carbapenemases in a 
quick and cost-effective test. Nevertheless, this test requires additional sample preparation 
steps and 2h incubation with the antibiotic reagent.(215) To assess the feasibility of 
determining antibiotic sensitivity using REIMS, sampling was performed on 22 strains of K. 
pneumoniae (sensitive n=10, resistant n=12) grown for 18hrs on ISO sensitest agar (Oxoid, 
Basingstoke, UK) with a single disk of 10mcg ertapenem (ETP 10) close to the rim of the 
Petri-dish (approx. 2cm from the rim towards center of the dish). Two sampling points were 
taken from each plate, one at the border of bacterial growth towards the antibiotic disk, and a 
second one at the opposite end of the Petri-dish. Carbapenem-resistant strains were 
molecularly analysed to identify the resistance mechanism (2xKlebsiella pneumoniae 
carbapenemase (KPC), 5xNDM metallo beta lactamase, 3xOXA-48 carbapenemase, 2xVIM 
metallo beta lactamase) as part of a project performed at the Department of Microbiology 
(Charing Cross Hospital, London, UK). 
 
Figure 81. RMMC plot of carbapenem-resistant (red) and sensitive (orange) Klebsiella pneumoniae. 
Cross-validation results 75% accuracy. 
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No signal corresponding to the antibiotic ertapenem or its metabolites could be detected in 
the REIMS spectra, thus REIMS spectral profiles were subjected to multivariate statistical 
tools for pattern recognition analysis. While no separation could be observed in PCA 
analysis, using supervised RMMC analysis leads to separated datagroups for datapoints 
corresponding to resistant and sensitive K. pneumoniae (see Figure 81). When performing 
leave-strain-out cross-validation, an overall classification accuracy of 75.0% was obtained. 
Misclassifications were randomly distributed over sensitive and resistant strains. For resistant 
strains, misclassifications could not be associated with a particular resistance mechanism. 
Although overall accuracy was not very good, this might be improved using larger sample 
sets as is commonly observed for pattern recognition algorithms.(216) However, the current 
results suggest that REIMS spectral profiles contain some degree of information on antibiotic 
sensitivity and might be a useful tool to help clinicians decide on suitable antibiotic treatment 
more quickly than using standard clinical microbiology workflows by providing indicative 
treatment suggestions without any additional hands-on work required. This would allow for 
the right treatment to be given while more time-consuming follow-up tests could be 
performed. 
4.3.6. Analysis of yeasts 
Clinical microbiologists are increasingly being confronted with infections caused by fungal 
pathogens, especially in immuno-compromised patients such as those suffering from HIV or 
cystic fibrosis (CF).  
Identification of yeasts using MALDI-TOF-MS requires the pre-treatment of the yeast 
sample prior to mass spectrometric analysis in order to give reliable identification 
performances (score >2.0). While the recommended sample pre-treatment for MALDI-TOF-
MS comprises the complete extraction of the fungal material using formic acid and 
acetonitrile,(63) intact yeast species can directly be analysed by REIMS without any 
modifications in experimental setup or analysis workflow and without compromising spectral 
intensity. 209 strains of 16 different genera of pathogenic yeasts have been recorded until 
today, however, statistically significant numbers of strains per species (>10 strains) have only 
been recorded for the following five Candida species: C. albicans, C. glabrata, C. 
parapsilosis, C. lusitaniae and C. tropicalis. 
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Figure 82 shows the PCA plot of a dataset comprising 298 strains of bacteria (87 species, 
both Gram-negative and Gram-positive) and 209 strains of yeasts (16 species). No overlap 
between bacteria and fungi was observed in the PCA data space and cross-validation shows 
100% correct classification using a leave-genus-out approach for the supervised RMMC 
model. This was attributed to the markedly different phospholipid composition between 
bacteria and fungi. Whereas REIMS spectra obtained from bacteria mostly feature PGs, PEs 
and low abundance PAs, the spectra obtained from yeasts mainly feature highly abundant 
PAs, PEs and phosphatidylinositols (PIs), with the latter being very rare among bacteria. Of 
the >228 bacterial species recorded until the end of this project, PIs have only been found in 
some members of the Actinobacteria phylum such as Corynebacterium spp., Nocardia spp., 
Mycobacterium spp., Rhodococcus spp., Actinomyces spp., Rothia spp., Propionibacterium 
spp.. 
 
Figure 82. PCA plot generated from a dataset comprising a variety of bacteria and yeast. Reprinted with 
permission from Ref. (142). Copyright 2014 American Chemical Society. 
As it is shown by the PCA plot in Figure 82, the data cloud representing bacteria exhibits a 
much larger extension than the one representing yeasts. This in turn means that the 
phospholipid constituents of bacteria display a much wider variety and variability than for 
yeasts. Indeed, REIMS spectral profiles of bacteria are differing extensively, whereas the 
REIMS spectra of yeasts, similarly to mammalian tissue spectra, have an overall very 
conserved appearance with observed differences largely arising from different phospholipid 
ratios rather than lipid species being present or completely absent.  
To determine whether REIMS is able to distinguish yeast species despite the apparently 
smaller spectral variability, five different clinically relevant Candida species were analysed. 
Figure 83 shows the separation of the resulting data groups both in supervised and 
unsupervised analysis. C. glabrata is clearly separated from the four other species along the 
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first principal component while C. lusitanie, C. parapsilosis, C. tropicalis and C. albicans are 
largely separated along the second principal component. This separation into two groups is 
tentatively attributed to the fact that C. glabrata was found to belong to a separate 
phylogenetic clade than the other Candida species based on DNA sequences.(135) Two 
misclassifications were observed when performing leave-one-out cross-validation resulting in 
98.8 % correct classification.  
 
Figure 83. A) PCA and B) RMMC plot of C. albicans (n=20), C. glabrata (n=19), C. lusitaniae (n=12), C. 
parapsilosis (n=19) and C. tropicalis (n=16). CV = 98.8 %. Reprinted with permission from Ref. (142). 
Copyright 2014 American Chemical Society. 
The clear separation of Candida glabrata from all the other Candida spp. cannot be 
explained by variation of a single molecular species but is a result of an overall different 
spectral profile. This can clearly be seen in the ANOVA plot displayed below (Figure 84). 
However, certain molecular species show a significantly different distribution, such as the 
PI(36:1) species at m/z 863.5655 or the PA(36:2) species at m/z 699.4991 that are both highly 
abundant within Candida glabrata while being a minor spectral component in the other 
Candida species. However, it will need the addition of further Candida species to the model 
to determine whether these are generally specific features for C. glabrata and whether the 
separation observed does indeed follow the clustering observed by Butler et al. using DNA 
sequencing.(135) 
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Figure 84. ANOVA plot (threshold p=0.05) for the model shown in Figure 83 comparing C. glabrata 
against the remaining 4 Candida species. Peak statistics plots are shown for two molecular species specific 
for C. glabrata. 
4.3.7. Analysis of bacterial mixtures 
While some clinical sample types are expected to contain a single causative pathogen at high 
concentrations, other clinical specimens are expected to contain a mixture of different 
bacteria either belonging to commensal microflora or pathogenic species. Specimens of the 
latter type include faeces and mucosal swabs. Thus, for direct on sample applications it is 
important to analyse bacterial communites by REIMS. As an initial experiment, binary 
mixtures of bacteria were created at different ratios and analysed by REIMS. Bacterial 
biomass was cultured for 48hrs on Columbia horse blood agar and subsequently scraped off 
using a 10µL loop and collected in a microcentrifuge tube for Pseudomonas aeruginosa, 
Bacteroides fragilis, Staphylococcus aureus and Escherichia coli.  
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Figure 85. Comparison of spectral profiles obtained for binary bacterial mixtures of Staphylococcus 
aureus and Pseudomonas aeruginosa. A and C) Simulated REIMS spectrum of a binary mixture (1:1 w/w) 
assuming identical ionisation, B and D) REIMS spectrum of a binary mixture of both bacteria. A and B) 
show spectra over the full mass range m/z 150-2000, while C and D) show mass range m/z 600-900 only. 
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Using an analytical balance, bacteria were weighed into a fresh microcentrifuge tube in ratios 
of 1:5, 1:3, 1:1, 3:1, and 5:1 (weight:weight) and homogenised by stirring with a loop. 
Artificially generated mixtures from bacteria grown on separate plates do not resemble 
properties of microbial communities where presence of other species of bacteria might alter 
the production of metabolites (such as would be expected for rhamnolipids and quorum-
sensing molecules in case of P. aeruginosa). However, this method of growing pure bacterial 
species on separate plates, collecting biomass and subsequent mixing was chosen as it allows 
most controlled generation of mixture ratios. 
Results obtained by the analysis of the 1:1 mixture of S. aureus and P. aeruginosa can be 
seen in Figure 85. Figure 85A shows a simulated mass spectrum of a 1:1 mixture of S. aureus 
(purple) and P. aeruginosa (dark grey) in which it was assumed that the ionisation response 
factor for both bacterial species is identical. Figure 85B shows the REIMS spectrum of a 
binary mixture of both bacterial species. The spectrum of the mixture shows peaks of both 
bacterial species and within each species retains the peak ratios as observed in REIMS 
spectra of a pure culture (within the tolerated biological variance observed in routine REIMS 
measurements). Figure 85C and D show the same data for the reduced mass range of m/z 
600-900. Besides a group of peaks observed in pure P. aeruginosa between m/z 850-900 
which is reduced in intensity in the mixture with S. aureus, the overall spectral appearance 
shows an additive behaviour. Peak ratios between P. aeruginosa-originating and S. aureus-
originating spectral features are not 1:1 but rather show a ratio of 0.8:1. This was partly 
anticipated as S. aureus in general shows significantly better response to ionisation than P. 
aeruginosa (approx. factor of 2 to 4 difference in overall response factors). It is interesting to 
note that this difference in ionisation response seems partly eliminated by having both 
bacteria in a mixture. This raises the possibility that differences in ionisation response in case 
of S. aureus are not solely due to the fact that it has a thicker cell wall with less variety in its 
lipid composition, but instead might produce extracellular compounds that increase the 
response to ionisation. When producing a mixture of S. aureus with other bacteria this 
compound will get distributed among both species and thus increase ionisation of both. 
A slightly more complex behaviour was observed in a mixture of Bacteroides fragilis and 
Escherichia coli (see Figure 86). While in case of pure B. fragilis the signal at m/z 590 only 
has a relative intensity of 80% compared to the base peak of the heavier sphingolipid at m/z 
653, in case of mixtures with E. coli this changes to m/z 590 becoming the dominant spectral 
feature. This is tentatively associated with the nature of the m/z 590 ion; as a [M+Cl]- ion its 
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response might be affected by changes in chloride ion content which is a likely side effect 
when preparing mixtures of different bacteria. Besides the effect of changes in response of 
chlorinated to quasi-molecular ions, response to ionisation correlates well with the ratio of the 
mixture. In case of Figure 86C and D, spectral profile of B. fragilis are visible at about 35 and 
20% for mixture ratios of 1:3 and 1:5, respectively. In Figure 86B (B. fragilis : E. coli (3:1), 
very little E. coli is detected (at about 10% relative intensity), however, the effect of changes 
associated with chloride adduct formation was still clearly visible. Low detection of E. coli in 
this sample was tentatively associated with poor homogeneity of the mixture. 
REIMS spectral profiles acquired of binary mixtures suggest an additive nature of m/z 
features. This is an important prerequisite for identification of microorganisms in microbial 
communities and is paramount for the success of a taxon-specific marker approach as ion 
suppression does not seem to significantly alter REIMS profiles. Although overall signal 
abundance cannot be compared to that of pure cultures, relative abundances between spectral 
features seem conserved. 
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Figure 86. Full scan REIMS spectra obtained from different binary mixtures of Escherichia coli and Bacteroides fragilis. A) B. fragilis : E. coli (3:1), B) B. fragilis : 
E. coli (5:1), C) Bacteroides fragilis (100%), D) B. fragilis : E. coli (1:3), E) B. fragilis : E. coli (1:5), and F) Escherichia coli (100%). 
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5. Analysis of cell lines using REIMS 
5.1. Introduction 
The proposed REIMS-based microbial characterisation and identification tool and workflow 
allows for adaptation to the analysis of other unicellular forms of life such as cell lines. Cell 
lines are popular models to study various biochemical and disease processes in vitro. In case 
of cancer studies, cell lines provide a means to study cancer development and progression as 
well as the investigation of pathobiochemical processes as close to the human body as 
possible while still allowing free manipulation of experimental parameters. The most 
extensively characterised cell line collection up to date is the NCI60 cell line panel compiled 
by the National Cancer Institute as part of the In Vitro Cell Line Screening Project (IVCLSP). 
The panel comprises 60 human cancerous cell lines from nine different organs of origin, 
namely leukaemia, melanoma, cancers of the lung, colon, brain, ovary, breast, prostate, and 
kidney. A large variety of data is available for these cell lines including drug sensitivity 
patterns for more than 100,000 compounds and natural products, global protein and gene 
expression data and common mutations associated with cancer.(137,217-219) Large parts of 
the data are publicly available and accessible via the CellMiner database 
(http://discover.nci.nih.gov/cellminer/home.do).(150) 
However, the associated metabolomics and lipidomics data is comparatively sparse. Although 
many publications are available investigating the lipid composition of certain types of cell 
lines using both chromatography-based(220,221) and shotgun mass spectrometry 
methods,(89,222-225) to our knowledge there is no work available characterising the 
lipidome of the NCI60 cell line panel as a whole using a single set of conditions. This 
represents a striking gap in the cancer-related biochemical data, as complex lipids are the 
main constituents of cell membranes and play important functional, structural, and metabolic 
roles by acting as signaling molecules (e.g., PI phosphates, ceramides, lysophosphatidic 
acids) or as precursors for secondary messengers (e.g., inositol triphosphate/diacylglycerol). 
Changes in the membrane lipid composition can regulate function of membrane proteins and 
affect cell signaling and transport mechanisms.  
Mammalian tissue studies using REIMS revealed that the information content of the spectral 
profiles is not limited to the histological classification of tissues but contains additional 
information on the phenotype of the organism examined.(2,142) REIMS is therefore expected 
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to serve as a lipidomics-based shotgun phenotyping technique, however, the general 
sensitivity and specificity of the method to certain changes (as changes in protein expression 
patterns) in a biological system still needs to be assessed. For this purpose, the analysis of cell 
lines is significantly better suited than ex-vivo tissue specimens.  
The traditional technique of choice for lipid profiling is liquid chromatography-mass 
spectrometry (LC-MS). However, even using state-of-the-art ultra-high performance liquid 
chromatography (UPLC-MS), run-time per sample is still in the range of 10-20 minutes and 
the analysis requires extensive sample preparation (homogenisation, extraction, etc.). Several 
mass spectrometric profiling methodologies have been developed in the recent past and the 
field has gained additional momentum with the introduction of ambient mass spectrometry in 
2004.(89) Ambient mass spectrometric methods such as desorption electrospray ionisation 
mass spectrometry (DESI-MS), offer the capabilities to analyse samples in their native state, 
without any significant sample preparation steps.(82) These ambient lipid profiling 
technologies have recently been deployed in cancer studies to characterise the lipid 
composition of breast cancer compared to normal breast tissue(226), the identification of 
cancer metastasis within lymph nodes (124), colorectal cancer compared to normal 
mucosa(119), and brain cancer(227) among others. While these studies provided excellent 
basis for the development of novel diagnostic approaches, the molecular background of the 
differentiation between different histological classes remains unclear, due to the limited 
coverage of tissue metabolome/lipidome/proteome and lack of functional tests (e.g. gene 
silencing) in case of human samples. A complementary approach for studying the molecular 
background of histologically specific lipid profiles involves the use of cell lines, which solves 
the problems regarding sample availability and standardisation of sampling, lifts most of the 
ethical constraints and also allows functional testing including gene silencing or metabolic 
flux analysis.  
Very promising results for high throughput metabolite profiling of cell lines was obtained 
using laser-assisted electrospray ionisation mass spectrometry (LAESI-MS). Combined with 
multivariate statistical tools this methodology was applied for the characterisation of human 
T-lymphotrophic virus (HTLV)-induced alterations of the biochemical processes of the host 
cells. Spectral differences were observed that could be directly correlated to one of either 
virus type studied (HTLV1 vs. HTLV3) and Tax protein expression (Tax1 vs. Tax3).(225) 
Furthermore, this approach was applied to the analysis of Kaposi's sarcoma-associated herpes 
virus (KSHV) in latently infected B-lymphocytes (BCBL-1).(224) In both cases, differences 
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in mass spectral profiles were found to be largely due to relative changes in phospholipid 
composition, highlighting the power of an ambient mass spectrometry-based shotgun-
lipidomic profiling approach. 
5.2. Assessment of robustness of REIMS spectral profiles 
REIMS analysis has been applied to different types of biological samples and showed good 
spectral pattern reproducibility in case of human tissues and microorganisms including both 
bacteria and fungi.(2,142) To combine these two application areas and to test the general 
hypothesis that REIMS spectral patterns are reproducible and sufficiently specific to 
differentiate between different human cancer cell lines, three different cell lines (HeLa – 
cervical adenocarcinoma, MES-SA – uterine sarcoma, and SNB-19 – glioblastoma) were 
analysed in an experiment designed to test spectral reproducibility. The experimental scheme 
is depicted in Figure 87 and accounts for variance introduced by different culture batches or 
passage numbers and for analytical variance introduced by multiple measurements. 
Replicates were randomly analysed over three analysis days in order to assess the analytical 
variance and robustness of a REIMS-based lipid profiling method. In addition, the influence 
of one freeze-thaw cycle on spectral variance was investigated and was found to be 
insignificant. A detailed sampling schedule can be found in Table 22. 
Raw REIMS profiles of all three cell lines show a high degree of similarity (Figure 88). As 
analysis is performed in negative ion mode, the spectral content is similar to that described in 
earlier studies reporting REIMS profiles of various biological materials, featuring 
predominantly glycerophospholipid-type membrane lipid components such as 
phosphatidylethanolamines (PEs), phosphatidylinositols (PIs), phosphatidylglycerols (PGs), 
phosphatidic acids (PAs) and phosphatidylserines (PSs) as well as other complex lipids 
including ceramides and glycosylated ceramide species.(2,128,133) Similarly to earlier 
observations, all detected ions carried a single negative charge, the vast majority by forming 
the quasi-molecular [M-H]- ion. In addition, thermal degradation product [M-NH3-H]- was 
observed in case of PEs. Sphingolipid species were commonly detected as [M+Cl]- ions. 
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Figure 87. Experimental scheme to assess spectral reproducibility and self-identity of three different cell 
lines. p(N) indicates passage number, A and B different culture batches, while A/B1-3 indicates replicates 
of same culture batch. Reprinted with permission from Ref. (134). Copyright (2016) American Chemical 
Society. 
Table 22. Cell lines and respective number of replicates recorded for reproducibility assessment sorted by 
measurement day. Number of technical replicates recorded are given in parantheses. 
Measurement day 1 Measurement day 2 Measurement day 3 
HeLa p4 A1 (6) HeLa p4 A3 (3)* HeLa p4 A2 (6) 
HeLa p4 A3 (3) HeLa p4 B1 (3)* HeLa p4 B3 (6) 
HeLa p4 B1 (3) HeLa p4 B2 (6) HeLa p6 A2 (6) 
HeLa p6 A1 (3) HeLa p6 A1 (3) * HeLa p6 B2 (6) 
HeLa p6 B1 (3) HeLa p6 A3 (6) 
HeLa p6 B3 (6) HeLa p6 B1 (3)* 
MES-SA p8 A1 (3) MES-SA p8 A1 (3)* MES-SA p8 A2 (6) 
MES-SA p8 A3 (6) MES-SA p8 B2 (6) MES-SA p8 B3 (6) 
MES-SA p8 B1 (3) MES-SA p10 A2 (3)* MES-SA p10 A1 (6) 
MES-SA p10 A2 (3) MES-SA p10 B1 (3)* MES-SA p10 A3 (6) 
MES-SA p10 B1 (3) MES-SA p10 B2(5) 
MES-SA p10 B3 (6) 
SNB p4 A1 (6) SNB p4 A2 (3)* SNB p4 A3 (6) 
SNB p4 A2 (3) SNB p4 B1 (6) SNB p4 B3 (6) 
SNB p4 B2 (3) SNB p4 B2 (2)* SNB p6 A2 (5) 
SNB p6 A3 (3) SNB p6 A1 (5) SNB p6 B3 (4) 
SNB p6 B1 (2) SNB p6 A3 (2)* 
SNB p6 B1 (2)* 
* underwent a planned freeze-thaw cycle 
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Figure 88. A) Mass spectral profiles between m/z 600-900 as obtained for HeLa, MES-SA, and SNB-19 
cell line pellets, B) 3-dimensional PCA plot for dataset comprising HeLa, MES-SA and SNB-19 cell lines 
over the spectral mass range of m/z 600-900. Data were binned to 0.01Da, median normalised and log-
transformed. Adapted with permission from Ref. (134). Copyright (2016) American Chemical Society. 
173 
 
For clinically oriented applitions, REIMS spectral profiles were commonly analysed using 
supervised multivariate statistical methods such as linear discriminant analysis (LDA) to 
explore the feasibility of differentiation of various tissue types including healthy and diseased 
tissues.(2,130) In this study, data analysis was intentionally restricted to exploratory 
unsupervised analysis methods to assess whether REIMS profiles would reproducibly cluster 
into different groups corresponding to cell line identities. Cross-validation was performed to 
further validate clustering behaviour of the cell line REIMS patterns.  
Spectral profiles as obtained for each cell line using the proposed methodology (Figure 12, 
page 60) are shown in Figure 88A and demonstrate high inter-strain similarity. However, 
differences in relative signal abundances were observed for each cell line leading to three 
clearly differentiated data groups corresponding to the cell types when performing principal 
component analysis on the respective dataset (see Figure 88B). SNB-19 cells are clearly 
differentiated from HeLa and MES-SA cells along the first principal component. Second and 
third principal component are required to fully separate HeLa and MES-SA cell lines from 
each other. A slight separation along the second principal component due to passage numbers 
can be seen for HeLa and SNB-19 cells, but is less pronounced for the MES-SA cell lines. 
Further separation correlating with the analysis day was observed for all three cell lines along 
the third principal component and it is especially pronounced for the third analysis day for 
MES-SA and HeLa cell lines while being less pronounced for SNB-19. However, these 
analytical and biological variances are small compared to the inherent spectral differences 
between the different cell lines. These results suggest that although there is an expected 
biological and analytical variance in the data, the REIMS spectral profiles show sufficient 
reproducibility and specificity to characterise and distinguish human cancer cell lines. 
Cross-validations were performed based on PCA models of a training set created as described 
in Materials and Methods - Analysis of cell cultures using REIMS - Data Analysis of REIMS 
cell line data. Following this procedure, three different training sets were generated and 
subjected to PCA analysis. These training sets comprised between 25-28 sampling points, 
which represent <15% of the overall amount of samples (n=203). The composition of the 
training sets and corresponding cross-validation results are shown in Table 23. Consistently, 
the cross-validation results show ≥98% correct classification for SNB-19 samples, with only 
a single misclassification into MES-SA observed for the third training set which was 
associated with the unequal sample size for MES-SA (n=12) and SNB-19 (n=7). This might 
lead to a bias of the PCA calculations towards the larger sample subset and thus more likely 
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misclassifications into the MES-SA group. While the first test set proved to be very robust for 
the classification of all three cell lines, the second and third test set do lead to occasional 
misclassifications between MES-SA and HeLa cells, respectively. This suggests a more close 
spectral relationship between HeLa (cervical origin) and MES-SA (uterine origin) compared 
to the SNB-19 cells (CNS origin) which is in agreement with the PCA analysis results of the 
whole dataset as described above.  
Table 23. Cross-validation results for SNB-19, HeLa and MES-SA cell lines based on PCA model 
comprising the first 4 principal components and using 3 nearest neighbour as classifier. Adapted with 
permission from Ref. (134). Copyright (2016) American Chemical Society. 
kept in test set 
predicted 
correct 
HeLa MES-SA SNB-19 
HeLa p6 A day2 (9 samples) 63 - - 100% 
MES-SA p8 A day1 (9 samples) 2 57 - 97% 
SNB-19 p4 A day1 (9 samples) - - 54 100% 
HeLa p4 B day2 (9 samples) 62 1 - 98% 
MES-SA p10 B day1 (9 samples) 17 42 - 71% 
SNB-19 p4 B day2 (7 samples) - - 56 100% 
HeLa p4 A day1 (9 samples) 49 14 - 78% 
MES-SA p10 A day3 (12 samples) - 56 - 100% 
SNB-19 p6 A day2 (7 samples) - 1 55 98% 
5.3. REIMS profiles for the NCI60 cell line set 
Following the confirmation that REIMS spectral patterns are able to distinguish between 
three cancer cell lines, we set out to profile the entire NCI60 panel, consisting of 60 human 
different cancer cell lines. Based on amount of available biomass after culture, we recorded 4 
to 15 individual measurement points for each cell line, and included eight biological 
replicates (see Table 24 for detailed sample set). Hierarchical cluster analysis (HCA; Figure 
89, all technical replicates per cell line averaged) and principal component analysis (PCA, 
Figure 90) of the resulting dataset indicated that the 60 cells are characterised by unique 
REIMS profiles. Biological replicates showed the expected level of similarity as indicated by 
the cluster analysis (see Figure 89) showing close clustering in the HCA dendrogram. This is 
true for all cell lines except IGROV-1 and SF-268. In case of IGROV-1, a comparably small 
number of 3 and 5 REIMS spectra were available for each respective replicate, which was 
tentatively associated with the incorrect classification. The spectral difference observed in the 
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case of SF-268 raises the possibility of strong biological variance or a potentially 
compromised biological replicate.  
 
Figure 89. Hierarchical cluster dendrogram of the NCI60 cell lines including biological replicates 
(highlighted by asterisks). Arrows indicate closely related cell lines, blue MDA-MB-435 and M14, green 
NCI-ADR-RES and OVCAR-8. Distance was calculated using Pearson correlation and agglomeration via 
the Ward metric. Adapted with permission from Ref. (134). Copyright (2016) American Chemical 
Society. 
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Table 24. Cell lines and respective number of replicates used in this study. Numbers of respective 
biological replicates are given in parantheses. Reprinted with permission from Ref. (134). Copyright 
(2016) American Chemical Society. 
Tissue of origin Cell line No of biological replicates No of technical replicates 
Breast BT549 1 4 
HS-578-T 1 6 
MCF-7 1 12 
MDA-MB-231 2 10 (6+4) 
MDA-MB-468 1  
TD-47-D 1 11 
CNS SF268 2 18 (8+10) 
SF295 2 18 (8+10) 
SF539 1 8 
SNB-19 1 (3) 10 (10+?+?) 
SNB-75 not measured  
U251 1 9 
Colon COLO-205 1 10 
HCC2998 1 7 
HCT-15 1 7 
HCT-116 1 11 
HT-29 2 9 (5+4) 
KM-12 1 7 
SW-620 1 12 
Leukaemia CCRF-CEM 1 10 
HL-60 1 7 
K562 1 (2) 9 (9+?) 
MOLT-4 1 6 
RPMI-8226 1 5 
SR 1 8 
Melanoma LOX-IMVI 1 9 
M14 2 15 (7+8) 
Malme-3M 1 6 
MDA-MB-435 2 14 (4+10) 
SK-MEL-2 1 10 
SK-MEL-5 1 8 
SK-MEL-28 1 9 
UACC62 1 6 
UACC257 1 9 
Non small cell lung 
cancer  
A549 1 10 
EKVX 1 9 
HOP-62 1 6 
HOP-92 1 13 
NCI-H23 1 11 
NCI-H226 1 9 
NCI-H322M 1 7 
NCI-H460 1 9 
NCI-H522 1 9 
Ovarian IGROV-1 2 8 (5+3) 
NCI-ADR-RES 1 9 
OVCAR-3 1 6 
OVCAR-4 1 7 
OVCAR-5 1 10 
OVCAR-8 1 8 
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SK-OV-3 1 9 
Prostate DU-145 1 9 
PC-3 1 11 
Renal 786-0 1 9 
A498 1 11 
ACHN 1 10 
CAKI-1 1 6 
RXF393 1 6 
SN-12-C 1 8 
TK-10 1 9 
UO31 1 7 
Similar results were obtained for cross-validation results performed on the PCA model (see 
Table 25 for identification accuracies based on PCA model shown in Figure 90) which reveal 
partial misclassification for IGROV-1 and no correct results for SF-268. 
 
Figure 90. PCA plot of REIMS data obtained for the NCI60 dataset. Biological replicates are highlighted 
by triangular markers. Reprinted with permission from Ref. (134). Copyright (2016) American Chemical 
Society. 
Gene expression profiling revealed that the MDA-MB-435 cells more closely resembled 
melanoma cell lines than the other breast tumour lines.(228) Consistent with further gene 
expression,(229) high-density single-nucleotide polymorphism(230) and karyotype 
analyses,(231) the REIMS profiles also indicate that cell lines MDA-MB-435 and M14 are 
closely related (Figure 89, blue arrow, right). Karyotyping has also found that NCI-ADR-
RES is in fact a drug-resistant derivative of OVCAR-8.(232) As shown in Figure 89, these 
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cell lines (indicated by blue arrow, left) also show close similarity based on their REIMS 
profiles. Taken together, these results confirm that REIMS profiles are strongly associated 
with the biological identity of cancer cell lines.  
Gene and protein expression patterns of the NCI-60 panel were found to largely correlate 
with tissue type of origin to some extent,(137,229) whereas metabolic signatures did not 
differentiate well between tissue origins.(219) Clustering of the cell lines based on their 
REIMS lipid profile showed extensive heterogeneity within most tissue types, except for 
melanoma samples (Figure 89, light blue coloured cell lines). 
Table 25. Cross-validation results for replicated NCI60 cell lines based on PCA model shown in Figure 
90. Three nearest neighbour as classifier. Reprinted with permission from Ref. (134). Copyright (2016) 
American Chemical Society. 
kept in test set predicted correct 
K562 P5 (9 samples) LE:K562 (9) 100% 
K562 P11 (9 samples) LE:K562 (9) 100% 
MDA-MB-231 (6 samples) BR:MDAMB231 (4) 100% 
MDA-MB-231 P10 (4 samples) BR:MDAMB231 (6) 100% 
SF295 1 (10 samples)  CNS:SF295 (4), CNS:SNB19 (4) 50% 
SF295 2 (8 samples) CNS:SF295 (10) 100% 
M14 (7 samples) ME:M14 (5), ME:MDAMB435 (1), ME:SKMEL28 (2) 63% 
M14 (2) (8 samples) ME:M14 (1), ME:MDAMB435 (6) 14% 
MDA-MB-435 (10 samples) ME:MDAMB435 (4) 100% 
MDA-MB-435 P6 (4 samples) ME:MDAMB435 (10) 100% 
SF268 (8 samples) LC:HOP62 (7), RE:UO31 (2), BR:HS578T (1) 0% 
SF268 p4 (10 samples) RE:SN12C (8) 0% 
HT-29 (5 samples) CO:HT29 (3), OV:OVCAR5 (1) 75% 
HT-29 P3 (4 samples) CO:HT29 (4) CO:COLO205 (1) 80% 
IGROV-1 (5 samples) OV:IGROV1 (3) 100% 
IGROV-1 P9 (3 samples) OV:OVCAR8 (4) RE:UO31 (1)  0% 
 
5.4. Comparison of REIMS spectral profiles of bulk cancer tissue 
samples and cell lines 
In previous studies, the REIMS spectral profiles of ex-vivo human tissue specimens were 
shown to be highly specific for the histological/anatomical tissue type.(2)  
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Figure 91. A) 2-dimensional PCA plot of averaged REIMS data collected from the NCI60 cells (squares) 
and cancer tissue samples (circles). The tissue of origin is indicated by red (colon) and blue (ovarian) 
colors. B) Comparison of spectral profiles for bulk tissue samples and cell lines of the corresponding 
tissue type of origin for i) ovarian cancer and ii) ovarian cancer cell line, and iii) colorectal cancer and iv) 
colon cancer cell line. Adapted with permission from Ref. (134). Copyright (2016) American Chemical 
Society. 
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To test how well cell line lipid profiles correspond to those of bulk tissue specimens, REIMS 
profiles of the NCI60 panel were compared to ex-vivo tissue samples of ovarian and 
colorectal adenocarcinomas analysed using the same bipolar experimental setup. A PCA plot 
of the resulting dataset is shown in Figure 91A and reveals clear differences between cell 
lines and bulk tissue specimens along the first principal component suggesting strong 
differences among their membrane lipid composition. A tentative separation according to 
tissue type of origin can be observed for both cell lines and tissue specimens, although more 
pronounced in the latter. Only a small number of tissue specimens (n=4) were available in 
case of ovarian tumours, but based on previous studies a significant increase in separation 
power can be expected for larger sample sets.(2) Nevertheless, the direction of separation is 
similar in both cases, suggesting similar lipidomic differences.  
 
Figure 92. Box plot visualisation of m/z values (incl. p-value and annotation) found to be significantly 
increased in either bulk cancerous tissue (orange, comprising colorectal and ovarian cancer) or cancer 
cell lines (blue, comprising colorectal and ovarian cancer cell lines) using ANOVA. Adapted with 
permission from Ref. (134). Copyright (2016) American Chemical Society. 
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Representative spectral profiles of both ovarian and colon cancer tissue and cell line samples 
are shown in Figure 91B. Bulk tissues display larger amounts of long-chain 
phosphatidylinositols such as PI(38:4) at m/z 885.55. Similar trends were observed in case of 
certain phosphatidylethanolamines, for instance the peaks detected in the mass range of m/z 
790-794 corresponding to PE(40:6)-PE(40:4) species or those occurring at m/z 766.54 and 
768.55 corresponding to PE(38:4) and PE(38:3), respectively. On the other hand, m/z 645.45, 
corresponding to PA(32:1), was found in significantly higher proportions in cell lines. We 
speculate that the characteristic differences in lipid composition are due to the uniform lipid 
content of the culturing medium, which does not represent the complex lipid source of real 
tumours that rely on dietary and liver-synthesised lipids as well as de-novo lipid synthesis 
(see Figure 92 for a statistical analysis of distinct spectral features associated with cell lines 
and bulk tumours). This data adds to the controversy around the applicability of cell lines to 
model the complex behaviour of bulk cancer specimens. Thus, careful consideration around 
the translatability of results of cell line experiments is necessary in order to avoid wrong or 
simplified conclusions about bulk cancer. Experiments using bulk human cancer specimen, 
cell lineages derived from the same bulk tumour and xenografts of these same cell lines 
(patient-derived xenografts) can be conducted in order to further investigate this 
phenomenon. 
5.5. NCI60 cell line panel - Correlation with gene expression data 
The NCI60 cell panel has been extensively characterised and global transcriptomics and 
protein expression datasets were made publicly available. In order to correlate the REIMS 
dataset to previously published gene expression data, the respective dataset was obtained 
from the CellMiner online query tool (150,151).  
Using an exhaustive search strategy, each m/z intensity value was correlated with each gene 
expression across all the overlapping cell lines as described in Materials and Methods - 
Analysis of cell cultures using REIMS - Data Analysis of REIMS cell line data. 
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Figure 93. Correlation analysis between fads2 gene expression and mass spectral data. A) Histogram of 
the correlation values between fads2 gene expression and m/z peak intensities. B) Correlation values with 
fads2 gene expression as a function of m/z values, and the putative lipids corresponding to the highly 
positively correlated m/z signals.  
Strong positive correlation was obtained for the expression of genes playing an important role 
in lipid metabolism including the fads2 gene, which is encoding the fatty acid desaturase 
enzyme (FADS2). The mammalian Δ6-desaturase encoded by the fads2 gene catalyses the 
biosynthesis of polyunsaturated fatty acids from precursor essential fatty acids such as 
linoleic acid C18:2n-6 and linolenic acid C18:3n-3. Other reported substrates include C16:0, 
C20:2n-6, C20:3n-3) C24:4n-6 and C24:5n-3.(233-235).  
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Figure 94. A) Binned peak intensity of m/z 786.54 as a function of scaled fads2 gene expression, B) ratio of 
intensity values for peaks at m/z 768.55 and 770.57 as a function of fads2 gene expression, C) Relative 
abundances of peaks m/z 768.55 and 770.57 in raw data for cell lines HL-60 (leukemia, left) and HT-29 
(colon, right). 
 
Figure 95. A) PE(38:3)/PE(38:2) peak intensity ratio and B) PE(38:3) peak intensity as a function of 
FADS2 protein expression as obtained from Gholami et al.(137) 
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Figure 96. Correlation analysis between ugcg gene expression and mass spectral data. A) Histogram of 
the correlation values between ugcg gene expression and m/z peak intensities. B) Correlation values with 
ugcg gene expression as a function of m/z values including putative lipid identity for highly positively 
correlating m/z values. 
The fads2 gene expression data shows good positive correlation with the abundance of 
several signals in the REIMS data set (see Figure 93), among those m/z 768.54 (Figure 94A 
for correlation plot). This spectral feature was attributed to a peak at m/z 768.5578 in the 
corresponding raw data which in turn was assigned to PE(38:3) based on exact mass 
measurements, associated with PE(18:0/20:3) based on MS/MS data. Assuming that both 
enzyme substrate and product would be incorporated into the same phospholipid species, the 
putative substrate can indirectly be detected incorporated into PE(38:2) at m/z 770.5733. To 
investigate any changes in the relative abundances of PE(38:2) and PE(38:3) the ratio or raw 
signal intensities for both molecular species was determined for each cell line and plotted 
against the fads2 gene expression (see Figure 94B). Similar correlation behaviour was 
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observed for both the signal at m/z 768.54 and the ratio of 768.54/770.57, with similar cell 
lines being situated at either end of the correlation curves. Figure 94C depicts the 
corresponding signal intensities in case of the HL-60 leukemia cell line and the colon HT-29 
cell line which are showing high and low fads2 expression, respectively. In case of the latter, 
PE(38:3) accounts for approximately 15% of relative abundance compared to PE(38:2), for 
HL-60 the relative abundance increases to approximately 40% of the PE(38:2). 
Correlation between lipid profiles and protein expression data (sourced from Ref. (137)) was 
demonstrated by plotting both PE(38:3)/PE(38:2) intensity ratio and PE(38:3) abundance 
against the expression level values for the FADS2 protein (see Figure 95). However, in the 
database from Reference (137), FADS2 protein expression has only been determined in case 
of 29 cell lines, hence a comparably clear correlation pattern cannot be obtained. 
Nevertheless, the cell lines showing enzyme activity correspond to those that show high gene 
expression for the fads2 gene. Unfortunately, no protein expression values were available for 
those cell lines that displayed low fads2 gene expression.(137) 
Strong correlations have also been found in case of ugcg gene expression (see Figure 96). 
This gene encodes the UDP-glucose ceramide glucosyltransferase (UGCG) enzyme, which 
catalyses the first glycosylation step in glycosphingolipid biosynthesis, having ceramides and 
UDP-glucose as substrates. Glycosylated lipids are enriched in lipid rafts/lipid micro-
domains and play fundamental roles in a variety of cellular processes.(236) Positive 
correlations were observed for several signals between m/z 700-900 and their respective 
isotopes as shown in Figure 96 and Table 26. Based on exact mass measurements and 
MS/MS experiments, these species were tentatively identified as homologous mono-
hexosylated ceramides in form of [M+Cl]- ions. Isotopic patterns recorded for these species 
and MS/MS data support the presence of a chloride in the adduct ion. All ions show 
analogous fragmentation behaviour, displaying a loss of the chloride ion (m = 35Da) and 
additional loss of the hexose moiety (m = 198Da, loss of HCl and C6H10O5). Using tandem 
mass spectrometry only it is not possible to differentiate between glucosylated and 
galactosylated ceramide species as they exhibit identical fragment ions. Exemplary tandem 
mass spectra and mass spectrometric signal intensities as a function of gene expression 
numbers can be found in Figure 97 and Figure 98, respectively. No negative correlation was 
observed for the ugcg gene expression with the precursor ceramide species nor the ratio of 
glucosylceramides to precursor ceramides. This is tentatively associated with the fact that 
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ceramides are ubiquitous precursors in sphingolipid biosynthesis and there are numerous 
biosynthetic pathways where ceramides act as substrates, intermediates or products.  
Table 26. Mass spectrometric signals that show strong positive correlation with the ugcg gene expression 
for the NCI60 dataset. 
Exp. mass Exact mass ppm Tentative ID Formula Adduct 
Correlation 
coefficient 
734.5355 734.5343 0.2 GlyCer(d18:1/16:0) C40H77NO8 [M+Cl]- 0.552 
818.6295 818.6282 0.2 GlyCer(d18:1/22:0) C46H89NO8 [M+Cl]- 0.662 
842.6312 842.6332 -0.2 GlyCer(d18:1/24:2) C48H89NO8 [M+Cl]- 0.602 
844.6451 844.6439 0.1 GlyCer(d18:1/24:1) C48H91NO8 [M+Cl]- 0.668 
846.6627 846.6595 0.4 GlyCer(d18:1/24:0) C48H93NO8 [M+Cl]- 0.688 
872.6733 872.6752 -0.2 GlyCer(d18:1/26:1) C50H95NO8 [M+Cl]- 0.707 
 
 
Figure 97. MS/MS spectra for signals at m/z 842, 844, and 846 identified as glycosylated ceramides 
GlyCer(d18:1/24:2), GlyCer(d18:1/24:1) and GlyCer(d18:1/24:0). Loss of chloride to form the [M-H]- and 
loss of the hexose moiety to form [M-Hex-H]- are observed. 
Other putative sphingolipid species detected at m/z 860.6411, 862.6552 and 864.6775 showed 
positive correlations with the expression profiles of a number of genes encoding proteins 
involved in sphingolipid synthesis, e.g. fa2h, a gene encoding a protein that catalyses the 
synthesis of 2-hydroxysphingolipids. Further genes include the degs2 gene, which encodes 
the Delta(4)-desaturase, sphingolipid 2 protein, and the nr1h3 gene, which encodes the Liver 
X receptor alpha protein. Liver X receptors are part of the control system for transcriptional 
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programs involved in lipid homeostasis and inflammation and might thus indirectly influence 
the intracellular levels of certain sphingolipid species. 
 
Figure 98. Mass spectrometric signal intensity (TIC normalised and log-transformed) as a function of 
ugcg gene expression for glycosylates ceramide species listed in Table 26. A) m/z 842.63, B) m/z 844.65, C) 
m/z 846.65, D) m/z 734.53, E) m/z 818.63, and F) m/z 872.66.   
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5.6. Analysis of mycoplasma infected cell lines 
Cell cultures frequently get infected by Mycoplasma, a genus of bacteria that lack a cell wall 
encapsulating their cell membrane. Mycoplasma infection can alter many physiological 
processes and thus lead to misleading experimental results if a study is performed using 
infected cells. PlasmocinTM (InvivoGen, San Diego, CA, USA) is a commercially available 
antibiotic treatment that is frequently used to eradicate Mycoplasma infection in cell 
cultures.(237) 
 
Figure 99. A) Number of binned m/z signals significantly higher in Mycoplasma-infected versus 
Mycoplasma-free samples in HEK and HeLa cell lines. B) Untreated Mycoplasma-free (blue, u-), 
Mycoplasma-infected (red, u+), Mycoplasma-free and PlasmocinTM-treated (white, t+), Mycoplasma-
infected and PlasmocinTM-treated (white, t-); HEK (rectangle) and HeLa (triangle) samples as a function 
of PC1 and PC2 of PCA transformed untreated samples in the space of the 18 overlapping m/z signals. 
Reprinted with permission from Ref. (134). Copyright (2016) American Chemical Society. 
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REIMS profiles of Mycoplasma-free, Mycoplasma-infected and PlasmocinTM-cured HEK and 
HeLa cell lines were recorded. The data was pre-processed as described for the NCI60 
dataset. For both HEK and HeLa cell lines, the aim was to obtain m/z values that are 
significantly different between the untreated Mycoplasma-positive and -negative samples. 
Adjusted p-values were obtained using the adaptive Benjamini–Hochberg (BH) procedure to 
correct for multiple testing.(238) 
Table 27. Values and tentative annotations of m/z signals that were found to be significantly higher in 
Mycoplasma-infected samples as compared to Mycoplasma-free samples in both HEK and HeLa cell lines. 
Adapted with permission from Ref. (134). Copyright (2016) American Chemical Society. 
significantly different 
binned m/z   
corresponding m/z 
signal 
Annotation 
687.54 687.5468 unknown 
722.51 722.5156 PE(P-36:4) 
733.53 733.5231 PE(P-38:4) 
747.52 747.5193 PG(34:1) 
748.53 748.5243 Isotope  of m/z 747.52 
753.51 753.5090 PG(P-36:4) 
764.52 764.5264 PE(38:5) 
764.53 764.5262 PE(38:5) 
766.53 766.5412 PE(38:4) 
773.54 773.5359 PG(36:2) 
774.54 774.5391 PG(36:2), Isotope of m/z 773.54 
774.55 774.5391 PG(36:2), Isotope of m/z 773.54 
775.56 775.5520 PG(36:1) 
776.56 776.5564 PG(36:1), Isotope of m/z 775.56 
776.57 776.5564 PG(36:1), Isotope of m/z 775.56 
819.52 819.5189 PG(40:7) 
820.53 820.5268 PG(40:7), Isotope of m/z 819.52 
820.54 820.5268 PG(40:7), Isotope of m/z 819.52 
 
As shown in Figure 99A, 23 and 386 binned m/z signals were significantly higher in 
Mycoplasma-infected cells for HEK and HeLa cell lines, respectively. The higher number of 
significantly increased peaks found for HeLa cells may be explained with a higher number of 
sampling points (contributing to higher power in significance testing) or may reflect the 
increased reactivity of HeLa cells to Mycoplasma infection. Interestingly, we found only one 
signal showing reduced intensity in Mycoplasma-infected cell lines. Table 27 lists the 18 m/z 
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signals and their tentative annotations that were significantly higher in infected samples in 
both cell lines. An example for one of these values is shown in Figure 100 which visualises 
changes in intensity of Mycoplasma-free and -infected and PlasmocinTM-treated HEK and 
HeLa samples for the binned values around m/z 819.52 (identified as PG(40:7) based on 
exact mass measurements). This signal, as well as the signal corresponding to its isotope, was 
found significantly increased among Mycoplasma-infected cells for both HeLA and HEK cell 
lines but was found to return to the pre-infection level in the treated samples after successful 
PlasmocinTM treatment. Similar results were obtained for the other significant m/z signals. 
This change is tentatively associated with response of the host cell lipid metabolism to the 
Mycoplasma infection and highlights the possible negative influence of Mycoplasma 
infection on obtaining accurate and reliable data on cell line biochemistry.(239) 
 
Figure 100. Intensities of TIC nomalised and log transformed signal at m/z 819.52 in Mycoplasma-free or 
infected and PlasmocinTM-treated samples in A) HEK and B) HeLa cell lines. Reprinted with permission 
from Ref. (134). Copyright (2016) American Chemical Society. 
PCA was performed on the 18 distinguishing m/z features listed in Table 27 for Mycoplasma-
infected and Mycoplasma-free HEK and HeLa samples (see Figure 99B). The first principal 
component (PC) corresponds to differences between cell lines while the second PC 
corresponds to differences between Mycoplasma-free and -infected samples. When plotting 
the PlasmocinTM-treated HEK and HeLa (both originally infected and healthy) samples, they 
are found to cluster together with the untreated and Mycoplasma-free samples of the 
corresponding cell line. Most of the significantly different signals between healthy and 
infected cell lines were found to be of phosphatidylglycerol origin and were found present 
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both infected and healthy cell lines. This underpins that Mycoplasma infection introduces a 
reversible change in cell line lipidome rather than direct detection of Mycoplasma lipids 
which would be expected absent in uninfected samples. In order to use this information in a 
systematic way to detect Mycoplasma infection, more cell lines and samples need to be 
collected and tested. Nevertheless, the approach demonstrates the applicability of the REIMS 
methodology to study changes during Mycoplasma infection and as possible method for 
Mycoplasma screening. 
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6. Taxon-specific markers 
6.1. Introduction: Identification of bacteria in human tissues 
The main application area for the detection of microorganisms in human subjects is in clinical 
microbiology for the identification of pathogenic species in clinical specimens such as 
sputum, faeces, pus, urine, cerebral spinal fluid or blood in order to establish diagnosis and 
commence adequate therapy. However, there is steadily growing awareness about the 
influence of microbial communities colonising the human body and their influence on human 
health. An increasing number of studies are focused on the effect and composition of the 
microbiome and its interaction with the human host system in both health and disease 
development. Through these efforts, several seemingly unrelated clinical conditions could be 
associated with infection by either a single pathogen, such as Helicobacter pylori infection 
causing the development of gastric ulcers and eventually gastric cancer,(5) or changes in 
overall microbiome composition, such as the change of ratio of Firmuctes to Bacteroidetes in 
the gut of obese and lean mice(240) or a loss of biodiversity in gut microbiome in case of 
chronic inflammatory conditions such as Crohn’s disease.(241) There are several studies 
suggesting that the development of cancer might be influenced by the microbiome as well, 
such as the development of colorectal cancer (CRC). Evidence was presented that could 
correlate the occurrence of CRC with the presence of Streptococcus gallolyticus,(242) 
Enterococcus faecalis,(243) Fusobacterium nucleatum(244) and Bacteroides fragilis(245). In 
the light of these findings, it might be of considerable value to be able to characterise 
bacterial communities in a spatially-resolved manner and to associate local changes of the 
microbiome with the presence of a cancerous lesion in the gastrointestinal tract. Mass 
spectrometric methods such as imaging mass spectrometry of ex-vivo 
specimens(119,121,246) or REIMS incorporated into an endoscopic setup (so-called 
iEndoscope),(247) could be applied for this purpose. 
Traditionally, presence of microbial species in tissues are determined using culture-based 
methods for instance in the case of isolating a single pathogen causing infection. 
Identification results are obtained by observing primarily phenotypic characteristics including 
colony morphology, carbon source utilisation pattern and expression of certain enzymes to 
define genera and species. Swabs are taken from the area to be analysed and microorganisms 
are cultured on a range of different culturing media. Although this methodology is untargeted 
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in nature, it comes with the inherent disadvantage that only those microorganisms can be 
identified, which grow on conventional microbiological media. It is estimated though that 
only about 1% of all microorganisms can be cultured using these methods.(248) Instead of 
identifying bacteria using biochemical tests and colony morphology, more recently bacteria 
are more and more often identified using their protein profiles obtained by MALDI-TOF-MS. 
This methodology shortened the time-demand needed for identification by at least 24hrs but 
it still requires a pure culture. Direct-on sample applications of MALDI were reported for 
urine and positive blood cultures, however, these protocols are considerably more complex 
compared to the identification of pure cultures as they require the separation of cells of 
bacterial origin from those of human origin. Using these culturing-based techniques, any 
information about spatial distribution of the organisms is lost as well as information about 
organisms that cannot be conventionally cultured. 
Identification of bacteria using 16S rRNA gene sequencing can be performed directly from 
clinical and/or environmental samples and can thus resolve limitations posed by 
incorporation of culturing steps into the workflow. Two dominant technologies are generally 
used for culturing-independent characterisation of microbial communities, denaturing 
gradient gel electrophoresis (DGGE) and next generation sequencing (NGS).  
In case of DGGE, similar length fragments of PCR-amplified fragments of DNA are 
separated in a gel containing a gradient of DNA denaturant or along a linear temperature 
gradient (TGGE) according to their physicochemical properties which in turn are dependent 
on the sequence of the fragments. The 16S rRNA gene is of similar size across bacterial 
phyla and thus DGGE is a valuable tool to assess diversity of 16S rRNA gene sequences. The 
number of bands at differing horizontal positions can be used to assess the biodiversity within 
a microbial community. Several microbial communities can be analysed on a single gel 
which allows for multiplexing and thus more time- and cost-efficient analysis. As analysis is 
qualitative only, bands can be cut from the gel and sequenced for more detailed analysis on 
the identity of organisms present.(249) 
Using NGS methods, generic primer sets are directly added to a homogenate of the biological 
sample and the presence of bacterial taxa is determined by reading out the detected DNA 
fragments. This significantly increases the untargeted nature of sequencing-based techniques 
and this methodology is thus commonly applied to characterise microbiomes. This approach 
is currently the most commonly used tool in microbial community analysis. Analysis can be 
performed to either identify the bacterial taxa present in a sample or alternatively which 
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functional genes are present. Common NGS platforms allow sequencing of only comparably 
small regions of the 16S rRNA gene (Roche-454 pyrosequencing platform around 400 bases, 
Illumina MiSeq around 600 bases), allowing for cost-effective deep sequencing of large study 
cohorts, however, organism identification is less sensitive compared to sequencing the whole 
16S rRNA gene. For this reason, studies applying NGS generally focus on characterising the 
microbial community as whole rather than individual taxa.(250) Similarly to conventional 
culturing techniques, these culturing-independent molecular methods lose spatial information 
due to sample homogenisation and thus do not reflect spatial compositional changes. 
Fluorescent in-situ hybridisation (FISH) is a histological technique able to visualise the 
spatial distribution of given DNA sequences in tissue sections. Fluorescent DNA probes are 
applied which bind to complementary sequences of the DNA present in the sample. 
Fluorescence microscopy is subsequently used to detect and localise the fluorescent probes. 
rRNA-targeted oligonucleotide probes are available for a range of bacteria and can be used to 
selectively visualise bacteria in a complex microbial community or to detect bacterial and 
viral pathogens, including intracellular organisms such as Chlamydia.(251) The technique 
provides high spatial resolution and sensitivity, however, it is also highly targeted in nature 
and requires different probes for different species of bacteria and is thus not well suited for 
characterising microbial communities or untargeted detection of pathogens for clinical 
diagnostics.  
While most outlined technologies rely on either the detection of unique bacterial proteins or 
unique DNA sequences, in this study we assessed the feasibility of detecting bacteria based 
on unique bacterial metabolites, particularly lipids. Although microbial REIMS phospholipid 
profiles were shown to be highly specific and reproducible, detection and identification of 
microorganisms based on their full lipidomic profile in a complex human matrix such as 
sputum or tissues is most likely not feasible as the deconvolution of signals of human and 
bacterial origin will be very challenging, especially in case of lipid species produced by both 
eukaryotes and prokaryotes. This task increases in difficulty in case of bacterial communities. 
A large part of potential specimen types (e.g. saliva, mucosal lining fluids) is usually not 
sterile and thus instead of just a single pathogenic species, the presence of  an array of 
commensal pathogens is expected besides the pathogen. In this case the microbial profile 
would not only have to be separated from the human background profile but also the bacterial 
constituents of the bacterial community.  
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6.2. Assessment of feasibility of a taxon-specific marker approach 
Due to limitations in detection of bacteria directly in human matrices, this study was planned 
to assess the applicability of a univariate biomarker approach to determine different types of 
bacteria present in a given sample. These samples may contain a mixture of different bacteria 
as in microbial communities or bacteria in a complex human matrix such as tissues or 
biofluids. In principle, a bacterium in a complex matrix could be detected in two ways using 
mass spectrometry, either by finding its multivariate spectral fingerprint within the complex 
matrix or by detecting the bacterium using a specific biomarker. The former option is 
associated with non-trivial problems with regard to data analysis, especially when 
considering the possible presence of multiple bacterial species with partially overlapping 
mass spectrometric signals. For detecting bacteria in human matrices it would also require a 
separate equally exhaustive database comprising possible human matrices such as blood, 
sputum, faeces etc. In cases such as faeces it will not be possible to get specimens containing 
no bacteria at all which further complicates the problem. On the other hand, detecting a 
chemically well-defined bacterial biomarker in a biological sample is a routine analytical 
excercise.  
Therefore, a biomarker-based strategy is proposed that includes the identification of 
conservative lipid markers being specific for certain taxa of bacteria (phylum- down to 
species-level). These biomarkers were termed taxon-specific markers in the context of this 
work. A taxonomical marker-based approach would significantly reduce the bioinformatic 
requirements by reducing the multivariate profile-based methodology to the observation of 
presence or absence (and possible quantity) of biomarkers. These taxon-specific markers 
were identified using the REIMS-spectral database and subsequently used to detect bacteria 
in human matrices. These matrices can either be analysed using REIMS or by other mass 
spectrometric methods allowing the analysis of lipid compositions. In case of tissue-analysis, 
chromatography-based technologies offer high sensitivity however at the cost of loss of 
spatial information. For mapping of bacteria in tissue sections to assess their spatial 
distribution, mass spectrometry imaging (MSI) can be used. Commonly used MSI 
technologies are MALDI, SIMS and DESI-MS which all allow for the detection of complex 
lipid species and would thus be suited to detect taxonomic markers as obtained using REIMS. 
To assess feasibility of the proposed methodology, the visualisation of bacteria in colorectal 
tissue specimens using DESI-MSI was demonstrated. The tissue specimens were 
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cryosectioned and subsequently analysed using desorption electrospray ionisation mass 
spectrometry imaging as described in the Materials and Methods - Desorption Electrospray 
Ionisation Mass Spectrometry Imaging section. This mass spectrometry imaging-based 
approach is particularly interesting as using other techniques in this case would either lead to 
loss of spatial information (as with molecular or culturing-based methods) or loss of the 
untargeted nature (as in case of immunohistochemistry). 
6.3. Biomarkers specific for different bacterial taxonomic levels 
As observed for 28 bacterial species (shown in Figure 69 and Figure 70), closely related 
bacterial species are found to cluster together both in PCA and HCA analysis while unrelated 
bacterial species cluster separately. This indicates common spectral features among related 
bacteria which are not present in unrelated bacteria offering the possibility of finding 
biomarkers that are specific for a certain group. However, unsupervised multivariate analysis 
of a larger dataset shown in Figure 73 suggests that it might not be universally applicable to 
find taxonomic markers on all phylogenetic levels as the clustering results based on REIMS 
spectral profiles do not strictly match those of 16S rRNA sequences. Significant 
heterogeneity was observed especially among the very large phyla; however, better clustering 
results are obtained on lower taxonomic levels which would result in taxonomic markers 
providing more information on the exact nature of the bacteria present. Very distinct 
clustering behaviour of members of the phylum Bacteroidetes suggests that the biomarker 
approach will be well suited for this group of sphingolipid containing bacteria. 
Taxon-specific markers (TSM) were derived as described in Materials and Methods - 
Determination of taxon-specific markers (see Figure 17) using the sample set detailed in 
Appendix 4. As predicted based on multivariate statistical analyses, specific bacterial 
biomarkers were found for a range of bacteria and on different phylogenetic levels. A list of 
taxon-specific markers found for different bacterial taxa is shown in Table 28. There is not 
necessarily a specific marker available at every taxonomical level for a certain group of 
bacteria. This is particularly true for very large and heterogeneous groups of bacteria, such as 
members of the phyla Actinobacteria, Firmicutes or Proteobacteria. However, taxonomical 
markers can often be found on low taxonomical levels such as species, genus or family when 
the group of bacteria is narrowed down to only such members having similar biochemical 
behaviour and environmental habitat. Markers in Table 28 which are prone to show 
interference by signals originating from the human tissue matrix are marked and require a 
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decision to be made on a case to case basis by taking distributions of other TSM and 
histological tissue types on the other hand into account when deciding whether markers are of 
bacterial or human origin. No markers were calculated for those bacterial groups listed in 
Table 28 which are highlighted in grey due to the insufficient size of the sample set which 
might lead to a bias in TSM generation due to spectral noise in such cases where only a single 
file represents the bacterial group. In cases where only a single taxon is included within a 
higher taxonomic level (e.g. only one class of bacteria within a phylum, as for Fusobacteria, 
or only a single genus within a family, as in Bacteroidaceae), found taxon-specific markers 
were attributed to the higher taxonomic level. The reasoning being that although the 
possibility exists that the detected TSM are specific for the lower taxon only (but dataset 
insufficient to prove), the lower taxon by definition will always be part of the higher taxon 
and thus all TSM found for lower levels will always be TSM for the presence of a higher (and 
less specific) taxonomic level as well. 
There are two different types of taxonomical markers, those that are produced under arbitrary 
culturing conditions (conserved TSM) and others that are produced by certain strains only or 
under certain conditions only and hence often occur in highly variable amounts. Conserved 
taxon-specific markers are of particular interest as they might possibly be suitable to use for 
obtaining semi-quantitative information on certain bacterial species. Conserved (culture-
condition independent) taxonomical markers include  
• Mycolic acids for bacteria belonging to the Corynebacterineae suborder such as 
Mycobacterium spp., Corynebacterium spp. and Rhodococcus spp..  
From REIMS experiments and from literature it is known that the mycolic acid chain 
length is very specific to the genus of bacteria within the Corynebacterineae suborder. 
It was further shown that mycolic acid patterns can be specific for certain species 
within a single genus. However, the REIMS dataset has to be further enlarged to 
validate species-specific mycolic acid patterns. The following mycolic acids have 
been detected from the corresponding genera: 
o Mycobacterium spp.: C77-C81 (even and odd numbered, 0-2 unsaturations) 
o Corynebacterium spp.: C28-C36 (even numbered, 0-2 unsaturations), 
excluding C. amycolatum 
o Nocardia spp.: C48-C56 (even numbered, 0-3 unsaturations) 
o Rhodococcus spp.: C28-C38 (even and odd numbered, 0-4 unsaturations) 
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• A variety of sphingolipid species were found to be specific for members of the 
phylum Bacteroidetes. These sphingolipids include oxidised ceramides species, 
phosphoethanolamine dihydroceramides and C15:0-substituted phosphoglycerol 
dihydroceramides and dihydroceramide. 
Among those sphingolipid species, a series of galactosylated sphingolipids was found 
to be specific for Bacteroides fragilis species (Bacteroides fragilis alpha-
Galactosylceramides). 
• Among bacteria, plasmalogens are highly specific for anaerobic bacteria such as 
Clostridium spp. and Fusobacterium spp.. This is due to the fact that aerobic bacteria 
lost the biochemical pathway required for plasmalogen synthesis. Humans however 
are able to synthesise plasmalogens (although via a different biochemical pathway 
from anaerobes) although these were generally found to have longer chain lengths 
than bacterial plasmalogens. 
A detailed assessment of the conservative nature of these markers lies outside of the scope of 
this project and hence conservative only refers to the detection of these signals in bacteria 
grown under arbitrary culuturing conditions rather than stable detection levels. A throrough 
assessment of these properties will require a more comprehensive dataset with a larger 
number of strains per bacterial species as was used in the proof-of-principle study presented 
here. 
Other taxonomical markers are less conserved and their detection is highly dependent on 
culturing conditions. These TSM are still indicative of a certain group of bacteria and can be 
used to detect the presence bacteria in complex matrices (not the absence), however, they 
might show very different production amounts and will thus not be suitable for quantification 
purposes. Such compounds include  
• Lipopolypeptides that are produced specifically by certain Bacillus species such as 
surfactin for B. subtilis and B. pumilus and lichenysin for B. licheniformis. Production 
of these two molecules also enables straightforward differentiation of these otherwise 
very closely related bacteria.  
• PQS-derived quorum-sensing molecules and mono- and di-rhamnolipid species found 
in Pseudomonas aeruginosa.  
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Table 28. Taxon-specific markers (given as m/z values) obtained for sample set detailed in Appendix 4. No markers were calculated for those levels in grey due to 
insufficient size of sample set. † marks an isotope peak, * marks a m/z value with molecular identity known (see Table 29), ‡ marks m/z value that is likely to 
experience interference from mammalian cells, m/z values in bold font indicate relative spectral abundance >50% in spectrum of pure bacterial culture. 
 Phylum Class Order Family Genus Species 
Gram-negative Bacteroidetes 
328.2857* 
381.2765 
552.4643‡ 
553.4674†,‡ 
590.4923*,‡ 
623.5024 
624.5054† 
639.4954* 
651.4953 
653.5113* 
654.5143† 
677.5238* 
691.5395* 
705.5562* 
Bacteroidia 
286.2466 
627.4883 
628.4913 
465.3024*,‡ 
602.4783 
604.5083* 
605.5113† 
607.5074 
Bacteroidales 
 
Bacteroidaceae 
379.2605 
576.4764 
683.5583 
684.5613† 
812.7363 
824.5673 
826.7513 
Bacteroides Bacteroides acidifaciens 
Bacteroides caccae 
Bacteroides eggerthii 
Bacteroides fragilis 
752.5419* 
766.5574*,‡ 
780.5732*,‡ 
Bacteroides helcogenes 
Bacteroides ovatus 
Bacteroides pyogenes 
Bacteroides thetaiotaomicron 
Bacteroides uniformis 
Bacteroides vulgatus 
Porphyromonadaceae 
814.7063 
828.7232 
840.6842 
854.7022 
858.6972 
872.7072 
904.7051* 
918.7191* 
932.7332* 
933.7362† 
944.7342* 
945.7372† 
946.7472* 
947.7502† 
958.7461* 
Parabacteroides Parabacteroides distasonis 
Parabacteroides johnsonii 
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 Phylum Class Order Family Genus Species 
959.7501† 
961.7661* 
962.7691† 
Prevotellaceae 
661.5283 
675.5453 
676.5503† 
870.8002† 
908.7401 
922.7552 
Prevotella Prevotella bivia 
Rikenellaceae Alistipes Alistipes onderdonkii 
Flavobacteria 
324.2545* 
325.2576† 
333.2084‡ 
374.2365 
392.2484 
393.2504† 
564.4624 
566.4794* 
567.4834†,* 
568.4864† 
600.4664 
604.4633 
618.4773 
619.4813† 
620.4883† 
639.5334 
640.5363† 
Flavobacteriales Flavobacteriaceae Chryseobacterium Chryseobacterium indologenes 
Chryseobacterium sp 
Elizabethkingia Elizabethkingia meningoseptica 
Myroides 
590.4474 
Myroides odoratimimus 
Fusobacteria 
227.2015‡ 
644.4652 
645.4633† 
Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium Fusobacterium gonidiaformans 
Fusobacterium necrophorum 
Fusobacterium peridontiam 
Fusobacterium sp 
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 Phylum Class Order Family Genus Species 
646.4833* 
647.4812† 
882.6932 
883.6982† 
Proteobacteria 
768.5182‡ 
782.5342‡ 
783.5293† 
Alpha-Proteobacteria 
773.5332*,‡ 
Caulobacterales 
769.5502 
770.5562† 
771.5582† 
795.5572‡ 
797.5723† 
Caulobacteraceae Brevundimonas Brevundimonas diminuta 
Rhizobiales 
439.4155 
440.4195† 
739.5313‡ 
784.5902‡ 
785.5932†,‡ 
Rhizobiaceae Rhizobium Rhizobium radiobacter 
Rhodospirillales 
733.5752 
857.7252 
Acetobacteraceae Roseomonas Roseomonas mucosa 
Roseomonas sp 
Beta-Proteobacteria Burkholderiales Alcaligenaceae Achromobacter Achromobacter sp 
Achromobacter xylosoxidans 
Alcaligenes Alcaligenes faecalis 
Burkholderiaceae 
589.4013 
590.4083† 
591.4184 
592.4214† 
801.5662‡ 
Burkholderia Burkholderia cepacia complex 
Comamonadaceae 
 
Acidovorax Acidovorax temperans 
Comamonas Comamonas kerstersii 
Comamonas sp 
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 Phylum Class Order Family Genus Species 
Delftia Delftia acidovorans 
Delftia dentocariosa 
Delftia sp 
Sutterellaceae 
481.4274 
Sutterella Sutterella wadsworthensis 
Neisseriales 
494.3855 
502.3674 
526.3673 
527.3704† 
528.3653 
544.3774 
Neisseriaceae Eikenella Eikenella corrodens 
Kingella Kingella kingae 
Kingella sp 
Neisseria Neisseria cineria 
Neisseria elongata 
Neisseria flavescens 
Neisseria gonorrhoea 
Neisseria lactamica 
Neisseria meningitidis 
Neisseria mucosa 
Epsilon-Proteobacteria 
730.5422‡ 
731.5452†,‡ 
Campylobacterales Campylobacteraceae 
867.6582 
993.8381† 
Campylobacter Campylobacter coli 
Campylobacter fetus 
Campylobacter jejuni 
Campylobacter sp 
Helicobacteraceae 
271.2284*,‡ 
272.2305† 
299.2595*,‡ 
300.2625† 
400.2644 
492.3104‡ 
794.5783†,‡ 
Helicobacter Helicobacter pylori 
Gamma-Proteobacteria Aeromonadales Aeromonadaceae Aeromonas Aeromonas hydrophila 
Cardiobacteriales 
648.4603 
649.4623† 
650.4653† 
793.4792 
Cardiobacteriaceae Cardiobacterium Cardiobacterium hominis 
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 Phylum Class Order Family Genus Species 
794.4802† 
Enterobacteriales 
702.5083 
703.5092† 
993.7282 
994.7272† 
Enterobacteriaceae Citrobacter Citrobacter amalonaticus 
Citrobacter braakii 
Citrobacter freundii 
Citrobacter koseri 
Enterobacter Enterobacter absuriae 
Enterobacter aerogenes 
Enterobacter amnigenus 
Enterobacter cloacae 
Enterobacter gergoviae 
Escherichia Escherichia coli 
Hafnia Hafnia alvei 
Hafnia paralvei 
Hafnia sp 
Klebsiella Klebsiella oxytoca 
Klebsiella pneumoniae 
Morganella Morganella morganii 
Panthoea Panthoea sp 
Proteus Proteus mirabilis 
Proteus vulgaris 
Provedencia Provedencia rettgeri 
Provedencia stuartii 
Raoultella Raoultella ornithololytica 
Raoultella planticola 
Salmonella Salmonella poona 
Serratia Serratia liquifaciens 
Serratia marcescens 
Shigella Shigella sonnei 
Pasteurellales Pasteurellaceae Aggregatibacter Aggregatibacter aphrophilus 
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 Phylum Class Order Family Genus Species 
688.4913 
746.4503 
823.5453 
898.6921 
915.6902† 
Haemophilus Haemophilus influenzae 
Haemophilus parahaemolyticus 
Haemophilus parainfluenzae 
Pasteurella Pasteurella multocida 
Pseudomonadales 
745.5013*,‡ 
746.5053†,‡ 
Moraxellaceae Acinetobacter 
981.7171 
982.7191† 
Acinetobacter baumanii 
Acinetobacter iwoffii 
953.6811 
Acinetobacter johnsonii 
Acinetobacter junii 
Moraxella 
171.1395 
Moraxella catarrhalis 
771.5172*,‡ 
Moraxella osloensis 
Pseudomonadaceae 
490.3304 
514.3294 
Pseudomonas Pseudomonas aearuginosa 
242.1554* 
258.1508* 
531.3654* 
Pseudomonas luteola 
Pseudomonas monteilii 
Pseudomonas oryzihabitans 
Pseudomonas putida 
Pseudomonas stutzeri 
Vibrionales 
605.3823 
607.3983 
608.4013† 
633.4134 
843.6042† 
Vibrionaceae Vibrio Vibrio alginolyticus 
Vibrio cholerae 
Vibrio furnissii 
Xanthomonadales 
929.6852 
930.6892† 
Xanthomonadaceae Stenotrophomonas Stenotrophomonas maltophilia 
Gram-positive Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae 
757.5403‡ 
Actinobaculum 
287.2225 
Actinobaculum schaalii 
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 Phylum Class Order Family Genus Species 
Actinomyces Actinomyces graevenitzii 
Actinomyces israelii 
Actinomyces odontolyticus 
Actinomyces oris 
Actinomyces sp 
Actinomyces turicensis 
Actinomyces viscosis 
Corynebacteriaceae 
 
Corynebacterium Corynebacterium afermentans 
Corynebacterium amycolatum 
169.0616 
187.0735 
999.7541† 
Corynebacterium diphtheriae 
491.4474* 
492.4505† 
984.9051* 
Corynebacterium imitans 
Corynebacterium minutissimum 
Corynebacterium sp 
Corynebacterium striatum 
Microbacteriaceae Microbacterium Microbacterium sp 
Mycobacteriaceae 
391.3684 
727.4913‡ 
1122.1512* 
1166.1774* 
Mycobacterium Mycobacterium avium 
Mycobacterium fortuitum 
Mycobacterium peregrium 
Nocardiaceae 
 
Nocardia 
797.7762* 
799.7842* 
825.8083* 
827.8162† 
828.8222† 
Nocardia sp 
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 Phylum Class Order Family Genus Species 
Rhodococcus 
481.4630* 
509.4943* 
537.5259* 
Rhodococcus equi 
Rhodococcus sp 
Propionibacteriaceae 
361.2155 
713.4752 
779.5072‡ 
877.5592 
905.5842 
990.7091† 
Propionibacterium Propionibacterium acnes 
Bifidobacteriales 
789.5293‡ 
792.5502†,‡ 
819.5783‡ 
830.5622‡ 
855.5272‡ 
884.6092 
885.6142† 
Bifidobacteriaceae Bifidobacterium 
827.4882 
867.5942‡ 
909.5752 
Bifidobacterium adolescentis 
Bifidobacterium bifidum 
Bifidobacterium breve 
805.5612‡ 
923.5902 
Bifidobacterium infantis 
Bifidobacterium longum 
Bifidobacterium pseudocatenulatum 
Gardnerella 
766.5392‡ 
Gardnerella vaginalis 
Micrococcales 
913.5682‡ 
914.5711†,‡ 
915.5671† 
Micrococcaceae Arthrobacter Arthrobacter creatinolyticus 
Arthrobacter sp 
Kokuria Kokuria kristina 
Kokuria rhizophila 
Kokuria varians 
Micrococcus Micrococcus luteus 
Micrococcus lylae 
Rothia Rothia aeria 
Rothia amarne 
Rothia dentocariosa 
Rothia mucilaginosa 
885.5352 
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 Phylum Class Order Family Genus Species 
Rothia sp 
Micrococcineae Brevibacterium Brevibacterium paucivorans 
Brevibacterium sp 
Dermabacter 
679.4953 
707.5272 
708.5282† 
722.5453 
735.5563 
Dermabacter hominis 
Dermobacter sp 
Firmicutes Bacilli Bacillales Bacillaceae Bacillus Bacillus cereus 
677.4413 
Bacillus clausii 
Bacillus lichenformis 
1033.6927* 
Bacillus pumilus 
Bacillus sonorensis 
Bacillus sp 
Bacillus subtilis 
1034.6766* 
Listeriaceae 
675.9793 
832.5352‡ 
Listeria Listeria monocytogenes 
Paenibacillaceae 
903.7221 
914.7282 
Paenibacillus Paenibacillus sp 
Paenibacillus unalis 
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 Phylum Class Order Family Genus Species 
Staphylococcaceae 
202.0525 
228.0335 
245.0596 
763.5512‡ 
765.5482† 
Staphylococcus Staphylococcus aureus 
Staphylococcus capitis 
Staphylococcus caprae 
Staphylococcus cohnii 
Staphylococcus epidermis 
Staphylococcus haemolyticus 
Staphylococcus hominis 
Staphylococcus lugdunensis 
Staphylococcus pasteuri 
Staphylococcus pettenkoferi 
Staphylococcus saprophyticus 
Staphylococcus warneri 
Lactobacillales 
898.5391 
923.5512 
925.5671 
926.5701† 
949.5672 
951.5832 
952.5861† 
953.5981 
954.6011† 
955.5971† 
956.5971† 
979.6111 
Aerococcaceae 
163.0506 
Abiotrophia Abiotrophia defectiva 
Aerococcus 
213.1245 
Aerococcus sp 
Aerococcus viridians 
160.0615 
197.0829 
Carnobacteriaceae Granulicatella Granulicatella adiacens 
Enterococcaceae Enterococcus Enterococcus avium 
Enterococcus casseliflavus 
Enterococcus cecorum 
Enterococcus faecalis 
Enterococcus faecium 
Enterococcus gallinarum 
Enterococcus raffinosus 
Lactobacillaceae Lactococcus Lactococcus lactis 
Lactococcus spp 
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 Phylum Class Order Family Genus Species 
Leuconostocaceae Leuconostoc Leuconostoc sp 
Streptococcaceae 
897.5351 
Lactobacillus Lactobacillus gasseri 
Lactobacillus rhamnosus 
Streptococcus 
 
Streptococcus agalactiae 
Streptococcus anginosus 
Streptococcus bovis 
Streptococcus canis 
Streptococcus constellatus 
Streptococcus cristatus 
Streptococcus dysagalactiae 
Streptococcus gallolyticus 
Streptococcus gordonii 
Streptococcus intermedius 
Streptococcus lutetiensis 
Streptococcus milleri 
Streptococcus mitis 
Streptococcus mutans 
348.2184 
372.2175 
Streptococcus oralis 
Streptococcus parasanguinus 
Streptococcus pneumoniae 
Streptococcus povas 
Streptococcus pseudoporcinus 
450.1635 
Streptococcus pyogenes 
Streptococcus salivarius 
Streptococcus sanguinis 
Streptococcus vestibularis 
Streptococcus viridans 
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 Phylum Class Order Family Genus Species 
Clostridia 
449.2685 
703.4923‡ 
704.4953‡ 
731.5253‡ 
732.5283 
925.7262 
Clostridiales Clostridiaceae 
649.4453 
759.5583‡ 
897.6951 
969.7481 
970.7541‡ 
Clostridium Clostridium celerecrescens 
Clostridium difficile 
Clostridium histolyticum 
Clostridium innocuum 
Clostridium paraputrificum 
Clostridium perfringens 
427.2104 
829.6192 
Clostridium ramosum 
Clostridium septicum 
Clostridium sporogenes 
896.7072‡ 
Clostridium tertium 
Peptostreptococcaceae 
496.4124 
497.4214 
498.4244 
635.3944‡ 
645.4133 
646.4173 
681.3923 
Parvinomas Parvinomas micra 
Peptoniphilus 
 
Peptoniphilus harei 
Negativicutes 
461.3394 
628.4443 
851.7352 
Selenomonadales Acidaminococcaceae 
199.1696 
643.4343‡ 
644.4383‡ 
730.4652 
Acidaminococcus Acidaminococcus fermentans 
Veillonellaceae 
213.1855 
439.3795 
641.4563 
655.4713‡ 
669.4883‡ 
Dialister Dialister sp 
Veillonella Veillonella atypica 
Veillonella dispar 
Veillonella parvula 
Veillonella ratti 
† Isotope peak, * molecular identity known (see Table 29), ‡ likely interference from mammalian cells, bold font indicates relative spectral abundance >50% 
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Table 29. Molecular assignment of taxon-specific markers labelled with an asterisk in Table 28. 
m/z TSM molecular identity  m/z TSM molecular identity 
242.1554 2-Heptylquinoline-4(1H)-one  766.5574 B. fragilis α-galactosylceramide 
258.1508 2-Heptyl-3-hydroxy-4(1H)-quinolone (PQS)  771.5172 PG(36:3) 
271.2284 FA16:0 plus 16Da (O)  773.5332 PG(36:2) 
299.2595 FA18:0 plus 16Da (O)  780.5732 B. fragilis α-galactosylceramide 
324.2545 Dihydroceramide -H2  797.7762 Mycolic acid 
328.2857 Dihydroceramide  799.7842 Mycolic acid 
465.3024 Cholesterol sulfate  825.8083 Mycolic acid 
481.4630 Mycolic acid  904.7051 C15:0 substituted PG Dihydroceramides  
491.4474 Mycolic acid  918.7191 C15:0 substituted PG Dihydroceramides  
509.4943 Mycolic acid  932.7332 C15:0 substituted PG Dihydroceramides  
531.3654 Rhamnolipid  933.7362 C15:0 substituted PG Dihydroceramides, Isotope 
537.5259 Mycolic acid  944.7342 C15:0 substituted PG Dihydroceramides  
590.4923 Ceramide plus 16Da (O)  945.7372 C15:0 substituted PG Dihydroceramides, Isotope 
604.5083 Ceramide  946.7472 C15:0 substituted PG Dihydroceramides  
639.4954 Homologue m/z 653.5113 (-CH2)  947.7502 C15:0 substituted PG Dihydroceramides, Isotope 
646.4833 PE Plasmalogen  958.7461 C15:0 substituted PG Dihydroceramides  
653.5113 Sphingolipid  959.7501 C15:0 substituted PG Dihydroceramides, Isotope 
677.5238 Ceramide Phosphorylethanolamine  961.7661 C15:0 substituted PG Dihydroceramides, Isotope 
691.5395 Ceramide Phosphorylethanolamine  962.7631 C15:0 substituted PG Dihydroceramides  
703.4923 PG Plasmalogen  984.9051 Mycolic acid dimer (m/z 491) 
705.5562 Ceramide Phosphorylethanolamine  1033.6927 Lichenysin 
731.5253 PG Plasmalogen  1034.6766 Surfactin 
745.5013 PG(34:2)  1122.1512 Mycolic acid 
752.5419 B. fragilis α-galactosylceramide  1166.1774 Mycolic acid 
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6.4. Detection of bacteria in human colorectal tissue specimens 
To demonstrate the applicability of these taxonomical markers for the detection of bacteria in 
biological samples, we attempted to visualise the presence and distribution of bacteria in 
human colorectal tissue specimens. This was performed by generating single ion images for 
the taxonomical markers that are listed in Table 28. Bacteria are known to cover the mucosal 
membranes in the gut and the gut microbial community is arguably most extensively studied 
and characterised. Among cancerous specimens, bacteria were largely found localised in such 
areas that were identified as necrotic by histopathological examination of the H&E stained 
tissue sections. However, bacteria were also frequently detected along healthy mucosa. An 
example of both will be further discussed below. 
6.4.1. Detection of bacteria in necrotic tissue 
Figure 101A and B shows the tissue type-distribution of a cancerous tissue specimen A35 
that originated from the centre of tumour dissected during a right hemicolectomy. 
Histopathological examination revealed the presence of cancerous and stromal tissue. Smaller 
amounts of necrotic tissue and lymphoid aggregates were observed. 
 
Figure 101. A) DESI-MS ion image displaying tissue type distribution in colorectal tissue specimen A35; 
green = tumour, red = stroma, blue = lymphoid aggregates. B) H&E stained and histopathologically 
annotated section post-DESI. Areas for average spectrum generation (see Figure 102) indicated using 
blue arrows. 
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Mass spectra of the necrotic tissue area as well as surrounding cancerous and stromal tissue 
are shown in Figure 102 and display a markedly different phospholipid composition for the 
necrotic area compared to viable human tissues, namely a significantly reduced 
glycerophospholipid content and a variety of lower molecular weight sphingolipid-derived 
taxonomic marker species in the mass range of m/z 500-700.  
 
Figure 102. Full scan mass spectra for colorectal adenocarcinoma, tumour surrounding stroma and 
necrotic tissue of same tissue section shown in Figure 101. Blue stars indicate major taxonomic markers. 
Areas chosen for generating average mass spectra indicated in Figure 101 B) by blue arrows.  
An array of single ion images of taxon-specific markers is displayed in Figure 103 for 
markers of which the molecular identity is known. The majority of markers found could be 
attributed to sphingolipid species originating from members of the Bacteroidetes phylum. 
Dihydroceramide (m/z 381.2765) is found to be predominantly located into two areas on the 
left of the tissue specimen while sphingolipids at m/z 639.4954 and 653.5113 are additionally 
found in a third hotspot closer to the center of the tissue section. Ceramide 
phosphorylethanolamine species at m/z 677.5238, 691.5395 and 705.5560 are showing co-
localised distribution to sphingolipids at m/z 639 and 653. Iso-C15:0-substituted 
phosphoglycerol dihydroceramides were found to be specific for the Porphyromonadaceae 
family (part of Bacteroidetes phylum), which in this study were only represented by 
Parabacteroides spp., however, these compounds are reportedly present in high abundance in 
Porphyromonas gingivalis,(180) suggesting general applicability of this marker for this 
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family. The distribution of the homologues series of signals at m/z 932.7332, 946.7472 and 
962.7631 slightly differs from that of earlier mentioned sphingolipid compounds as it shows a 
closely situated but non-identical hotspot pattern. Notably, the signal at m/z 962.7631 shows a 
different localisation from its shorter chain homologues suggesting the influence of at least 
two different types of bacteria with different amounts of these compounds as compared to the 
composition reported for members of the Parabacteroides genus. Members of the 
Bacteroidetes phylum were reported in metagenomic studies to be accountable for up to 50% 
of the gut microbial community.(252,253) However, taxon-specific markers for Bacteroidetes 
fragilis were not detected suggesting that the Bacteroidetes bacteria present do not contain a 
high amount of the opportunistic pathogen B. fragilis.  
Further groups of bacteria detected include members of the Clostridia class of Firmicutes 
bacteria (taxon-specific markers at m/z 703.4923 and 731.5253 corresponding to 
plasmalogens species). The marker at m/z 731.5253 showed the most extensive distribution 
pattern suggesting colonisation with strong growth of Clostridia over wider tissue areas than 
for Bacteroidetes. Further two hotspots of this marker can be seen at the bottom right 
periphery of the tissue section which did not seem to be colonised by detectable amounts of 
Bacteroidetes. By detecting a plasmalogens species at m/z 646.4833, Fusobacteria could be 
further detected in similar locations to the Bacteroidetes bacteria. 
All of these detected bacterial classes are capable of living under anaerobic conditions and 
were reported to be major components of the human gut microbiome.(252) The large 
bacterial presence observed in the necrotic tissue areas is tentatively associated with the lack 
of immunoresponse of the human body, which enables bacteria to grow and multiply nearly 
uncontrolled. However, distributions of bacteria over the tissue section were seen to be non-
identical for different types of bacteria which highlights the benefit of the proposed taxon-
specific marker approach over 16S rRNA sequencing-based methods by retaining spatial 
information and allowing for more detailed study of compositional changes of the 
microbiome such as close to cancerous lesions. Although localisation of bacteria using FISH 
tests is expected to be more sensitive and allow for visualisation of even low densities of 
bacterial cells, the proposed methodology offers untargeted and multiplexed detection of 
bacteria. 
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Figure 103. Single ion images for known taxon-specific markers (TSM) of sample A35 center of tumour. 
A to F) TSM for taxon Bacteroidetes, G to I) TSM for taxon Porphyromonadaceae, J and K) TSM for 
taxon Clostridia, L) TSM for taxon Fusobacteria. Spatial resolution: 65µm. 
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6.4.2. Detection of bacteria in healthy mucosa 
Figure 104 shows the tissue type-distribution of a healthy tissue specimen A56 10cm that 
originated from a right hemicolectomy. It originated from healthy colon tissue 10cm distant 
from the centre of tumour. Histopathological examination revealed healthy mucosa and 
submucosa, divided by the muscularis mucosae layer. Figure 104 shows single ion images for 
a subset of taxon-specific markers that were detected in this sample. Taxon-specific markers 
were predominantly detected in several hotspots in two separated pockets of submucosa. 
Generally, far less and less intense TSM signals were observed in those submucosa regions 
than in case of necrotic tissue shown in th eprevious example. This is tentatively attributed 
with the healthy immunoresponse that restricts unlimited bacterial growth as is more likely to 
happen in the necrotic tissue specimen. The highest number of taxon-specific markers could 
again be detected for the Bacteroidetes phylum, however, markers for Proteobacteria and 
Clostridia were additionally detected.  
6.4.3. Detection of bacteria in entire colorectal tissue sample set  
To assess the correlation between the proposed taxon-specific marker approach and 16S 
rRNA sequencing-based community analysis, results of both methodologies were compared 
for samples from 16 patients and each three tissue locations (centre of tumour, 5cm and 10cm 
distant from tumour). Sequencing data was recorded as part of the Imperial College BRC 
Stratified Medicine project and was kindly provided by Mr Reza Mirnezami and Mr James 
Kinross. Results for samples with information available from both methodologies are shown 
in Table 30 and Table 31 for results on phylum- and class-level, respectively. Detailed lists of 
those taxon-specific markers detected in each sample can be found in Appendix 5. 
Bacteria of at least one phylum could be visualised in 87.23% of analysed colorectal 
specimens both including healthy and cancerous tissues. No bacterial markers were detected 
in 6 out of a total of 47 samples (A17 5cm, A22 5cm, A31 5cm, A49 5cm, A51 CT, A55 
5cm). In agreement with gut community compositions reported in literature,(252,253) main 
bacterial species detected using next generation sequencing are Bacteroidetes, Proteobacteria 
and Firmicutes. A small number of samples feature larger copy numbers of Fusobacteria 
while generally small copy numbers of Actinobacteria are detected. Due to lack of taxon-
specific markers of sufficient universal applicability in human matrices, no Fusobacteria were 
detected in this sample set using DESI-MSI.  
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Figure 104. Single ion images of taxon-specific markers (TSM) detected in healthy colorectal tissue 
specimen A56 10cm and F) H&E image of same tissue section. A) TSM detected for taxon Flavobacteria, 
B to H) TSM detected for taxon Bacteroidetes, I) TSM detected for taxon Porphyromonadaceae. Spatial 
resolution: 110µm. J) and K) average spectra for mucosa and submucosa showing bacterial TSM, areas 
for spectrum generation indicated in F) by blue arrows. 
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In general, all bacterial phyla detected using DESI-MSI and the proposed taxon-specific 
marker approach were confirmed as present in the same patient sample using sequencing-
based analysis (see Table 30). Although a certain degree of correlation between copy 
numbers and number of detected taxon-specific markers can be found in some patient 
samples, this is not true in all of the cases. However, due to the inherently different 
methodologies which were used on spatially different parts of the same sample, numbers 
given in Table 30 are not strictly comparable and sequencing-derived results are only 
displayed for validation of the presence of a certain taxon in question. The number of taxon-
specific markers found cannot be directly compared to the copy-numbers found per bacterial 
taxon using molecular methods as the number of taxon-specific markers is not related to 
number of bacterial cells. Instead, the number of TSM found per taxon is an indication of the 
homogeneity of bacterial groups within each taxon and heterogeneity in comparison with 
other taxa. However, TSMs for the same taxon showing similar localisation patterns are 
increasing the confidence in detection of the bacterial group in question. The absolute 
intensity of each TSM in turn is potentially related to absolute bacterial cell numbers, 
however, additional experiments are required that would allow assessment of the quantitative 
nature of TSMs.  
Bacteria that could be visualised using TSMs were in most cases found to be highly localised 
into histological features of less than a millimetre in size. As sequencing-based analysis 
involves tissue homogenisation, such features might get missed and/or diluted. DESI-MSI 
analysis of TSM clearly shows large spatial heterogeneity in bacterial composition and 
densities which complicates comparison of data obtained from two non-identical areas of 
tissues even within the same macroscopic tissue specimen. As bacterial markers detected by 
DESI were associated with tissue necrosis in many cases, detected bacteria most likely 
originate from a local overpopulation of areas with larger cell densities rather than the 
commensal bacterial community. To further investigate this, future work using FISH 
(fluorescent in-situ hybridisation) tests on serial tissue sections are necessary to assess 
whether bacteria are found over the entire tissue section but at significantly increased density 
in those areas where bacteria were detected using DESI-MSI or whether bacteria can indeed 
be only found in the latter areas. This will allow an assessment of sensitivity of the taxon-
specific marker approach in direct infusion mass spectrometry techniques such as DESI-MSI.  
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Table 30. Comparison of number of taxon-specific markers detected by DESI-MSI and copy numbers of 
bacteria detected by 16S rRNA sequencing-based community analysis for the same colorectal tissue 
specimens on phylum-level. 
 
Number of taxon-specific markers 
detected by DESI-MSI 
Bacteria detected by 16S rRNA sequencing-
based community analysis 
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A14 10CM 1 3 0 3  
608 836 6 2425 5 
A14 5CM 2 3 0 0  
297 197 2 686 2 
A14 CT 3 6 2 4  
557 1386 15 3453 171 
A15 10CM 0 3 0 1  
650 61 2 1129 62 
A15 5CM 2 1 0 1  
1105 114 18 1922 160 
A15 CT 3 2 0 0  
758 64 17 1745 986 
A17 10CM 5 5 1 0  
1965 283 2 2190 102 
A17 5CM 0 0 0 0  
661 146 7 917 60 
A17 CT 13 9 2 3  
2300 98 5 599 1782 
A22 10CM 5 2 0 0  
310 56 28 1297 18 
A22 5CM 0 0 0 0  
1185 216 25 2324 275 
A22 CT 7 1 2 2  
1057 212 32 2176 466 
A31 10CM 0 0 0 0  
248 1061 3 710 6 
A31 5CM 1 1 0 0  
805 1032 6 532 20 
A31 CT 8 5 0 1  
1597 733 19 1951 61 
A36 10CM 8 9 0 3  
1156 101 6 1258 6 
A36 5CM 4 0 0 2  
906 19 1 1379 0 
A36 CT  2 9 4 1  
876 23 2 1700 6 
A37 10CM 7 9 2 1  
236 83 14 1881 2 
A37 5CM 7 4 0 4  
255 277 46 1369 150 
A37 CT 2 5 0 1  
226 112 6 1469 4 
A38 10CM 6 2 0 0  
1478 1151 10 1421 2 
A38 5CM 9 2 0 3  
585 441 2 386 0 
A38 CT  13 6 1 5  
3572 102 11 621 749 
A42 10CM 4 2 0 1  
1207 210 23 5027 50 
A42 5CM 5 3 0 1  
584 222 3 2468 230 
A42 CT 6 3 1 2  
1432 394 8 2850 233 
A49 10CM 8 6 2 2  
551 414 33 1812 98 
A49 5CM 0 0 0 0  
829 195 30 2446 240 
A49 CT 10 9 3 6  
380 97 16 1188 392 
A51 10CM 4 0 0 2  
360 103 10 2368 39 
A51 5CM 10 0 1 4  
140 43 4 1007 27 
A51 CT 0 0 0 0  
163 125 7 2531 132 
A55 10CM 4 4 0 2  
378 1622 39 103 0 
A55 5CM 0 0 0 0  
858 2240 88 504 42 
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Number of taxon-specific markers 
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Bacteria detected by 16S rRNA sequencing-
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A55 CT 0 2 0 0  
307 919 10 362 1 
A56 10CM 20 7 0 4  
1035 340 2 1099 17 
A56 5CM 8 2 0 2  
2049 706 35 2002 31 
A56 CT 17 3 0 1  
1195 847 6 1488 40 
A57 10CM 3 0 0 1  
623 33 14 3167 0 
A57 5CM 19 2 1 7  
809 34 18 2435 4 
A57 CT 6 2 1 2  
607 16 9 1602 4 
A62 5CM 6 0 0 1  
1337 501 8 1146 0 
A62 CT 6 2 0 3  
1032 46 2 1330 2 
A64 10CM 5 2 0 0  
245 454 5 638 4 
A64 5CM 24 11 4 6  
994 1248 10 1969 6 
A64 CT 23 7 3 7  
569 1053 9 1108 14 
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Table 31. Comparison of number of taxon-specific markers detected by DESI-MSI and copy numbers of bacteria detected by 16S rRNA sequencing-based 
community analysis for the same colorectal tissue specimens on class-level. 
Number of taxon-specific markers detected by DESI-MSI Bacteria detected by 16S rRNA sequencing-based community analysis 
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A14 10CM 0 1 0 0 0 3 0 1 2 0 596 11 7 256 0 573 6 1 2421 0 5 
A14 5CM 2 0 1 0 2 0 0 0 0 0 294 3 1 29 0 167 2 2 682 0 2 
A14 CT 1 2 0 1 4 1 2 1 2 2 525 32 33 516 0 837 15 159 3286 0 171 
A15 10CM 0 0 0 0 2 1 0 0 1 0 648 2 1 27 0 33 2 10 1119 0 62 
A15 5CM 2 0 0 0 0 1 0 0 1 0 1105 0 2 51 3 58 18 23 1896 0 160 
A15 CT 3 0 1 0 0 1 0 0 0 0 758 0 0 36 18 10 17 3 1742 0 986 
A17 10CM 4 1 0 0 2 3 1 0 0 0 1940 25 40 130 5 108 2 280 1843 3 102 
A17 5CM 0 0 0 0 0 0 0 0 0 0 635 23 33 39 17 57 7 48 849 0 60 
A17 CT 10 3 0 0 4 5 2 1 1 1 2287 13 6 46 31 15 5 89 509 0 1782 
A22 10CM 2 3 1 0 1 0 0 0 0 0 310 0 5 29 0 16 28 6 1288 0 18 
A22 5CM 0 0 0 0 0 0 0 0 0 0 1143 41 55 107 0 54 25 14 2303 0 275 
A22 CT 5 2 0 0 0 1 2 1 1 0 1056 0 47 125 0 40 32 36 2118 0 466 
A31 10CM 0 0 0 0 0 0 0 0 0 0 237 10 6 447 0 608 3 142 321 0 6 
A31 5CM 0 1 0 0 1 0 0 0 0 0 758 46 8 475 0 549 6 59 442 0 20 
A31 CT 6 2 0 0 3 2 0 0 0 1 1594 3 1 291 1 440 19 42 1779 0 61 
A36 10CM 7 1 3 0 0 6 0 2 1 0 1139 15 0 46 2 53 6 3 1229 0 6 
A36 5CM 4 0 0 0 0 0 0 0 2 0 887 19 4 12 0 3 1 1 1337 0 0 
A36 CT  2 0 2 1 4 2 4 0 1 0 834 40 0 4 4 14 2 14 1671 0 6 
A37 10CM 2 5 4 1 3 1 2 0 1 2 233 2 38 3 0 42 14 4 1877 0 2 
A37 5CM 5 2 1 0 0 3 0 1 2 1 160 16 83 59 9 94 46 89 1280 0 150 
A37 CT 2 0 1 0 3 1 0 0 0 1 226 0 57 11 1 43 6 9 1460 0 4 
A38 10CM 3 3 0 0 1 1 0 0 0 0 1463 4 2 260 0 886 10 268 1082 45 2 
A38 5CM 6 3 0 0 1 1 0 0 2 1 582 0 0 58 0 383 2 76 295 12 0 
A38 CT  8 5 0 0 1 5 1 0 4 1 3572 0 0 35 35 31 11 125 487 3 749 
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Number of taxon-specific markers detected by DESI-MSI Bacteria detected by 16S rRNA sequencing-based community analysis 
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A42 10CM 3 1 0 0 1 1 0 0 0 1 1202 5 11 130 2 67 23 601 4392 0 50 
A42 5CM 4 1 0 0 2 1 0 0 1 0 584 0 0 124 7 85 3 302 2150 0 230 
A42 CT 4 2 0 0 2 1 1 0 1 1 1432 0 0 319 8 67 8 297 2523 0 233 
A49 10CM 6 2 0 0 4 2 2 0 2 0 446 96 55 200 1 158 33 215 1537 5 98 
A49 5CM 0 0 0 0 0 0 0 0 0 0 826 3 19 113 4 59 30 978 1299 15 240 
A49 CT 5 5 0 2 4 3 3 0 4 2 379 1 0 30 51 16 16 717 430 0 392 
A51 10CM 2 2 0 0 0 0 0 1 1 0 345 15 7 21 0 75 10 16 2349 0 39 
A51 5CM 8 2 0 0 0 0 1 0 4 0 140 0 4 1 0 38 4 3 1002 0 27 
A51 CT 0 0 0 0 0 0 0 0 0 0 160 3 14 50 1 60 7 20 2508 0 132 
A55 10CM 3 1 1 1 0 2 0 0 2 0 28 347 216 638 0 768 39 6 96 0 0 
A55 5CM 0 0 0 0 0 0 0 0 0 0 181 126 63 262 0 594 10 2 356 0 1 
A55 CT 0 0 0 0 1 1 0 0 0 0 462 392 310 926 2 1002 88 82 412 0 42 
A56 10CM 16 4 0 1 0 6 0 1 3 0 1029 6 0 153 1 186 2 12 1076 0 17 
A56 5CM 7 1 0 0 1 1 0 0 2 0 2009 29 25 281 1 399 35 34 1937 0 31 
A56 CT 14 3 0 0 1 2 0 0 1 0 1194 1 0 165 0 681 6 14 1467 0 40 
A57 10CM 2 1 0 0 0 0 0 0 0 1 623 0 2 24 0 4 14 9 3158 0 0 
A57 5CM 14 5 2 0 0 0 1 1 4 2 798 11 6 14 0 9 18 10 2420 0 4 
A57 CT 4 2 0 1 0 1 1 0 1 1 607 0 0 14 0 2 9 1 1601 0 4 
A62 5CM 4 2 0 0 0 0 0 0 1 0 1328 2 3 48 2 448 8 13 1127 0 0 
A62 CT 4 2 0 0 1 1 0 1 2 0 1027 0 0 28 0 18 2 28 1297 0 2 
A64 10CM 3 2 0 0 1 1 0 0 0 0 241 1 27 12 0 415 5 12 608 0 4 
A64 5CM 20 4 1 1 4 5 4 0 4 2 972 6 73 25 0 1149 10 22 1885 0 6 
A64 CT 17 6 1 0 2 4 3 1 5 1 556 3 75 17 0 961 9 12 1086 0 14 
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This study demonstrates that molecular species differ significantly between microbial 
lipidomes and the human tissue lipidome. Based on a database of REIMS lipid profiles of 
both microorganisms and human cell lines, taxon-specific markers were found for a variety of 
bacterial species at different taxonomic levels. These markers were shown to be absent in 
human tissues and can thus be used to visualise the presence of bacteria in human samples 
such as presented for human colorectal tissues. It was further demonstrated that taxonomic 
markers derived by the REIMS technique can be used in conjunction with other mass 
spectrometric ionisation techniques capable of detecting the same molecular species such as 
DESI, which is more suitable to the direct analysis of mucosal sampling devices or mass 
spectrometry imaging. The presented approach can be extended to a wide variety of 
applications as the characterisation of microbial communities during endoscopic 
interventions using REIMS, and for the detection of microbes in human sterile and non-sterile 
biofluid samples to facilitate appropriate antibiotic treatment. Although currently only a small 
number of taxon-specific markers was detected, this number is likely to increase with 
increasing number of database entries and by using molecular validation of microorganism 
identity during REIMS database building. Further markers are additionally expected in the 
higher mass range which was not analysed as part of this study (m/z 1000-2000). Eventually, 
larger number of entries per bacterial species and increased variability of culturing conditions 
will enable the establishment of conservative taxon-specific markers and allow the 
assessment of using these markers to quantify the amount of certain bacterial species.  
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Summary 
 
A novel REIMS-based mass spectrometric method was developed for the purpose of 
identifying and characterising unicellular organisms. A pair of bipolar forceps with an 
irrigation port directly connected to the mass spectrometer inlet was found to be most suited 
for reproducible and sensitive generation of mass spectral data. Spectral profiles obtained 
using REIMS were found to be highly independent from most instrumental parameters such 
as the electrosurgical power supply model and its power settings, instrument tube lens and 
capillary voltages and mass analyser. However, adaptations were necessary for 
implementation on a Waters platform which was chosen as the instrument for 
commercialisation of the proposed technology. These included insertion of a heated collision 
surface into the atmospheric pressure interface to remove instrument contaminants. 
The technology was found to be suitable to identify bacteria and yeasts directly from the agar 
culturing plate without any further sample pre-treatment and acquisition times of just 3-5 
seconds. The technology was found to perform equally well for Gram-negative, Gram-
positive bacteria and yeasts although the latter two contain far thicker cell walls than Gram-
negative bacteria. Specificity for 28 bacterial species was found to be comparable to 
specificity obtained using the Bruker BioTyper at 95.8% on species-level. Species ID was 
obtained using the BioTyper which is why performance of REIMS was not expected to 
exceed performance by MALDI-TOF-MS. 
Deviations in the sampling workflow were necessary in case of liquid cultures and cell lines 
in which case the organism biomass was centrifuged to a cell pellet before analysis. Mass 
spectrometric profiles were found to differ from those of the same species grown on solid 
culturing medium and thus it is suggested to include spectra obtained from liquid culture into 
a future spectral database. However, changes were largely found to be due to relative changes 
in intensity of spectral features rather than presence or absence of signals. The same was 
found to be true for different culturing media, although changes were found to be less 
significant in this case.  
Different degrees of subspecies-specificity was found in several cases such as ribotypes in C. 
difficile, serotypes in S. pneumoniae, and antibiotic resistance for K. pneumoniae.  
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Direct on-sample microbial detection was found to be feasible using a taxon-specifc marker 
approach in which bacteria are identified based on biomarkers that were determined to be 
uniquely specific at a certain taxonomic level. For this purpose, a bacterial spectral database 
was built comprising REIMS spectral profiles of 217 bacterial species. A strategy involving 
ANOVA tests followed by Tukeys Honestly Significant Difference test was used on all 
taxonomic levels to determine biomarker compounds. Using these taxon-specific markers, 
bacteria were detected in DESI-MS imaging datasets in both healthy and canceorus tissue 
specimens. Particularly high microbial density was found in necrotic tissue areas. Detected 
bacterial species were found to correlate with bacterial species known to be present in the gut 
and results of 16S rRNA-based community analysis. This shows that lipid-based microbial 
markers detected using REIMS can be equally applied to other mass spectrometric techniques 
that are a suitable means for obtaining information on the lipid content of a sample. 
The methodology was further applied to the characterisation of the NCI60 human cancer cell 
line panel to obtain shotgun lipidomic information on all members of the panel. REIMS 
spectral profiles were shown to be sufficiently specific to identify different cancer cell lines 
as shown using PCA models. However, cell line lipid profiles were found to significantly 
differ from those obtained from ex-vivo tissue specimen. REIMS lipid profiles were 
correlated with gene expression data and good positive correlation was found with genes 
involved in lipid metabolism as shown for fads2 and ugcg genes. Discussions are undergoing 
to make REIMS data publicly available by incorporating it into the CellMiner database. 
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Impact 
 
The proposed REIMS-based microbial identification and characterisation tool was proven to 
be capable of performing similar tasks as the market-leading commercial Bruker BioTyper 
platform, namely specific identification of bacteria with >95% accuracy on species-level. 
Furthermore, the technique seems to be a promising platform to perform subspecies 
identifications such as strain-level identification, or detection of ribotype or antibiotic 
resistance. In many cases, this information can be found in the same spectral profiles without 
having to introduce further culturing or sample preprocessing steps. An inherent advantage of 
REIMS is its robustness and simple sampling probe making it amenable to automation. 
During the course of this PhD work and based on results obtained in this study, an automated 
sampling robot was developed in collaboration with the Waters Research Center (Budapest, 
Hungary) based on a modified Tecan Evo colony picking unit. This unit was installed at 
Imperial College for characterisation and testing in June 2015 and enables acquisition of 
REIMS spectral profiles and sampling for 16S rRNA sequencing of up to 1000 strains per 
day. This corresponds to the numbers of bacterial strains that are processed in a large clinical 
microbiology unit such as in Charing Cross Hospital, London per day. These developments 
make REIMS a promising alternative for bacterial identification when compared to the 
MALDI-based systems. However, initial culturing steps are still necessary, thus no further 
time-savings can be obtained as compared to MALDI-TOF-MS for species-level 
identification. However, potentially the time needed and costs associated with follow-up 
experiments for subspecies-typing could be significantly reduced using a REIMS-based 
workflow. One significant advantage of the automated REIMS method is that is is equally 
well suited to the analysis of bacteria and yeasts which currently require different sample pre-
treatment steps in order to provide accurate species identification. 
However, the largest impact on changing clinical practice could be obtained in case of direct 
detection of bacteria in clinical samples without the need for culturing steps which could 
reduce the time-demand needed for identification by a further 24hrs and would allow 
identification of causative agents on the same day as samples are received in the 
microbiology laboratory. Mass spectrometric technologies can be envisioned working in GP 
offices and would enable better diagnostic performance in minutes. The taxon-specific 
marker approach for detection of bacteria in complex matrices was found to be able to detect 
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bacteria in healthy and cancerous human tissue specimens analysed using DESI-MSI. This 
indicates that bacterial biomarkers derived from REIMS-spectral profiles can be detected 
using alternative and more sensitive means for lipid detection. While DESI and MALDI-MS 
are particularly interesting for tissue imaging applications, screening of taxonomic markers 
using LC-MS would be a promising alternative to identify causative agents of septicemia in 
blood samples or meningitidis in cerebrospinal fluids. The proposed taxon-specific marker 
approach can possibly also be applied for in-vivo REIMS applications such as in endoscopic 
examinations to identify overgrowth of certain species in a bacterial community. 
Technologies are currently developed at Imperial College that aim to enable the detection of 
mucosal abnormalies using DESI-MS of functionalised clinical swabs. This method 
combined with the taxonomical-marker approach could be used to identify for instance 
respiratory, genital or urinary tract infections.  
An automated REIMS-based approach can be further used to screen for succesful gene 
insertion into genetically modified bacteria and yeasts in which case thousands of colonies 
would have to be screened for successful production of the desired compounds. An example 
would be identification of best producers for biodegradable polymers such as 
polyhydroxyalkanoates or best producers of rhamnolipid biosurfactants for biosynthetic 
applications. Such applications are becoming more and more important in a society that 
becomes increasingly environmentally conscious. 
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Future work 
Microorganisms 
The presented work is proof-of-principle data which triggered the development of a 
commercially available REIMS-based microbial identification and characterisation tool. 
Waters Corporation expressed intentions in developing instrumentation and funded 
appropriate instrumentation and personnel to develop an extensive validated spectral database 
covering the most common human pathogens and commensals. This database will comprise 
>50,000 entries, each complemented by gene sequencing results, and relevant phenotypic test 
results such as antibiotic resistance, ribotypes or serotypes. Once comprehensive datasets will 
have been acquired, the database can be queried in order to test sensitivity and specificity for 
different applications. This will help establishing where this REIMS-based approach will fit 
into routine clinical microbiology.  
An enlarged and detailed database will be the central piece of future studies as well as a 
commercial identification system. With increasing database size, more comprehensible 
sensitivity testing can be performed which will allow for a direct comparison with MALDI-
TOF-MS and sequencing analyses. This will be accompanied by the development of an 
appropriate identification algorithm for accurate species identification. A comprehensive 
database is crucial for this development as the amount of species analysed in this study does 
not sufficiently reflect the complexity of thousands of different bacterial species. A detailed 
sampling protocol should be followed that includes initial identification of pure cultures of 
clinical isolates using MALDI-TOF-MS as part of clinical microbiology routine. Based on 
initial ID, samples will be sent for sequencing analysis to assign their species unambiguously. 
The same sample will be frozen in glycerol. Microorganisms will then be grown under 
several relevant culturing conditions and subjected to automated REIMS analysis. A large 
scale database will also facilitate the generation of robust taxon-specific markers by having a 
more populated phylogenetic tree structure. This will likely lead to some taxon-specific 
markers currently thought to be specific being lost, while other markers for currently 
underpopulated groups will be found.  
As these taxonomical markers are not REIMS-specific they will be suitable for detection 
using any mass spectrometric technique that is suitable for the detection of lipids as presented 
here for DESI-MSI datasets. More such applications will be developed and an especially 
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promising application is the detection of a subset of most relevant taxonomic markers in 
biofluids using UPLC-MS. One example is detecting the causative agent of bacterial 
septicaemia; it can be expected that both intracellular and extracellular bacterial metabolites 
can be detected using such a methodology in poisitive blood cultures by using a short 
gradient screening run in multiple reaction monitoring (MRM) mode searching only for a 
small number of taxonomic markers for the most common causative agents of sepsis. 
Although this would not be a shotgun approach but would require approximately 2-5minutes 
per sample, it is still considerably quicker than culturing-based techniques or identification 
using MALDI-TOF-MS due to the lengthy extraction process required by the latter. This will 
require the selection of appropriate taxonomic markers and the development of a short 
UPLC-based screening run for these markers. Limits of detection will then have to be 
determined for a dilution series of the respective bacteria in blood cultures and in blood 
samples to determine suitability of this approach and bacterial cell numbers that can be 
detected. 
As presented experiments showed that for the development of a commercial platform it 
would be beneficial for identification accuracy to include several different culturing 
conditions such as culturing atmospheres, different culturing media and solid as well as liquid 
cultures into the database. Especially the latter is expected to greatly enhance identification 
accuracy for bacteria grown in liquid cultures and directly from clinical specimens. The 
present sampling setup is not ideally suited for automated analysis of liquid cultures as it 
requires centrifugation of the liquid cultures to provide a solid cell pellet which can be 
subjected to REIMS analysis. Thus, a dedicated tool for analysis of such cultures will be 
developed which will feature separate aspiration ports for the analyte containing aerosol 
produced during REIMS analysis and the liquid culturing medium (and solution for 
subsequent liquid discharge). Alternatively, this could be achieved using a three-way valve. 
Such setup will also be suitable for automation which is an important feature for large scale 
database collection of several tens of thousands strains per year. 
Cell lines 
The present proof-of-principle study demonstrated the applicability of a REIMS-based shot-
gun lipidomic characterisation approach for human cancerous cell lines. Individual cancer 
cell lines were found to exhibit reproducible and cell line-specific spectral profiles while 
spectra could be acquired in less than 5s. This does not only allow rapid identification of cell 
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lines based on their spectral fingerprint, but also detailed characterisation of membrane lipid 
composition in order to study the changes in the cell membrane composition in different 
cancer phenotypes. The lipid analyses of the NCI60 cell line panel obtained using REIMS 
will be published as part of the CellMiner database where it will be available alongside drug 
sensitivity patterns, DNA mutation analysis results and gene and protein expression data.  
By continued analysis of the correlation between REIMS spectral data and gene and protein 
expression data, the sensitivity of the REIMS spectral method for tumour phenotypic 
characterisation can be assessed in detail. In addition, this technique offers a unique 
possibility to investigate gene knock-out models for changes in lipid metabolism or the 
effects of feeding experiments with stable isotope-labelled nutrient sources. Better 
bioinformatic tools will be developed that link gene and protein expression profiles to the 
respective m/z signals in order to identify both positive and negative correlation behaviour for 
the NCI60 panel as well as for future studies involving cell lines. This will lead to robust 
links being found between lipid profiles as determined by REIMS and gene/protein 
expression which will shed light on the sensitivity and specificity that it observed using intra-
operative REIMS. Such information will help to gain approval by regulatory bodies and 
increase confidence into lipid-profiling based diagnostic methods. Due to speed of acquisition 
and observed specificity, REIMS will has the potential to be a vital tool to better understand 
the relationship of lipid profiles between cell lines and solid tumours.  
Further cell line systems will be explored such as epithelial-mesenchymal transitions in 
different cancer cell lines (in collaboration with Dr Emre Sayan, University of Southhampton, 
UK), different stages of breast cancer (George Poulagiannis, ICR) and the effect of different 
cell cycle stages on the lipid composition (currently studied using mouse embryonic stem 
cells, in collaboration with Prof Amanda Fisher, Imperial College London, UK). All these 
studies will benefit from being able to correlate REIMS spectral profiles to gene and protein 
expression data to understand the biochemical basis of observed differences in lipid profiles.  
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Appendix 
 
Appendix 1. Determination of biomass needed for REIMS measurements for S. warneri, P. aeruginosa 
and H. influenzae. Measurement pre- and post-biomass uptake each performed in triplicate. 
tube empty [g] tube full [g] biomass 
Rep1 Rep2 Rep3 mean Rep1 Rep2 Rep3 mean [mg] 
Staphylococcus warneri 
1.1890 1.1887 1.1891 1.1889 1.1894 1.1895 1.1894 1.1894 0.5000 
1.1870 1.1872 1.1873 1.1872 1.1881 1.1880 1.1880 1.1880 0.8667 
1.1944 1.1945 1.1950 1.1946 1.1947 1.1949 1.1949 1.1948 0.2000 
1.1975 1.1975 1.1978 1.1976 1.1982 1.1984 1.1983 1.1983 0.7000 
1.1863 1.1865 1.1863 1.1864 1.1869 1.1870 1.1870 1.1870 0.6000 
Pseudomonas aeruginosa 
1.1936 1.1936 1.1938 1.1937 1.1947 1.1948 1.1946 1.1947 1.0333 
1.2038 1.2037 1.2038 1.2038 1.2044 1.2044 1.2042 1.2043 0.5667 
1.2005 1.2005 1.2000 1.2003 1.2011 1.2015 1.2012 1.2013 0.9333 
1.1924 1.1914 1.1925 1.1921 1.1927 1.1928 1.1930 1.1928 0.7333 
1.2114 1.2115 1.2117 1.2115 1.2120 1.2123 1.2123 1.2122 0.6667 
Haemophilus influenzae 
1.1826 1.1827 1.1824 1.1826 1.1830 1.1829 1.1828 1.1829 0.3333 
1.1978 1.1976 1.1975 1.1976 1.1981 1.1979 1.1982 1.1981 0.4333 
1.1987 1.1988 1.1987 1.1987 1.1994 1.1993 1.1992 1.1993 0.5667 
1.1947 1.1948 1.1947 1.1947 1.1952 1.1950 1.1949 1.1950 0.3000 
1.1946 1.1947 1.1947 1.1947 1.1948 1.1949 1.1950 1.1949 0.2333 
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Appendix 2. List of bacterial species and number of respective spectral entries in REIMS spectral 
database as determined on 14.01.2015. 
Species Database entries 
Abiotrophia defectiva 1 
Acetomicrobium faecale 1 
Achromobacter spp 6 
Achromobacter xylosoxidans 6 
Acidaminococcus fermentans 2 
Acidovorax temperans 2 
Acinetobacter baumannii 22 
Acinetobacter iwoffii 15 
Acinetobacter johnsonii 2 
Acinteobacter junii 1 
Acinetobacter pittii 1 
Actinobaculum schaalii 2 
Actinomyces gravenitzii 1 
Actinomyces israelii 1 
Actinomyces odontolyticus 5 
Actinomyces oris 5 
Actinomyces turicensis 1 
Actinomyces sp 1 
Actinomyces viscosus 2 
Aerococcus sp 1 
Aerococcus viridans 2 
Aeromonas hydrophila 1 
Aggregatibacter aphrophilus 7 
Alcaligenes faecalis 3 
Alistipes onderdonkii 1 
Arthrobacter creatinolyticus 1 
Arthrobacter sp 1 
Bacillus cereus 21 
Bacillus clausii 8 
Bacillus licheniformis 8 
Bacillus pumilus 1 
Bacillus sonorensis 1 
Bacillus subtilis 7 
Bacillus spp 5 
Bacteroides acidifaciens 2 
Bacteroides caccae 2 
Bacteroides eggerthii 2 
Bacteroides fragilis 39 
Bacteroides helcogenes 1 
Bacteroides ovatus 15 
Bacteroides pyogenes 1 
Bacteroides thetaiotaomicron 10 
Bacteroides uniformis  7 
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Species Database entries 
Bacteroides vulgatus 26 
Bifidobacterium adolescentis 1 
Bifidobacterium animalis 1 
Bifidobacterium bifidum 2 
Bifidobacterium breve 4 
Bifidobacterium infantis 1 
Bifidobacterium longum 11 
Bifidobacterium pseudocatenulatum 2 
Brevibacterium sp 3 
Brevibacterium paucivorans 1 
Brevundimonas diminuta 2 
Burkholderia cepacia complex 16 
Campylobacter coli 2 
Campylobacter fetus 3 
Campylobacter jejuni 6 
Campylobacter sp 15 
Cardiobacterium hominis 4 
Chryseobacterium sp 1 
Chryseobacterium indologenes 3 
Citrobacter amalonaticus 1 
Citrobacter braakii 3 
Citrobacter freundii 16 
Citrobacter koseri 31 
Clostridium difficile 702 
Clostridium celerecrescens 1 
Clostridium hystolyticum 2 
Clostridium innocuum 5 
Clostridium paraputrificum 2 
Clostridium perfringens 11 
Clostridium ramosum 3 
Clostridium septicum 2 
Clostridium sordellii 1 
Clostridium sporogenes 2 
Clostridium tertium 3 
Comamonas kerstersii 2 
Comamonas sp 1 
Corynebacterium afermentans 2 
Corynebacterium amycolatum 4 
Corynebacterium diphtheriae 2 
Corynebacterium imitans 3 
Corynebacterium minutissimum 1 
Corynebacterium striatum 5 
Corynebacterium spp 11 
Delftia acidovorans 4 
Delftia dentocariosa 1 
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Species Database entries 
Delftia sp 2 
Dermabacter sp 3 
Dialister sp 1 
Eggerthella hongkongensis 1 
Eggerthella lenta 1 
Eikenella corrodens 1 
Elizabethkingia meningoseptica 4 
Enterobacter absuriae 2 
Enterobacter aerogenes 34 
Enterobacter amnigenus 1 
Enterobacter cloacae 76 
Enterobacter gergoviae 1 
Enterococcus avium 3 
Enterococcus casseliflavus 2 
Enterococcus cecorum 1 
Enterococcus faecalis 34 
Enterococcus faecium 31 
Enterococcus gallinarum 5 
Enterococcus gallolyticus 1 
Enterococcus raffinosus 3 
Escherichia coli 142 
Gardnerella vaginalis 3 
Fusobacterium gonidiaformans 3 
Fusobacterium necrophorum 2 
Fusobacterium nucleatum 20 
Fusobacterium peridontiam 4 
Fusobacterium sp 1 
Granulicatella adiacens 1 
Haemophilus influenzae 34 
Haemophilus parahaemolyticus 2 
Haemophilus parainfluenzae 1 
Hafnia alvei 3 
Hafnia paralvei 2 
Hafnia sp 1 
Helicobacter pylori 3 
Kingella kingae 2 
Kingella sp 1 
Klebsiella oxytoca 35 
Klebsiella pneumoniae 119 
Kokuria kristina 2 
Kokuria rhizophila 2 
Kokuria varians 1 
Lactobacillus rhamnosus 3 
Lactococcus gasseri 2 
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Species Database entries 
Lactococcus lactis 1 
Lactococcus sp 2 
Leuconostoc sp 1 
Listeria monocytogenes 14 
Microbacterium sp 1 
Micrococcus luteus 33 
Micrococcus lylae 1 
Moraxella catarrhalis 18 
Moraxella osloensis 3 
Morganella morganii 30 
Mycobacterium avium 2 
Mycobacterium fortuitum 1 
Mycobacterium peregrium 1 
Myroides odoratimimus 2 
Neisseria cineria 1 
Neissera gonorrhoeae 20 
Neisseria elongata 2 
Neisseria flavescens 5 
Neisseria lactamica 3 
Neisseria meningitidis 7 
Neisseria mucosa 2 
Nocardia asteroides 1 
Nocardia sp 1 
Paenibacillus sp 5 
Paenibacillus unalis 1 
Pandoraea spp 1 
Panthoea sp. 1 
Parabacteroides distonasis 7 
Parabacteroides johnsonii 2 
Parvimonas micra 1 
Pasteurella multocida 1 
Peptoniphilus harei 5 
Propionibacterium acnes 14 
Prevotella bivia 9 
Proteus mirabilis 34 
Proteus vulgaris 8 
Provedencia rettgeri 2 
Provedencia stuartii 2 
Pseudomonas aeruginosa 268 
Pseudomonas luteola 1 
Pseudomonas monteilii 2 
Pseudomonas oryzihabitans 2 
Pseudomonas putida 1 
Pseudomonas stutzeri 11 
Raoultella ornithololytica 1 
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Species Database entries 
Raoultella planticola 1 
Rhizobium radiobacter 5 
Rhodococcus equi 1 
Rhodococcus sp 2 
Rosemonas mucosa 6 
Roseomonas sp 1 
Rothia aeria 3 
Rothia amarne 1 
Rothia dentocariosa 6 
Rothia mucilaginosa 12 
Rothia sp 1 
Salmonella poona 1 
Serratia liquifaciens 3 
Serratia marcescens 41 
Shigella sonnei 1 
Staphylococcus aureus 80 
Staphylococcus capitis 30 
Staphylococcus caprae 1 
Staphylococcus cohnii 4 
Staphylococcus epidermis 34 
Staphylococcus haemolyticus 21 
Staphylococcus hominis 30 
Staphylococcus lugdunensis 10 
Staphylococcus pasteuri 3 
Staphylococcus pettenkoferi 3 
Staphylococcus saprophyticus 10 
Staphylococcus simulans 5 
Staphylococcus warneri 21 
Stenotrophomonas maltophilia 30 
Streptococcus agalactiae 94 
Streptococcus anginosus 14 
Streptococcus bovis 3 
Streptococcus canis 1 
Streptococcus constellatus 2 
Streptococcus cristitus 2 
Streptococcus dysagalactiae 17 
Streptococcus gallolyticus 10 
Streptococcus gordonii 6 
Streptococcus group C or G 7 
Streptococcus intermedius 5 
Streptococcus lutetiensis 6 
Streptococcus milleri group 19 
Streptococcus mitis 5 
Streptococcus mutans 7 
Streptococcus oralis 24 
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Species Database entries 
Streptococcus parasanguinus 11 
Streptococcus pneumoniae 88 
Streptococcus povas 1 
Streptococcus pseudoporcinus 2 
Streptococcus pyogenes 32 
Streptococcus salivarius 23 
Streptococcus sanguinus 14 
Streptococcus vestibularis 1 
Streptococcus viridans 6 
Sutterella wadsworthensis 2 
Veillonella atypica 1 
Veillonella dispar 1 
Veillonella parvula 1 
Veillonella ratti 1 
Vibrio alginolyticus 1 
Vibrio cholerae 1 
Vibrio furnissii 1 
Vibrio parahaemolyticus 1 
Virgibacillus proomii 3 
Yersinia enterocolitica 1 
TOTAL 3054 
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Appendix 3. List of fungal species and number of respective spectral entries in REIMS spectral database 
as determined on 14.01.2015. 
Species Number of database entries 
Candida albicans 56 
Candida dubliensis 2 
Candida famata 4 
Candida glabrata 32 
Candida guillermondii 7 
Candida inconspicua 4 
Candida kefyr 4 
Candida kruzei 14 
Candida lambica 2 
Candida lipolytica 3 
Candida lusitaniae 15 
Candida maris 1 
Candida nivariensis 1 
Candida parapsilosis 44 
Candida pelliculosa 1 
Candida rugosa 1 
Candida sake 1 
Candida sphaerica 1 
Candida tropicalis 17 
Candida utilis 6 
Cryptococcus albidus 1 
Cryptococcus gattii 1 
Cryptococcus humicolus 1 
Cryptococcus laurentii 1 
Cryptococcus neoformans 11 
Cryptococcus saito 1 
Cryptococcus terreus 1 
Geotrichum candidum 2 
Hensenula apis 1 
Hensenula polymorpha 1 
Kloeckera apis 1 
Kloeckera japonica 1 
Lodderomyces elongisporus 2 
Pichia kluyveri 1 
Pichia manshurica 1 
Rhodutorula mucilaginosa 3 
Rhodutorula rubra 1 
Saccharomyces cerevisiae 2 
Trichosporon asahii 1 
Trichosporon beigelii 1 
Trichosporon cutaneum 1 
Trichosporon mucoides 2 
TOTAL 254 
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Appendix 4. Sample set compiled for deriving of bacterial taxonomic markers. 
Gram-stain Phylum Class Order Family Genus Species No. 
Gram-
negatives 
Bacteroidetes 
Bacteroidetes Bacteroidales 
Bacteroidaceae Bacteroides 
Bacteroides acidifaciens 
Bacteroides caccae 
Bacteroides eggerthii 
Bacteroides fragilis 
Bacteroides helcogenes 
Bacteroides ovatus 
Bacteroides pyogenes 
Bacteroides thetaiotaomicron 
Bacteroides uniformis 
Bacteroides vulgatus 
2 
2 
2 
5 
1 
3 
1 
3 
3 
3 
Porphyromonadaceae Parabacteroides 
Parabacteroides distasonis 
Parabacteroides johnsonii 
5 
2 
Prevotellaceae Prevotella Prevotella bivia 7 
Rikenellaceae Alistipes Alistipes onderdonkii 1 
Flavobacteria Flavobacteriales Flavobacteriaceae 
Chryseobacterium 
Chryseobacterium indologenes 
Chryseobacterium sp 
3 
1 
Elizabethkingia Elizabethkingia meningoseptica 4 
Myroides Myroides odoratimimus 2 
Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium 
Fusobacterium gonidiaformans 
Fusobacterium necrophorum 
Fusobacterium peridontiam 
Fusobacterium sp 
3 
7 
4 
1 
Proteobacteria 
Alpha-
Proteobacteria 
Caulobacterales Caulobacteraceae Brevundimonas Brevundimonas diminuta 2 
Rhizobiales Rhizobiaceae Rhizobium Rhizobium radiobacter 5 
Rhodospirillales Acetobacteraceae Roseomonas 
Roseomonas mucosa 
Roseomonas sp 
6 
1 
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Gram-stain Phylum Class Order Family Genus Species No. 
Beta-
Proteobacteria 
Burkholderiales 
Alcaligenaceae 
Achromobacter 
Achromobacter sp 
Achromobacter xylosoxidans 
3 
3 
Alcaligenes Alcaligenes faecalis 3 
Burkholderiaceae Burkholderia Burkholderia cepacia complex 7 
Comamonadaceae 
Acidovorax Acidovorax temperans 2 
Comamonas 
Comamonas kerstersii 
Comamonas sp 
2 
1 
Delftia 
Delftia acidovorans 
Delftia dentocariosa 
Delftia sp 
4 
1 
2 
Sutterellaceae Sutterella Sutterella wadsworthensis 2 
Neisseriales Neisseriaceae 
Eikenella Eikenella corrodens 1 
Kingella 
Kingella kingae 
Kingella sp 
3 
1 
Neisseria 
Neisseria cineria 
Neisseria elongata 
Neisseria flavescens 
Neisseria gonorrhoea 
Neisseria lactamica 
Neisseria meningitidis 
Neisseria mucosa 
1 
2 
3 
4 
3 
4 
2 
Epsilon-
Proteobacteria 
Campylobacterales 
Campylobacteraceae Campylobacter 
Campylobacter coli 
Campylobacter fetus 
Campylobacter jejuni 
Campylobacter sp 
1 
3 
3 
6 
Helicobacteraceae Helicobacter Helicobacter pylori 3 
Gamma-
Proteobacteria 
Aeromonadales Aeromonadaceae Aeromonas Aeromonas hydrophila 1 
Cardiobacteriales Cardiobacteriaceae Cardiobacterium Cardiobacterium hominis 4 
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Gram-stain Phylum Class Order Family Genus Species No. 
Enterobacteriales Enterobacteriaceae 
Citrobacter 
Citrobacter amalonaticus 
Citrobacter braakii 
Citrobacter freundii 
Citrobacter koseri 
1 
3 
4 
4 
Enterobacter 
Enterobacter absuriae 2 
Enterobacter aerogenes 
Enterobacter amnigenus 
Enterobacter cloacae 
Enterobacter gergoviae 
3 
1 
3 
1 
Escherichia Escherichia coli 7 
Hafnia 
Hafnia alvei 
Hafnia paralvei 
Hafnia sp 
3 
2 
1 
Klebsiella 
Klebsiella oxytoca 
Klebsiella pneumoniae 
5 
5 
Morganella Morganella morganii 7 
Panthoea Panthoea sp 1 
Proteus 
Proteus mirabilis 
Proteus vulgaris 
5 
5 
Provedencia 
Provedencia rettgeri 
Provedencia stuartii 
2 
2 
Raoultella 
Raoultella ornithololytica 
Raoultella planticola 
1 
1 
Salmonella Salmonella poona 1 
Serratia 
Serratia liquifaciens 
Serratia marcescens 
3 
5 
Shigella Shigella sonnei 1 
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Gram-stain Phylum Class Order Family Genus Species No. 
Pasteurellales Pasteurellaceae 
Aggregatibacter Aggregatibacter aphrophilus 5 
Haemophilus 
Haemophilus influenzae 
Haemophilus parahaemolyticus 
Haemophilus parainfluenzae 
5 
2 
1 
Pasteurella Pasteurella multocida 2 
Pseudomonadales 
Moraxellaceae 
Acinetobacter 
Acinetobacter baumanii 
Acinetobacter iwoffii 
Acinetobacter johnsonii 
Acinetobacter junii 
5 
5 
2 
1 
Moraxella 
Moraxella catarrhalis 
Moraxella osloensis 
5 
2 
Pseudomonadaceae Pseudomonas 
Pseudomonas aearuginosa 
Pseudomonas luteola 
Pseudomonas monteilii 
Pseudomonas oryzihabitans 
Pseudomonas putida 
Pseudomonas stutzeri 
7 
1 
2 
2 
1 
5 
Vibrionales Vibrionaceae Vibrio 
Vibrio alginolyticus 
Vibrio cholerae 
Vibrio furnissii 
1 
1 
1 
Xanthomonadales Xanthomonadaceae Stenotrophomonas Stenotrophomonas maltophilia 7 
Gram-
positives 
Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae Actinobaculum Actinobaculum schaalii 2 
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Gram-stain Phylum Class Order Family Genus Species No. 
Actinomyces 
Actinomyces graevenitzii 
Actinomyces israelii 
Actinomyces odontolyticus 
Actinomyces oris 
Actinomyces sp 
Actinomyces turicensis 
Actinomyces viscosis 
1 
1 
2 
5 
1 
1 
2 
Corynebacteriaceae Corynebacterium 
Corynebacterium afermentans 
Corynebacterium amycolatum 
Corynebacterium diphtheriae 
Corynebacterium imitans 
Corynebacterium minutissimum 
Corynebacterium sp 
Corynebacterium striatum 
2 
3 
2 
3 
1 
5 
3 
Microbacteriaceae Microbacterium Microbacterium sp 1 
Mycobacteriaceae Mycobacterium 
Mycobacterium avium 
Mycobacterium fortuitum 
Mycobacterium peregrium 
2 
1 
1 
Nocardiaceae 
Nocardia Nocardia sp 1 
Rhodococcus 
Rhodococcus equi 
Rhodococcus sp 
1 
2 
Propionibacteriaceae Propionibacterium Propionibacterium acnes 7 
Bifidobacteriales Bifidobacteriaceae 
Bifidobacterium 
Bifidobacterium adolescentis 
Bifidobacterium bifidum 
Bifidobacterium breve 
Bifidobacterium infantis 
Bifidobacterium longum 
Bifidobacterium pseudocatenulatum 
1 
2 
3 
1 
3 
2 
Gardnerella Gardnerella vaginalis 2 
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Gram-stain Phylum Class Order Family Genus Species No. 
Micrococcales 
Micrococcaceae 
Arthrobacter 
Arthrobacter creatinolyticus 
Arthrobacter sp 
1 
1 
Kokuria 
Kokuria kristina 
Kokuria rhizophila 
Kokuria varians 
2 
2 
1 
Micrococcus 
Micrococcus luteus 
Micrococcus lylae 
5 
2 
Rothia 
Rothia aeria 
Rothia amarne 
Rothia dentocariosa 
Rothia mucilaginosa 
Rothia sp 
3 
1 
5 
5 
1 
Micrococcineae 
Brevibacterium 
Brevibacterium paucivorans 
Brevibacterium sp 
1 
3 
Dermabacter 
Dermabacter hominis 
Dermobacter sp 
2 
1 
Firmicutes Bacilli Bacillales 
Bacillaceae Bacillus 
Bacillus cereus 
Bacillus clausii 
Bacillus lichenformis 
Bacillus pumilus 
Bacillus sonorensis 
Bacillus sp 
Bacillus subtilis 
3 
3 
3 
1 
1 
3 
3 
Listeriaceae Listeria Listeria monocytogenes 7 
Paenibacillaceae Paenibacillus 
Paenibacillus sp 
Paenibacillus unalis 
5 
1 
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Gram-stain Phylum Class Order Family Genus Species No. 
Staphylococcaceae Staphylococcus 
Staphylococcus aureus 
Staphylococcus capitis 
Staphylococcus caprae 
Staphylococcus cohnii 
Staphylococcus epidermis 
Staphylococcus haemolyticus 
Staphylococcus hominis 
Staphylococcus lugdunensis 
Staphylococcus pasteuri 
Staphylococcus pettenkoferi 
Staphylococcus saprophyticus 
Staphylococcus warneri 
3 
3 
1 
4 
3 
3 
3 
3 
3 
3 
3 
3 
Lactobacillales 
Aerococcaceae 
Abiotrophia Abiotrophia defectiva 1 
Aerococcus 
Aerococcus sp 
Aerococcus viridans 
1 
2 
Carnobacteriaceae Granulicatella Granulicatella adiacens 1 
Enterococcaceae Enterococcus 
Enterococcus avium 
Enterococcus casseliflavus 
Enterococcus cecorum 
Enterococcus faecalis 
Enterococcus faecium 
Enterococcus gallinarum 
Enterococcus raffinosus 
3 
2 
1 
3 
3 
3 
3 
Lactobacillaceae Lactococcus 
Lactococcus lactis 
Lactococcus spp 
1 
2 
Leuconostocaceae Leuconostoc Leuconostoc sp 1 
Streptococcaceae Lactobacillus 
Lactobacillus gasseri 
Lactobacillus rhamnosus 
2 
3 
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Gram-stain Phylum Class Order Family Genus Species No. 
Streptococcus 
Streptococcus agalactiae 
Streptococcus anginosus 
Streptococcus bovis 
Streptococcus canis 
Streptococcus constellatus 
Streptococcus cristatus 
Streptococcus dysagalactiae 
Streptococcus gallolyticus 
Streptococcus gordonii 
Streptococcus intermedius 
Streptococcus lutetiensis 
Streptococcus milleri 
Streptococcus mitis 
Streptococcus mutans 
Streptococcus oralis 
Streptococcus parasanguinus 
Streptococcus pneumoniae 
Streptococcus povas 
Streptococcus pseudoporcinus 
Streptococcus pyogenes 
Streptococcus salivarius 
Streptococcus sanguinis 
Streptococcus vestibularis 
Streptococcus viridans 
3 
3 
3 
1 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
1 
2 
3 
3 
3 
1 
3 
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Gram-stain Phylum Class Order Family Genus Species No. 
Clostridia Clostridiales 
Clostridiaceae Clostridium 
Clostridium celerecrescens 
Clostridium difficile 
Clostridium histolyticum 
Clostridium innocuum 
Clostridium paraputrificum 
Clostridium perfringens 
Clostridium ramosum 
Clostridium septicum 
Clostridium sporogenes 
Clostridium tertium 
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Appendix 5. Detailed list of taxon-specific markers detected in colorectal tissue specimens using DESI-MSI. 
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TSM = Taxon-specific markers; Level abbreviations: P = Phylum, C = Class, O = Order, F = Family, G = Genus, S = Species; CT = Center of tumour. 
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